<!DOCTYPE html>
<html lang="en" class="scroll-smooth">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Btr General Path-Pharma-Physio - 05-09-2025 - Brain And Scalpel</title>
    <link rel="preload" href="assets/background.jpg" as="image">
    <script src="https://cdn.tailwindcss.com"></script>
    <!-- HLS.js for M3U8 support -->
    <script src="https://cdn.jsdelivr.net/npm/hls.js@latest"></script>
    <style>
        
/* Liquid Glass Morphism Universal Theme - Enhanced & Mobile-First */
:root {
  --glass-bg: rgba(0, 0, 0, 0.6);
  --glass-bg-light: rgba(255, 255, 255, 0.1);
  --glass-bg-medium: rgba(255, 255, 255, 0.15);
  --glass-bg-heavy: rgba(255, 255, 255, 0.2);
  --glass-border: rgba(255, 255, 255, 0.2);
  --glass-border-light: rgba(255, 255, 255, 0.1);
  --text-primary: rgba(255, 255, 255, 0.95);
  --text-secondary: rgba(255, 255, 255, 0.7);
  --text-tertiary: rgba(255, 255, 255, 0.5);
  --accent-blue: #60a5fa;
  --accent-purple: #a855f7;
  --accent-green: #34d399;
  --accent-orange: #fb923c;
  --accent-red: #f87171;
  --accent-yellow: #fbbf24;
}

* {
  margin: 0;
  padding: 0;
  box-sizing: border-box;
}

html {
  scroll-behavior: smooth;
}

body {
  margin: 0;
  min-height: 100vh;
  font-family: system-ui, -apple-system, BlinkMacSystemFont, 'Segoe UI', sans-serif;
  position: relative;
  overflow-x: hidden;
  color: var(--text-primary);
  background-color: #000;
}

/* iOS Background Fix */
body::before {
  content: '';
  position: fixed;
  top: 0;
  left: 0;
  height: 100vh;
  width: 100vw;
  z-index: -2;
  background: url("assets/background.jpg") center center / cover no-repeat;
}

body::after {
  content: "";
  position: fixed;
  inset: 0;
  background: rgba(0, 0, 0, 0.4);
  backdrop-filter: blur(10px);
  -webkit-backdrop-filter: blur(10px);
  z-index: -1;
}

/* Glass morphism components */
.glass {
  background: var(--glass-bg);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid var(--glass-border);
  border-radius: 16px;
}

.glass-light {
  background: var(--glass-bg-light);
  backdrop-filter: blur(15px);
  -webkit-backdrop-filter: blur(15px);
  border: 1px solid var(--glass-border-light);
  border-radius: 12px;
}

.glass-medium {
  background: var(--glass-bg-medium);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid var(--glass-border);
  border-radius: 16px;
}

.glass-heavy {
  background: var(--glass-bg-heavy);
  backdrop-filter: blur(25px);
  -webkit-backdrop-filter: blur(25px);
  border: 1px solid var(--glass-border);
  border-radius: 20px;
}

.glass-card {
  background: rgba(255, 255, 255, 0.08);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid rgba(255, 255, 255, 0.15);
  border-radius: 20px;
  transition: all 0.3s cubic-bezier(0.4, 0, 0.2, 1);
  box-shadow: 0 8px 32px rgba(0, 0, 0, 0.3);
}

.glass-card:hover {
  transform: translateY(-8px);
  background: rgba(255, 255, 255, 0.12);
  border-color: rgba(255, 255, 255, 0.25);
  box-shadow: 0 20px 60px rgba(0, 0, 0, 0.4);
}

.glass-button {
  background: linear-gradient(135deg, rgba(96, 165, 250, 0.8), rgba(168, 85, 247, 0.8));
  backdrop-filter: blur(15px);
  -webkit-backdrop-filter: blur(15px);
  border: 1px solid rgba(255, 255, 255, 0.2);
  border-radius: 12px;
  color: white;
  font-weight: 600;
  transition: all 0.3s cubic-bezier(0.4, 0, 0.2, 1);
  box-shadow: 0 4px 20px rgba(96, 165, 250, 0.3);
  cursor: pointer;
  border: none;
}

.glass-button:hover {
  transform: translateY(-2px);
  box-shadow: 0 8px 30px rgba(96, 165, 250, 0.4);
  background: linear-gradient(135deg, rgba(96, 165, 250, 0.9), rgba(168, 85, 247, 0.9));
}

.glass-button:disabled {
  opacity: 0.5;
  cursor: not-allowed;
  transform: none;
}

.glass-input {
  background: rgba(255, 255, 255, 0.08);
  backdrop-filter: blur(15px);
  -webkit-backdrop-filter: blur(15px);
  border: 1px solid rgba(255, 255, 255, 0.2);
  border-radius: 12px;
  color: var(--text-primary);
  transition: all 0.3s ease;
}

.glass-input:focus {
  outline: none;
  border-color: var(--accent-blue);
  background: rgba(255, 255, 255, 0.12);
  box-shadow: 0 0 20px rgba(96, 165, 250, 0.3);
}

.glass-input::placeholder {
  color: var(--text-tertiary);
}

/* Performance analysis styles */
.performance-card {
  background: rgba(255, 255, 255, 0.08);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid rgba(255, 255, 255, 0.15);
  border-radius: 20px;
  box-shadow: 0 8px 32px rgba(0, 0, 0, 0.3);
}

.score-circle {
  position: relative;
  width: 150px;
  height: 150px;
  margin: 0 auto;
}

.score-circle svg {
  transform: rotate(-90deg);
}

.score-circle .circle-bg {
  fill: none;
  stroke: rgba(255, 255, 255, 0.1);
  stroke-width: 8;
}

.score-circle .circle-progress {
  fill: none;
  stroke-width: 8;
  stroke-linecap: round;
  transition: stroke-dasharray 2s cubic-bezier(0.4, 0, 0.2, 1);
}

.score-text {
  position: absolute;
  top: 50%;
  left: 50%;
  transform: translate(-50%, -50%);
  text-align: center;
}

/* Review question styles */
.review-question {
  background: rgba(255, 255, 255, 0.05);
  border: 1px solid rgba(255, 255, 255, 0.1);
  border-radius: 16px;
  padding: 20px;
  margin-bottom: 20px;
}

.review-question.correct {
  border-left: 4px solid #22c55e;
}

.review-question.incorrect {
  border-left: 4px solid #ef4444;
}

.review-question.not-attempted {
  border-left: 4px solid #6b7280;
}

/* Gradient backgrounds for accents */
.gradient-blue {
  background: linear-gradient(135deg, var(--accent-blue), #3b82f6);
}

.gradient-purple {
  background: linear-gradient(135deg, var(--accent-purple), #8b5cf6);
}

.gradient-green {
  background: linear-gradient(135deg, var(--accent-green), #10b981);
}

.gradient-orange {
  background: linear-gradient(135deg, var(--accent-orange), #f97316);
}

.gradient-red {
  background: linear-gradient(135deg, var(--accent-red), #ef4444);
}

.gradient-yellow {
  background: linear-gradient(135deg, var(--accent-yellow), #f59e0b);
}

/* Navigation button styles */
.nav-btn-not-attempted {
  background: rgba(255, 255, 255, 0.1);
  border: 1px solid rgba(255, 255, 255, 0.2);
  color: rgba(255, 255, 255, 0.7);
}

.nav-btn-current {
  background: linear-gradient(135deg, var(--accent-blue), #3b82f6);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
  box-shadow: 0 0 20px rgba(96, 165, 250, 0.4);
}

.nav-btn-correct {
  background: linear-gradient(135deg, var(--accent-green), #10b981);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-incorrect {
  background: linear-gradient(135deg, var(--accent-red), #ef4444);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-bookmarked {
  background: linear-gradient(135deg, var(--accent-yellow), #f59e0b);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-marked-review {
  background: linear-gradient(135deg, var(--accent-purple), #8b5cf6);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-answered {
  background: linear-gradient(135deg, #6b7280, #4b5563);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

/* Option button styles - REVISED FOR INLINE FEEDBACK */
.option-button {
  background: rgba(255, 255, 255, 0.05);
  border: 1px solid rgba(255, 255, 255, 0.15);
  transition: all 0.3s cubic-bezier(0.4, 0, 0.2, 1);
  position: relative;
  overflow: hidden;
  width: 100%;
  text-align: left;
  padding: 1rem;
  border-radius: 12px;
  color: var(--text-primary);
  cursor: pointer;
  display: flex;
  align-items: center;
  gap: 1rem;
  font-size: 1rem;
}

.option-button:hover {
  background: rgba(255, 255, 255, 0.1);
  border-color: rgba(96, 165, 250, 0.5);
  transform: translateX(8px);
}

.option-button.selected {
  background: linear-gradient(135deg, rgba(96, 165, 250, 0.3), rgba(59, 130, 246, 0.3));
  border-color: var(--accent-blue);
  transform: translateX(8px);
}

#optionsContainer.answered .option-button:hover {
    transform: translateX(0); /* Disable hover effect after answering */
}

#optionsContainer.answered .option-button {
    cursor: not-allowed;
    pointer-events: none;
}

#optionsContainer.answered .option-button:not(.correct):not(.incorrect) {
    opacity: 0.5;
}

.option-button.correct {
    background: linear-gradient(135deg, #22c55e, #16a34a);
    border-color: #22c55e;
    color: white;
    transform: translateX(0);
}

.option-button.incorrect {
    background: linear-gradient(135deg, #ef4444, #dc2626);
    border-color: #ef4444;
    color: white;
    transform: translateX(0);
}

.option-letter {
  background: rgba(255, 255, 255, 0.1);
  border: 1px solid rgba(255, 255, 255, 0.2);
  transition: all 0.3s ease;
  width: 2.5rem;
  height: 2.5rem;
  border-radius: 50%;
  display: flex;
  align-items: center;
  justify-content: center;
  font-weight: bold;
  color: var(--text-primary);
  flex-shrink: 0;
}

.option-button.selected .option-letter {
  background: var(--accent-blue);
  border-color: var(--accent-blue);
  color: white;
}

.option-button.correct .option-letter, .option-button.incorrect .option-letter {
    background: rgba(255, 255, 255, 0.2);
    border-color: rgba(255, 255, 255, 0.3);
}

.option-text {
  flex: 1;
  font-size: 1rem;
  line-height: 1.5;
}

/* Stats bar responsive grid */
.stats-grid {
  display: grid;
  grid-template-columns: repeat(5, 1fr);
  gap: 1rem;
  align-items: center;
  justify-items: center;
}

@media (max-width: 768px) {
  .stats-grid {
    grid-template-columns: repeat(3, 1fr);
    gap: 0.5rem;
  }
 
  .stats-grid > div:nth-child(4),
  .stats-grid > div:nth-child(5) {
    grid-column: span 1;
  }
}

@media (max-width: 480px) {
  .stats-grid {
    grid-template-columns: repeat(2, 1fr);
  }
 
  .stats-grid > div:last-child {
    grid-column: span 2;
    justify-self: center;
  }
}

/* Animations */
@keyframes float {
  0%, 100% { transform: translateY(0px); }
  50% { transform: translateY(-20px); }
}

@keyframes pulse-glow {
  0%, 100% { box-shadow: 0 0 20px rgba(96, 165, 250, 0.3); }
  50% { box-shadow: 0 0 40px rgba(96, 165, 250, 0.6); }
}

@keyframes checkmark {
  0% { transform: scale(0) rotate(0deg); }
  50% { transform: scale(0.8) rotate(180deg); }
  100% { transform: scale(1) rotate(360deg); }
}

@keyframes cross {
  0% { transform: scale(0) rotate(0deg); }
  50% { transform: scale(0.8) rotate(90deg); }
  100% { transform: scale(1) rotate(180deg); }
}

.animate-float {
  animation: float 6s ease-in-out infinite;
}

.animate-pulse-glow {
  animation: pulse-glow 2s ease-in-out infinite;
}

.animate-checkmark {
  animation: checkmark 0.6s cubic-bezier(0.4, 0, 0.2, 1);
}

.animate-cross {
  animation: cross 0.6s cubic-bezier(0.4, 0, 0.2, 1);
}

/* Custom scrollbar */
::-webkit-scrollbar {
  width: 8px;
}

::-webkit-scrollbar-track {
  background: rgba(255, 255, 255, 0.05);
  border-radius: 4px;
}

::-webkit-scrollbar-thumb {
  background: rgba(255, 255, 255, 0.2);
  border-radius: 4px;
}

::-webkit-scrollbar-thumb:hover {
  background: rgba(255, 255, 255, 0.3);
}

/* --- MOBILE RESPONSIVE STYLES --- */
.quiz-container {
    display: flex;
    flex-direction: column;
    gap: 1.5rem;
}

#mobile-nav-toggle {
    display: none; /* Hidden on desktop */
}

@media (min-width: 1024px) {
    .quiz-container {
        flex-direction: row;
        gap: 2rem;
    }
}

@media (max-width: 1023px) {
    .quiz-sidebar {
        position: fixed;
        top: 0;
        left: 0;
        width: 300px;
        height: 100%;
        z-index: 100;
        transform: translateX(-100%);
        transition: transform 0.3s ease-in-out;
        box-shadow: 10px 0px 30px rgba(0,0,0,0.5);
    }
    .quiz-sidebar.open {
        transform: translateX(0);
    }
    #mobile-nav-toggle {
        display: flex;
        position: fixed;
        bottom: 20px;
        left: 20px;
        z-index: 50;
    }
    .quiz-main-content {
        width: 100%;
    }
}

@media (max-width: 768px) {
    .glass-card, .glass {
        border-radius: 16px;
    }
    h1 { font-size: 2.5rem; }
    #questionText { font-size: 1.125rem; }
    .controls-container {
        flex-direction: column;
        gap: 1rem;
    }
    .controls-container button {
        width: 100%;
    }
}

    </style>
</head>
<body>
    <!-- Mode Selection Modal -->
    <div id="modeModal" class="fixed inset-0 bg-black bg-opacity-70 flex items-center justify-center z-50 backdrop-blur-sm">
        <div class="glass-heavy p-8 max-w-md w-full mx-4 shadow-2xl">
            <h2 class="text-2xl font-bold text-white mb-6 text-center">Choose Study Mode</h2>
            
            <div class="space-y-4">
                <button onclick="selectMode('study')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Study Mode</h3>
                            <p class="text-sm text-white text-opacity-70">Interactive learning with immediate feedback</p>
                        </div>
                        <div class="gradient-blue w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path d="M9 12l2 2 4-4m6 2a9 9 0 11-18 0 9 9 0 0118 0z"></path>
                            </svg>
                        </div>
                    </div>
                </button>
                
                <button onclick="selectMode('test')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Test Mode</h3>
                            <p class="text-sm text-white text-opacity-70">Practice test with performance analysis at end</p>
                        </div>
                        <div class="gradient-purple w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path d="M9 2a1 1 0 000 2h2a1 1 0 100-2H9z"></path>
                                <path fill-rule="evenodd" d="M4 5a2 2 0 012-2v1a1 1 0 001 1h6a1 1 0 001-1V3a2 2 0 012 2v6a2 2 0 01-2 2H6a2 2 0 01-2-2V5zm3 4a1 1 0 000 2h.01a1 1 0 100-2H7zm3 0a1 1 0 000 2h3a1 1 0 100-2h-3z" clip-rule="evenodd"></path>
                            </svg>
                        </div>
                    </div>
                </button>
                
                <button onclick="selectMode('timed_study')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Timed Study</h3>
                            <p class="text-sm text-white text-opacity-70">Study with time pressure and immediate feedback</p>
                        </div>
                        <div class="gradient-green w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path fill-rule="evenodd" d="M10 18a8 8 0 100-16 8 8 0 000 16zm1-12a1 1 0 10-2 0v4a1 1 0 00.293.707l2.828 2.829a1 1 0 101.415-1.415L11 9.586V6z" clip-rule="evenodd"></path>
                            </svg>
                        </div>
                    </div>
                </button>
                
                <button onclick="selectMode('timed_exam')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Timed Exam</h3>
                            <p class="text-sm text-white text-opacity-70">Real exam simulation with strict timing</p>
                        </div>
                        <div class="gradient-red w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path fill-rule="evenodd" d="M12.395 2.553a1 1 0 00-1.45-.385c-.345.23-.614.558-.822.88-.214.33-.403.713-.57 1.116-.334.804-.614 1.768-.84 2.734a31.365 31.365 0 00-.613 3.58 2.64 2.64 0 01-.945-1.067c-.328-.68-.398-1.534-.398-2.654A1 1 0 005.05 6.05 6.981 6.981 0 003 11a7 7 0 1011.95-4.95c-.592-.591-.98-.985-1.348-1.467-.363-.476-.724-1.063-1.207-2.03z" clip-rule="evenodd"></path>
                            </svg>
                        </div>
                    </div>
                </button>
            </div>
        </div>
    </div>

    <!-- Performance Analysis Modal -->
    <div id="performanceModal" class="hidden fixed inset-0 bg-black bg-opacity-80 flex items-center justify-center z-50 backdrop-blur-sm">
        <div class="glass-heavy p-8 max-w-4xl w-full mx-4 shadow-2xl max-h-[90vh] overflow-y-auto">
            <div class="flex items-center justify-between mb-8">
                <h2 class="text-3xl font-bold text-white">Performance Analysis</h2>
                <button onclick="closePerformanceModal()" class="glass-light p-2 rounded-lg text-white hover:bg-white hover:bg-opacity-20">
                    <svg class="w-6 h-6" fill="currentColor" viewBox="0 0 20 20">
                        <path fill-rule="evenodd" d="M4.293 4.293a1 1 0 011.414 0L10 8.586l4.293-4.293a1 1 0 111.414 1.414L11.414 10l4.293 4.293a1 1 0 01-1.414 1.414L10 11.414l-4.293 4.293a1 1 0 01-1.414-1.414L8.586 10 4.293 5.707a1 1 0 010-1.414z" clip-rule="evenodd"></path>
                    </svg>
                </button>
            </div>
            
            <!-- Score Overview -->
            <div class="grid grid-cols-1 md:grid-cols-3 gap-6 mb-8">
                <div class="performance-card p-6 text-center">
                    <div class="score-circle mb-4">
                        <svg width="150" height="150" class="mx-auto">
                            <circle class="circle-bg" cx="75" cy="75" r="65"></circle>
                            <circle id="scoreCircle" class="circle-progress" cx="75" cy="75" r="65" stroke="#22c55e" stroke-dasharray="0 408"></circle>
                        </svg>
                        <div class="score-text">
                            <div class="text-3xl font-bold text-white" id="accuracyScore">0%</div>
                            <div class="text-sm text-white text-opacity-70">Accuracy</div>
                        </div>
                    </div>
                </div>
                
                <div class="performance-card p-6">
                    <h3 class="text-lg font-bold text-white mb-4 text-center">Results Summary</h3>
                    <div class="space-y-3">
                        <div class="flex justify-between items-center">
                            <span class="text-white text-opacity-70">Total Questions:</span>
                            <span class="text-white font-semibold" id="totalQuestionsResult">0</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-green-400">Correct:</span>
                            <span class="text-green-400 font-semibold" id="correctResult">0</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-red-400">Incorrect:</span>
                            <span class="text-red-400 font-semibold" id="incorrectResult">0</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-gray-400">Not Attempted:</span>
                            <span class="text-gray-400 font-semibold" id="notAttemptedResult">0</span>
                        </div>
                    </div>
                </div>
                
                <div class="performance-card p-6">
                    <h3 class="text-lg font-bold text-white mb-4 text-center">Time Analysis</h3>
                    <div class="space-y-3">
                        <div class="flex justify-between items-center">
                            <span class="text-white text-opacity-70">Total Time:</span>
                            <span class="text-white font-semibold" id="totalTimeResult">0:00</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-white text-opacity-70">Avg per Question:</span>
                            <span class="text-white font-semibold" id="avgTimeResult">0:00</span>
                        </div>
                    </div>
                </div>
            </div>
            
            <!-- Action Buttons -->
            <div class="flex justify-center space-x-4 mb-8">
                <button onclick="reviewQuestions()" class="glass-button px-8 py-3 text-lg">
                    Review All Questions
                </button>
                <button onclick="retakeQuiz()" class="glass-light px-8 py-3 text-lg text-white hover:bg-white hover:bg-opacity-20">
                    Retake Quiz
                </button>
            </div>
            
            <!-- Question Review Section -->
            <div id="questionReviewSection" class="hidden">
                <h3 class="text-2xl font-bold text-white mb-6">Question Review</h3>
                <div id="reviewQuestionsContainer">
                    <!-- Review questions will be populated here -->
                </div>
            </div>
        </div>
    </div>

    <!-- Header -->
    <header class="glass sticky top-0 z-40 mb-6">
        <div class="container mx-auto px-6 py-4">
            <div class="flex items-center justify-between">
                <div class="flex items-center space-x-4">
                    <button onclick="goBack()" class="glass-light px-4 py-2 text-white hover:bg-white hover:bg-opacity-20 transition-all duration-300 flex items-center">
                        <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                            <path fill-rule="evenodd" d="M9.707 16.707a1 1 0 01-1.414 0l-6-6a1 1 0 010-1.414l6-6a1 1 0 011.414 1.414L5.414 9H17a1 1 0 110 2H5.414l4.293 4.293a1 1 0 010 1.414z" clip-rule="evenodd"></path>
                        </svg>
                        Back
                    </button>
                    <div id="quizHierarchy" class="text-sm text-white text-opacity-60">
                        Cerebellum / Mock Test / BTR
                    </div>
                </div>
                
                <div class="flex items-center space-x-4">
                    <div class="glass-light px-3 py-1 text-sm text-white">
                        Question <span id="currentQuestion">1</span> of <span id="totalQuestions">100</span>
                    </div>
                    
                    <!-- Timer -->
                    <div id="timerContainer" class="hidden gradient-red px-3 py-1 text-sm text-white font-bold animate-pulse-glow">
                        <span id="timeDisplay">2:00</span>
                    </div>
                </div>
            </div>
        </div>
    </header>

    <!-- Progress Bar -->
    <div class="w-full h-1 bg-black bg-opacity-30 mb-6">
        <div id="progressBar" class="h-1 gradient-blue transition-all duration-500 ease-out" style="width: 0%"></div>
    </div>

    <!-- Stats Bar - Show only in study modes -->
    <div id="statsBar" class="glass-light mb-8">
        <div class="container mx-auto px-6 py-4">
            <div class="stats-grid">
                <div class="text-center">
                    <div class="text-lg font-bold text-green-400" id="correctCount">0</div>
                    <div class="text-xs text-white text-opacity-60">Correct</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-red-400" id="incorrectCount">0</div>
                    <div class="text-xs text-white text-opacity-60">Incorrect</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-blue-400" id="totalAttempted">0</div>
                    <div class="text-xs text-white text-opacity-60">Attempted</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-purple-400" id="accuracy">0%</div>
                    <div class="text-xs text-white text-opacity-60">Accuracy</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-orange-400" id="timeSpent">0:00</div>
                    <div class="text-xs text-white text-opacity-60">Time</div>
                </div>
            </div>
        </div>
    </div>

    <div class="quiz-container container mx-auto px-6">
        <!-- Question Navigation Sidebar -->
        <div id="quizSidebar" class="quiz-sidebar glass p-6 h-fit lg:sticky top-24">
            <h3 class="text-lg font-bold text-white mb-4">Question Navigator</h3>
            <div id="questionNav" class="grid grid-cols-5 gap-2 mb-6">
                <!-- Question numbers will be populated here -->
            </div>
            
            <div class="space-y-3 text-xs">
                <h4 class="text-sm font-medium text-white text-opacity-80 mb-3">Legend</h4>
                <div class="flex items-center">
                    <div class="w-6 h-6 nav-btn-not-attempted rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Not Attempted</span>
                </div>
                <div class="flex items-center">
                    <div class="w-6 h-6 nav-btn-current rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Current</span>
                </div>
                <div id="studyModeLegend" class="space-y-2">
                    <div class="flex items-center">
                        <div class="w-6 h-6 nav-btn-correct rounded mr-2"></div>
                        <span class="text-white text-opacity-60">Correct</span>
                    </div>
                    <div class="flex items-center">
                        <div class="w-6 h-6 nav-btn-incorrect rounded mr-2"></div>
                        <span class="text-white text-opacity-60">Incorrect</span>
                    </div>
                </div>
                <div id="testModeLegend" class="hidden space-y-2">
                    <div class="flex items-center">
                        <div class="w-6 h-6 nav-btn-answered rounded mr-2"></div>
                        <span class="text-white text-opacity-60">Answered</span>
                    </div>
                </div>
                <div class="flex items-center">
                    <div class="w-6 h-6 nav-btn-bookmarked rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Bookmarked</span>
                </div>
                <div id="testModeReviewLegend" class="hidden items-center">
                    <div class="w-6 h-6 nav-btn-marked-review rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Marked for Review</span>
                </div>
            </div>
            
            <!-- Submit Quiz Button for test modes -->
            <div id="submitSection" class="hidden mt-6">
                <button onclick="submitQuiz()" class="glass-button w-full py-3 text-lg font-bold">
                    Submit Quiz
                </button>
            </div>
        </div>

        <!-- Main Quiz Interface -->
        <div class="quiz-main-content flex-1 max-w-4xl">
            <div class="glass-card p-4 md:p-8 lg:p-12 mb-8 relative">
                <!-- Question Text -->
                <div id="questionText" class="text-xl lg:text-2xl leading-relaxed text-white mb-8">
                    Loading question...
                </div>

                <!-- Question Media -->
                <div id="questionMedia" class="mb-8"></div>

                <!-- Options -->
                <div id="optionsContainer" class="space-y-3 mb-8">
                    <!-- Options will be inserted here -->
                </div>

                <!-- Solution Display (only for study modes) -->
                <div id="solutionContainer" class="hidden glass-light p-6 border-l-4 border-green-400">
                    <h3 class="text-lg font-bold text-green-400 mb-3 flex items-center">
                        <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                            <path fill-rule="evenodd" d="M18 10a8 8 0 11-16 0 8 8 0 0116 0zm-7-4a1 1 0 11-2 0 1 1 0 012 0zM9 9a1 1 0 000 2v3a1 1 0 001 1h1a1 1 0 100-2v-3a1 1 0 00-1-1H9z" clip-rule="evenodd"></path>
                        </svg>
                        Explanation
                    </h3>
                    <div id="solutionText" class="text-white text-opacity-90 leading-relaxed mb-4"></div>
                    <div id="solutionAudio" class="space-y-2 mt-4"></div>
                    <div id="solutionImages" class="space-y-4 mt-4"></div>
                    <div id="solutionVideo" class="hidden mt-4">
                        <video id="explanationVideoPlayer" class="w-full rounded-lg" controls>
                            Your browser does not support the video tag.
                        </video>
                    </div>
                </div>
            </div>

            <!-- Controls -->
            <div class="controls-container flex justify-between items-center mb-8">
                <button onclick="previousQuestion()" id="prevBtn" class="glass-button px-6 py-3 flex items-center justify-center disabled:opacity-50 disabled:cursor-not-allowed">
                    <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                        <path fill-rule="evenodd" d="M12.707 5.293a1 1 0 010 1.414L9.414 10l3.293 3.293a1 1 0 01-1.414 1.414l-4-4a1 1 0 010-1.414l4-4a1 1 0 011.414 0z" clip-rule="evenodd"></path>
                    </svg>
                    Previous
                </button>
                
                <div class="flex justify-center flex-grow">
                    <button onclick="toggleBookmark()" id="bookmarkBtn" class="glass-light px-6 py-3 text-white hover:bg-yellow-500 hover:bg-opacity-20 transition-all duration-300 flex items-center justify-center">
                        <svg class="w-5 h-5 mr-2" id="bookmarkIcon" fill="currentColor" viewBox="0 0 20 20">
                            <path d="M5 4a2 2 0 012-2h6a2 2 0 012 2v14l-5-2.5L5 18V4z"></path>
                        </svg>
                        <span id="bookmarkText">Bookmark</span>
                    </button>
                    
                    <button onclick="toggleMarkForReview()" id="markReviewBtn" class="hidden glass-light px-6 py-3 text-white hover:bg-purple-500 hover:bg-opacity-20 transition-all duration-300 flex items-center justify-center">
                        <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                           <path fill-rule="evenodd" d="M5 2a2 2 0 00-2 2v12a2 2 0 002 2h10a2 2 0 002-2V4a2 2 0 00-2-2H5zm0 2h10v12H5V4z" clip-rule="evenodd" />
                           <path d="M12.586 6.586a2 2 0 10-2.828 2.828l-3 3a2 2 0 102.828-2.828l3-3z" />
                        </svg>
                        <span id="markReviewText">Mark for Review</span>
                    </button>
                </div>
                
                <button onclick="nextQuestion()" class="glass-button px-6 py-3 flex items-center justify-center">
                    Next
                    <svg class="w-5 h-5 ml-2" fill="currentColor" viewBox="0 0 20 20">
                        <path fill-rule="evenodd" d="M7.293 14.707a1 1 0 010-1.414L10.586 10 7.293 6.707a1 1 0 011.414-1.414l4 4a1 1 0 010 1.414l-4 4a1 1 0 01-1.414 0z" clip-rule="evenodd"></path>
                    </svg>
                </button>
            </div>
        </div>
    </div>

     <!-- Mobile Nav Toggle -->
    <button id="mobile-nav-toggle" onclick="toggleSidebar()" class="glass-button w-14 h-14 rounded-full items-center justify-center">
        <svg class="w-6 h-6 text-white" fill="none" stroke="currentColor" viewBox="0 0 24 24"><path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M4 6h16M4 12h16M4 18h16"></path></svg>
    </button>


    <script>
        let questionsData = [
  {
    "id": 73789,
    "choices": [
      {
        "id": 294097,
        "text": "<p><span style=\"font-size:14.0pt;\">Somatic hypermutation</span></p>"
      },
      {
        "id": 294098,
        "text": "<p><span style=\"font-size:14.0pt;\">Alternative RNA splicing</span></p>"
      },
      {
        "id": 294099,
        "text": "<p><span style=\"font-size:14.0pt;\">Affinity maturation</span></p>"
      },
      {
        "id": 294100,
        "text": "<p><span style=\"font-size:14.0pt;\">Allelic exclusion</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">Due to which phenomenon, B cells express IgM and IgD antibodies at the same time?&nbsp;</span></p>",
    "unique_key": "Q2582294",
    "question_audio": null,
    "question_video": null,
    "map_id": 33501209,
    "difficulty_level": "intermediate",
    "subjects_id": [
      43
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Alternative RNA splicing</strong>&nbsp;</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">B cells express IgM and IgD antibodies at the same time due to alternative RNA splicing.</span></li><li><span style=\"font-size:14.0pt;\">Alternative splicing is&nbsp;the process that selectively removes introns or exons, or parts thereof, to generate multiple messenger RNAs (mRNAs) from a single precursor mRNA (pre-mRNA).</span></li><li><span style=\"font-size:14.0pt;\">Humoral immunity is mediated by antibodies, which are produced by B lymphocytes.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Upon maturation, B lymphocytes produce IgM as the first type of immunoglobulin, followed by immunoglobulin IgG, IgE, and IgA, as a result of irreversible rearrangement of the immunoglobulin gene after activation.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">In contrast, the IgM-to-IgD transition is produced through alternative splicing of a long primary mRNA transcript from the Ig heavy chain gene, IGH. The nuclear RNA-binding protein, <strong>HuR</strong>, is well known for its function in mRNA splicing and nuclear export.&nbsp;</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Option:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Options A. Somatic hypermutation and C. Affinity maturation</strong>: Affinity maturation is the process by which antibodies gain increased affinity, avidity, and anti-pathogen activity and is the result of somatic hypermutation (SHM) of immunoglobulin genes in B cells, coupled to selection for antigen binding.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Allelic exclusion</strong>: Allelic exclusion is a process by which only one allele of a gene is expressed while the other allele is silenced.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p><span style=\"font-size:14.0pt;\"><strong>&nbsp;</strong></span></p><p><span style=\"font-size:14.0pt;\">B cells express both IgM and IgD through alternative RNA splicing, allowing the simultaneous expression of these two immunoglobulins.</span></p>",
    "correct_choice_id": 294098,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 92350,
    "choices": [
      {
        "id": 367708,
        "text": "<p><span style=\"font-size:14.0pt;\">Antibody class switching&nbsp;</span></p>"
      },
      {
        "id": 367709,
        "text": "<p><span style=\"font-size:14.0pt;\">Cytoskeleton regulation&nbsp;</span></p>"
      },
      {
        "id": 367710,
        "text": "<p><span style=\"font-size:14.0pt;\">DNA repair&nbsp;</span></p>"
      },
      {
        "id": 367711,
        "text": "<p><span style=\"font-size:14.0pt;\">Maturation of T cells&nbsp;</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">An&nbsp;18-month-old boy is brought to the emergency department due to blood in his stool, which the parents noticed when changing his diaper. The infant has had no previous bleeding and has been eating and drinking normally. He has a history of recurrent otitis media, frequent herpes labialis, and 2 episodes of pneumonia. On examination, the patient is well developed, well nourished, and has a fair complexion. He has eczema on his cheeks, trunk, and extremities. Scattered petechiae are also visible on his lower extremities.&nbsp; Laboratory studies show a platelet count of 24,000/mm\u00b3 and a leukocyte count of 9,000/mm\u00b3. Peripheral smear confirms the low platelet count and that the platelets are small. Genetic testing confirms the diagnosis. Which of the following processes is most likely affected by this patient's gene mutation?</span></p>",
    "unique_key": "Q2093948",
    "question_audio": null,
    "question_video": null,
    "map_id": 33501210,
    "difficulty_level": "intermediate",
    "subjects_id": [
      43
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Cytoskeleton regulation&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">This patient has Wiskott\u2013Aldrich Syndrome (WAS). It is caused by mutations in the WASP gene, which regulates the actin cytoskeleton in hematopoietic cells. This leads to:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Small platelets \u2192 bleeding</span></li><li><span style=\"font-size:14.0pt;\">Immunodeficiency \u2192 recurrent infections</span></li><li><span style=\"font-size:14.0pt;\">Eczema \u2192 atopic features</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Option:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Antibody class switching:</strong> Hyper IgM syndrome; recurrent infections but platelets normal.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. DNA repair:</strong> Ataxia-telangiectasia or Fanconi anemia; ataxia, telangiectasias, or bone marrow failure, not small platelets with eczema.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Maturation of T cells:</strong> SCID; severe early infections without small platelets or eczema.</span></p>",
    "correct_choice_id": 367709,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 33511,
    "choices": [
      {
        "id": 133890,
        "text": "<p><span style=\"font-size:14.0pt;\">Abnormal B-lymphocyte maturation&nbsp;</span></p>"
      },
      {
        "id": 133891,
        "text": "<p><span style=\"font-size:14.0pt;\">Adenosine deaminase deficiency&nbsp;</span></p>"
      },
      {
        "id": 133892,
        "text": "<p><span style=\"font-size:14.0pt;\">Complement deficiency&nbsp;</span></p>"
      },
      {
        "id": 133893,
        "text": "<p><span style=\"font-size:14.0pt;\">Impaired oxidative burst&nbsp;</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:18px;\">A 3-year-old boy is brought to the emergency department for 2 days of fever, cough, and worsening shortness of breath. The patient's parents report that he recently recovered from prolonged diarrhea due to Giardia infection. Medical history is significant for recurrent ear infections treated with antibiotics since age 6 months and lobar pneumonia requiring hospitalization. Temperature is 38.7 C (101.7 </span><span style=\"font-size:14.0pt;\">\u00b0</span><span style=\"font-size:18px;\">F), pulse is 140/min, and respirations are 60/min. Physical examination reveals small tonsils and crackles in the lower lobe of the right lung. Which of the following is the most likely cause of this patient's recurrent infections?</span></p>",
    "unique_key": "Q4041769",
    "question_audio": null,
    "question_video": null,
    "map_id": 33501211,
    "difficulty_level": "intermediate",
    "subjects_id": [
      43
    ],
    "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. A) Abnormal B-lymphocyte maturation</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">This patient most likely has Bruton's X-linked agammaglobulinemia (XLA), caused by mutations in the BTK gene, which is necessary for B-cell maturation. Features include:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Recurrent bacterial infections (otitis media, pneumonia)</span></li><li><span style=\"font-size:14.0pt;\">Infections with Giardia (GI protozoa)</span></li><li><span style=\"font-size:14.0pt;\">Absent or small tonsils and lymph nodes due to lack of mature B cells</span></li><li><span style=\"font-size:14.0pt;\">Lab: markedly low or absent immunoglobulins</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Option:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Adenosine deaminase deficiency:</strong> Causes SCID; severe infections in early infancy affecting both T and B cells.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Complement deficiency:</strong> Predisposes mainly to Neisseria infections or immune complex diseases, not recurrent respiratory infections from common bacteria.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Impaired oxidative burst:</strong> Chronic granulomatous disease; leads to infections with catalase-positive bacteria and fungi, not Giardia.</span></p>",
    "correct_choice_id": 133890,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 92351,
    "choices": [
      {
        "id": 367712,
        "text": "<p><span style=\"font-size:14.0pt;\">Antitoxin</span></p>"
      },
      {
        "id": 367713,
        "text": "<p><span style=\"font-size:14.0pt;\">Maternal Monoclonal Antibody</span></p>"
      },
      {
        "id": 367714,
        "text": "<p><span style=\"font-size:14.0pt;\">IgA</span></p>"
      },
      {
        "id": 367715,
        "text": "<p><span style=\"font-size:14.0pt;\">Toxoid</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">Which of the following does not provide passive immunity?&nbsp;</span></p>",
    "unique_key": "Q3150372",
    "question_audio": null,
    "question_video": null,
    "map_id": 33501212,
    "difficulty_level": "intermediate",
    "subjects_id": [
      43
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) Toxoid</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Toxoids are inactivated bacterial toxins that stimulate the body to <strong>produce its own antibodies</strong>, providing <strong>active immunity</strong>, not passive.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Option:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Antitoxin:</strong> Contains preformed antibodies against toxins, providing <strong>immediate passive immunity</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Maternal Monoclonal Antibody:</strong> Provides <strong>passive immunity</strong> to the infant by transferring ready-made antibodies.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. IgA:</strong> Present in <strong>breast milk and mucosal secretions</strong>, giving the infant <strong>passive protection</strong> against infections.</span></p>",
    "correct_choice_id": 367715,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 82896,
    "choices": [
      {
        "id": 330184,
        "text": "<p><span style=\"font-size:14.0pt;\">Lipoxin LXA-4</span></p>"
      },
      {
        "id": 330185,
        "text": "<p><span style=\"font-size:14.0pt;\">IL-8</span></p>"
      },
      {
        "id": 330186,
        "text": "<p><span style=\"font-size:14.0pt;\">Lymphotactin</span></p>"
      },
      {
        "id": 330187,
        "text": "<p><span style=\"font-size:14.0pt;\">Fractalkine</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">Which of the following mediators of inflammation is an example of a C-X-C chemokine?&nbsp;</span></p>",
    "unique_key": "Q9376159",
    "question_audio": null,
    "question_video": null,
    "map_id": 33501213,
    "difficulty_level": "intermediate",
    "subjects_id": [
      43
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) IL-8</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">IL-8 is a C-X-C chemokine that primarily attracts neutrophils to sites of inflammation.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Option:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Lipoxin LXA-4:&nbsp;</strong>A lipid mediator that resolves inflammation, not a chemokine.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Lymphotactin:&nbsp;</strong>A C chemokine, attracts lymphocytes, not neutrophils.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Fractalkine:&nbsp;</strong>A CX3C chemokine, involved in leukocyte adhesion and migration.</span></p>",
    "correct_choice_id": 330185,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 73333,
    "choices": [
      {
        "id": 292285,
        "text": "<p><span style=\"font-size:14.0pt;\">Mature dendritic cells</span></p>"
      },
      {
        "id": 292286,
        "text": "<p><span style=\"font-size:14.0pt;\">Follicular dendritic cells</span></p>"
      },
      {
        "id": 292287,
        "text": "<p><span style=\"font-size:14.0pt;\">B lymphocytes</span></p>"
      },
      {
        "id": 292288,
        "text": "<p><span style=\"font-size:14.0pt;\">NK cell</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">Which of the following is the most potent stimulator of naive T-cells?</span></p>",
    "unique_key": "Q6591705",
    "question_audio": null,
    "question_video": null,
    "map_id": 33501414,
    "difficulty_level": "intermediate",
    "subjects_id": [
      43
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Mature dendritic cells&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Mature dendritic cells are professional antigen-presenting cells that express high levels of MHC and costimulatory molecules, efficiently activating naive T-cells.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Option:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Follicular dendritic cells:&nbsp;</strong>Present antigens to B-cells in germinal centers, not naive T-cells.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. B lymphocytes:&nbsp;</strong>Can present antigen but are less effective at stimulating naive T-cells.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. NK cell:&nbsp;</strong>Part of innate immunity; do not stimulate T-cells.</span></p>",
    "correct_choice_id": 292285,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 73451,
    "choices": [
      {
        "id": 292753,
        "text": "<p><span style=\"font-size:14.0pt;\">B cell</span></p>"
      },
      {
        "id": 292754,
        "text": "<p><span style=\"font-size:14.0pt;\">T cell</span></p>"
      },
      {
        "id": 292755,
        "text": "<p><span style=\"font-size:14.0pt;\">Both B and T cell</span></p>"
      },
      {
        "id": 292756,
        "text": "<p><span style=\"font-size:14.0pt;\">INK cell</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:18px;\">Nude mice are not resistant to xenograft due to the absence of?</span></p>",
    "unique_key": "Q2479314",
    "question_audio": null,
    "question_video": null,
    "map_id": 33501415,
    "difficulty_level": "intermediate",
    "subjects_id": [
      43
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) T cell</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Nude mice lack a thymus, leading to absence of T-cells, which are crucial for rejecting foreign grafts.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Option:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. B cell:&nbsp;</strong>B-cells are present; deficiency is not the reason for xenograft acceptance.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Both B and T cell:&nbsp;</strong>Only T-cells are absent; B-cells are normal.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. NK cell:&nbsp;</strong>NK cells are present; they provide partial innate immunity but cannot fully reject xenografts.</span></p>",
    "correct_choice_id": 292754,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 35007,
    "choices": [
      {
        "id": 139839,
        "text": "<p><span style=\"font-size:14.0pt;\">Infection following live-virus vaccines</span></p>"
      },
      {
        "id": 139840,
        "text": "<p><span style=\"font-size:14.0pt;\">Infection with Neisseria</span></p>"
      },
      {
        "id": 139841,
        "text": "<p><span style=\"font-size:14.0pt;\">Persistent leukocytosis</span></p>"
      },
      {
        "id": 139842,
        "text": "<p><span style=\"font-size:14.0pt;\">Small or absent lymph nodes</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:18px;\">A 2-year-old boy is evaluated for recurrent infections. He was born at term after a normal pregnancy. His mother states, \"He is always sick with something and is constantly on antibiotics.\" The patient's past medical records indicate multiple episodes of otitis media, skin infections, and pneumonia. Incision and drainage of his skin infections revealed Staphylococcus aureus on bacterial culture but no purulence. Laboratory testing reveals absent CD18 antigens on the surface of leukocytes. The patient is at greatest risk for which of the following?</span></p>",
    "unique_key": "Q9173835",
    "question_audio": null,
    "question_video": null,
    "map_id": 33501416,
    "difficulty_level": "difficult",
    "subjects_id": [
      43
    ],
    "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:18px;\"><strong>Ans. C) Persistent leukocytosis</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p><span style=\"font-size:14.0pt;\">The patient has Leukocyte Adhesion Deficiency (LAD-1) due to absent CD18. Neutrophils cannot migrate to infection sites, leading to persistent high WBC counts despite ongoing infections.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Option:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Infection following live-virus vaccines:&nbsp;</strong>Seen in T-cell immunodeficiencies</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Infection with Neisseria:&nbsp;</strong>Seen in complement deficiencies.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Small or absent lymph nodes:&nbsp;</strong>Seen in X-linked agammaglobulinemia.</span></p>",
    "correct_choice_id": 139841,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 35642,
    "choices": [
      {
        "id": 142371,
        "text": "<p><span style=\"font-size:14.0pt;\">NOTCH1&nbsp;</span></p>"
      },
      {
        "id": 142372,
        "text": "<p><span style=\"font-size:14.0pt;\">E2A&nbsp;</span></p>"
      },
      {
        "id": 142373,
        "text": "<p><span style=\"font-size:14.0pt;\">Rag 1/2&nbsp;</span></p>"
      },
      {
        "id": 142374,
        "text": "<p><span style=\"font-size:14.0pt;\">AIRE</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:18px;\">The Thymus gland is specialized in identifying the molecules of the Major Histocompatibility Complex that are presented to it. It discerns whether these cells belong to the body's own or are of foreign origin. Which specific gene is accountable for this function?</span></p>",
    "unique_key": "Q1487625",
    "question_audio": null,
    "question_video": null,
    "map_id": 33501417,
    "difficulty_level": "beginner",
    "subjects_id": [
      43
    ],
    "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. D) AIRE</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">AIRE (Autoimmune Regulator) allows thymic medullary epithelial cells to express peripheral tissue antigens, enabling negative selection of self-reactive T-cells and preventing autoimmunity.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Option:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. NOTCH1:&nbsp;</strong>Involved in T-cell lineage commitment, not self-tolerance.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. E2A:&nbsp;</strong>Transcription factor required for B-cell development.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Rag \u00bd:&nbsp;</strong>Required for V(D)J recombination in T- and B-cell receptor formation.</span></p>",
    "correct_choice_id": 142374,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 67043,
    "choices": [
      {
        "id": 267305,
        "text": "<p><span style=\"font-size:14.0pt;\">1-c, 2-b, 3-d, 4-a</span></p>"
      },
      {
        "id": 267306,
        "text": "<p><span style=\"font-size:14.0pt;\">1-b, 2-c, 3-d, 4-a</span></p>"
      },
      {
        "id": 267307,
        "text": "<p><span style=\"font-size:14.0pt;\">1-a, 2-c, 3-b, 4-d</span></p>"
      },
      {
        "id": 267308,
        "text": "<p><span style=\"font-size:14.0pt;\">1-d, 2-b, 3-c, 4-a</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">Match the CD markers-</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202024-12-19%20162253.png\" width=\"1100\" height=\"247\"></span></p>",
    "unique_key": "Q2898192",
    "question_audio": null,
    "question_video": null,
    "map_id": 33501418,
    "difficulty_level": "intermediate",
    "subjects_id": [
      43
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) 1-c, 2-b, 3-d, 4-a</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Pluripotent stem cells:&nbsp;</strong>CD34 is a classical marker.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Megakaryocytes: </strong>CD41/CD42 are specific for platelet lineage.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Erythrocytes: </strong>CD71 is the transferrin receptor on developing RBCs.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Monocytes: </strong>CD14/CD64 are monocyte/macrophage markers.</span></p>",
    "correct_choice_id": 267305,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "ImageBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 67146,
    "choices": [
      {
        "id": 267709,
        "text": "<p><span style=\"font-size:14.0pt;\">Mutation in WAS protein</span></p>"
      },
      {
        "id": 267710,
        "text": "<p><span style=\"font-size:14.0pt;\">Defect in DNA crosslink repair</span></p>"
      },
      {
        "id": 267711,
        "text": "<p><span style=\"font-size:14.0pt;\">Acute Lymphoblastic leukemia</span></p>"
      },
      {
        "id": 267712,
        "text": "<p><span style=\"font-size:14.0pt;\">Post Viral Autoimmune reaction</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">A 4-year-old boy is brought to his pediatrician by his mother for recurrent nosebleeds. The mother reports that the boy has had five nosebleeds within the past 2 weeks, each lasting between 15 and 20 minutes. The patient was born at term and has been hospitalized twice for pneumonia treatment. There is no family history of serious illness. The patient is at the 8th percentile for height and the 30th percentile for weight. Vital signs are within normal limits. Examination shows a small, thin child with two flat, dark brown areas of hyperpigmentation across the upper back and a similar discoloration on the left buttock. There is bilateral esotropia. Laboratory studies show a hemoglobin concentration of 9.3 g/dL, mean corpuscular volume of 107 um3, leukocyte count of 3800/mm3, and platelet count of 46,000/mm3. Which of the following is the most likely underlying cause of this patient's condition?</span></p>",
    "unique_key": "Q4987949",
    "question_audio": null,
    "question_video": null,
    "map_id": 33502268,
    "difficulty_level": "intermediate",
    "subjects_id": [
      43
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Defect in DNA crosslink repair</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The patient most likely has Fanconi anemia, caused by defects in DNA crosslink repair. It presents with pancytopenia, congenital anomalies, caf\u00e9-au-lait spots, and growth retardation.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Option:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Mutation in WAS protein:&nbsp;</strong>Causes Wiskott\u2013Aldrich syndrome; features include small platelets, eczema, and recurrent infections, but not congenital anomalies like caf\u00e9-au-lait spots.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Acute Lymphoblastic leukemia:&nbsp;</strong>Usually presents with blast cells on peripheral smear, rapid onset, and bone pain; not typical congenital anomalies.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Post Viral Autoimmune reaction:&nbsp;</strong>Usually causes isolated cytopenias transiently, not multiple congenital anomalies or chronic pancytopenia.</span></p>",
    "correct_choice_id": 267710,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 67160,
    "choices": [
      {
        "id": 267765,
        "text": "<p><span style=\"font-size:14.0pt;\">Formation of dimer</span></p>"
      },
      {
        "id": 267766,
        "text": "<p><span style=\"font-size:14.0pt;\">Binding to mast cells</span></p>"
      },
      {
        "id": 267767,
        "text": "<p><span style=\"font-size:14.0pt;\">Fixing of complement</span></p>"
      },
      {
        "id": 267768,
        "text": "<p><span style=\"font-size:14.0pt;\">Attachment to antigen</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">An investigator is studying the structure and function of immunoglobulins that are transmitted across the placenta from mother to fetus. The structure indicated by the arrow is primarily responsible for which of the following immunological events?</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202024-12-20%20124402.jpg\" width=\"405\" height=\"415\"></span></p>",
    "unique_key": "Q4238001",
    "question_audio": null,
    "question_video": null,
    "map_id": 33502269,
    "difficulty_level": "intermediate",
    "subjects_id": [
      43
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Fixing of complement</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The arrow points to the Fc region of the IgG molecule. This part of the antibody is primarily responsible for fixing complement via the classical pathway, allowing activation of immune effector functions such as cell lysis and phagocytosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Fc = helps in placental transfer, It binds specifically to the neonatal Fc receptor (FcRn) expressed on placental syncytiotrophoblast cells</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Option:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Formation of dimer:&nbsp;</strong>This is characteristic of IgA, not IgG.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Binding to mast cells:&nbsp;</strong>Mostly associated with IgE.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Attachment to antigen:&nbsp;</strong>Occurs at the Fab region, not the Fc region.</span></p>",
    "correct_choice_id": 267767,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "ImageBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 73813,
    "choices": [
      {
        "id": 294189,
        "text": "<p><span style=\"font-size:14.0pt;\">It is the only heat stable antibody&nbsp;</span></p>"
      },
      {
        "id": 294190,
        "text": "<p><span style=\"font-size:14.0pt;\">Levels are raised in helminthic infections&nbsp;</span></p>"
      },
      {
        "id": 294191,
        "text": "<p><span style=\"font-size:14.0pt;\">It does not pass the placental barrier&nbsp;</span></p>"
      },
      {
        "id": 294192,
        "text": "<p><span style=\"font-size:14.0pt;\">It has a half-life of 1-5 days&nbsp;</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">Casoni reaction is seen in patients with hydatid cyst. Which of the following is incorrect about the immunoglobulin causing this reaction?</span></p>",
    "unique_key": "Q7483584",
    "question_audio": null,
    "question_video": null,
    "map_id": 33502270,
    "difficulty_level": "intermediate",
    "subjects_id": [
      43
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) It is the only heat stable antibody</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The antibody involved is IgE, which is heat labile, not heat stable.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Option:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Levels are raised in helminthic infections:&nbsp;</strong>IgE levels increase during parasitic infections.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. It does not pass the placental barrier:&nbsp;</strong>IgE cannot cross the placenta.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. It has a half-life of 1-5 days:&nbsp;</strong>IgE has a short half-life of about 1\u20132 days in circulation.</span></p>",
    "correct_choice_id": 294189,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 67022,
    "choices": [
      {
        "id": 267221,
        "text": "<p><span style=\"font-size:14.0pt;\">CD14 on macrophages with bacterial lipopolysaccharide</span></p>"
      },
      {
        "id": 267222,
        "text": "<p><span style=\"font-size:14.0pt;\">CD16 on NK cells with IgG-coated infected cells</span></p>"
      },
      {
        "id": 267223,
        "text": "<p><span style=\"font-size:14.0pt;\">CD18 on neutrophils with ICAM-1 on endothelial cells</span></p>"
      },
      {
        "id": 267224,
        "text": "<p><span style=\"font-size:14.0pt;\">CD28 on T lymphocytes with CD80/86 on epidermal dendritic cells</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">A 28-year-old medical student undergoes a tuberculin skin test (TST) as part of a routine health check. He is asymptomatic with no history of recent fever, weight loss, or cough. He receives an intradermal injection of purified protein derivative (PPD) on the inner surface of his forearm. After 48 hours, a raised, erythematous induration measuring 18 mm is observed at the injection site. Which of the following interactions is critical to the development of this patient\u2019s skin reaction?</span></p>",
    "unique_key": "Q5195939",
    "question_audio": null,
    "question_video": null,
    "map_id": 33502271,
    "difficulty_level": "intermediate",
    "subjects_id": [
      43
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) CD28 on T lymphocytes with CD80/86 on epidermal dendritic cells</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The TST is a type IV hypersensitivity reaction mediated by CD4+ T-cells. Interaction of CD28 on T-cells with CD80/86 on antigen-presenting dendritic cells provides the costimulatory signal essential for T-cell activation.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Option:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. CD14 on macrophages with bacterial lipopolysaccharide:&nbsp;</strong>Involved in innate immune response to Gram-negative bacteria, not delayed-type hypersensitivity.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. CD16 on NK cells with IgG-coated infected cells:&nbsp;</strong>Mediates antibody-dependent cellular cytotoxicity (ADCC), not TST reaction.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. CD18 on neutrophils with ICAM-1 on endothelial cells:&nbsp;</strong>Involved in leukocyte adhesion and migration, not the critical T-cell activation in TST.</span></p>",
    "correct_choice_id": 267224,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 73921,
    "choices": [
      {
        "id": 294617,
        "text": "<p><span style=\"font-size:14.0pt;\">Bare lymphocytes</span></p>"
      },
      {
        "id": 294618,
        "text": "<p><span style=\"font-size:14.0pt;\">Chronic granulocyte deficiency</span></p>"
      },
      {
        "id": 294619,
        "text": "<p><span style=\"font-size:14.0pt;\">Hyper IgM syndrome</span></p>"
      },
      {
        "id": 294620,
        "text": "<p><span style=\"font-size:14.0pt;\">DiGeorge syndrome</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">A 3-year-old boy presents with recurrent bacterial infections and Pneumocystis jiroveci pneumonia. The flowcytometry analysis of the boy (Boxes c &amp; d) is shown below (Boxes a &amp; b are normal). What is the most likely diagnosis?&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-03-10%20134050.jpg\" width=\"514\" height=\"515\"></span></p>",
    "unique_key": "Q4755716",
    "question_audio": null,
    "question_video": null,
    "map_id": 33502272,
    "difficulty_level": "intermediate",
    "subjects_id": [
      43
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Hyper IgM syndrome</strong>&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The flow cytometry analysis shows that the patient (boxes c &amp; d) has normal numbers of B cells (CD19+) as seen in box c, but box d reveals a significant reduction or absence of CD40 ligand (CD40L) expression on T cells. This pattern is typical of&nbsp;Hyper IgM syndrome, an immunodeficiency caused by a defect in CD40L, preventing class switching of immunoglobulins. Patients present with recurrent bacterial infections and opportunistic infections like Pneumocystis jiroveci pneumonia due to impaired humoral and cell-mediated immunity.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Option:</strong></span><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Bare lymphocytes:</strong> Bare lymphocyte syndrome presents with combined immunodeficiency due to lack of MHC molecules and would show decreased B and T cells.</span><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Chronic granulocyte deficiency:</strong> Chronic granulocyte deficiency affects neutrophils and not lymphocyte populations.</span><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. DiGeorge syndrome:</strong> DiGeorge syndrome involves T cell deficiency due to thymic hypoplasia, not B cell or CD40L abnormalities.</span></p>",
    "correct_choice_id": 294619,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "ImageBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 73830,
    "choices": [
      {
        "id": 294257,
        "text": "<p><span style=\"font-size:14.0pt;\">1, 2, 3, 4, 5</span></p>"
      },
      {
        "id": 294258,
        "text": "<p><span style=\"font-size:14.0pt;\">4, 1, 3, 2, 5</span></p>"
      },
      {
        "id": 294259,
        "text": "<p><span style=\"font-size:14.0pt;\">4, 1, 5, 3, 2&nbsp;</span></p>"
      },
      {
        "id": 294260,
        "text": "<p><span style=\"font-size:14.0pt;\">1, 2, 4, 3, 5</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">Arrange the following sentences in the correct order for activation of B cells.</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:14.0pt;\">T-helper cells interact with the presented antigen peptides.</span></li><li><span style=\"font-size:14.0pt;\">Improved quality of the immune response with affinity maturation.</span></li><li><span style=\"font-size:14.0pt;\">Somatic hypermutation and immunoglobulin isotype class switching occur.</span></li><li><span style=\"font-size:14.0pt;\">Antigen binding to B cell receptor.</span></li><li><span style=\"font-size:14.0pt;\">Binding of CD40 ligand on T cells to CD 40 on B cells.</span></li></ol>",
    "unique_key": "Q2524453",
    "question_audio": null,
    "question_video": null,
    "map_id": 33502683,
    "difficulty_level": "intermediate",
    "subjects_id": [
      43
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C)&nbsp;4, 1, 5, 3, 2&nbsp;</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>4. Antigen binding to B cell receptor:&nbsp;</strong>B cell recognizes the antigen.</span></li><li><span style=\"font-size:14.0pt;\"><strong>1. T-helper cells interact with the presented antigen peptides:&nbsp;</strong>B cell presents antigen to T-helper cell.</span></li><li><span style=\"font-size:14.0pt;\"><strong>5. Binding of CD40 ligand on T cells to CD40 on B cells:&nbsp;</strong>Provides costimulatory signal for B-cell activation.</span></li><li><span style=\"font-size:14.0pt;\"><strong>3. Somatic hypermutation and immunoglobulin isotype class switching occur: \u2192&nbsp;</strong>Enhances antibody diversity and function.</span></li><li><span style=\"font-size:14.0pt;\"><strong>2. Improved quality of the immune response with affinity maturation:&nbsp;</strong>Produces high-affinity antibodies.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_0b4Sr0a.png\" width=\"940\" height=\"946\"></span></p>",
    "correct_choice_id": 294259,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 73825,
    "choices": [
      {
        "id": 294237,
        "text": "<p><span style=\"font-size:14.0pt;\">Alpha defensins</span></p>"
      },
      {
        "id": 294238,
        "text": "<p><span style=\"font-size:14.0pt;\">B lymphocytes</span></p>"
      },
      {
        "id": 294239,
        "text": "<p><span style=\"font-size:14.0pt;\">Gamma Delta T lymphocytes</span></p>"
      },
      {
        "id": 294240,
        "text": "<p><span style=\"font-size:14.0pt;\">Lectin pathway</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">All of the following are the part of the innate immunity except:</span></p>",
    "unique_key": "Q3564959",
    "question_audio": null,
    "question_video": null,
    "map_id": 33502684,
    "difficulty_level": "intermediate",
    "subjects_id": [
      43
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) B lymphocytes</strong>&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">B lymphocytes are part of the <strong>adaptive immune system</strong>, producing <strong>antigen-specific antibodies</strong> after activation.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Option:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Alpha defensins:Antimicrobial peptides</strong> that provide immediate defense against pathogens.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Gamma Delta T lymphocytes:</strong> Bridge innate and adaptive immunity; respond <strong>rapidly to non-peptide antigens</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Lectin pathway:</strong> A <strong>complement activation pathway</strong> of innate immunity.</span></p>",
    "correct_choice_id": 294238,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 92352,
    "choices": [
      {
        "id": 367716,
        "text": "<p><span style=\"font-size:14.0pt;\">Aortic dissection</span></p>"
      },
      {
        "id": 367717,
        "text": "<p><span style=\"font-size:14.0pt;\">Brain tumor</span></p>"
      },
      {
        "id": 367718,
        "text": "<p><span style=\"font-size:14.0pt;\">Cardiomyopathy</span></p>"
      },
      {
        "id": 367719,
        "text": "<p><span style=\"font-size:14.0pt;\">lntracranial bleeding</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">A 15-year-old girl comes to the office with gait instability. Since age 12, the patient has had mild weakness and \"clumsiness\" in her lower limbs that have progressed. Physical examination reveals kyphoscoliosis ,pes cavus. Joint position and vibration sense are also impaired. Further evaluation reveals that she is suffering from an inherited disease. This patient is at greatest risk of dying from which of the following conditions?</span></p>",
    "unique_key": "Q1670797",
    "question_audio": null,
    "question_video": null,
    "map_id": 33502685,
    "difficulty_level": "intermediate",
    "subjects_id": [
      43
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Cardiomyopathy</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The patient most likely has <strong>Friedreich ataxia</strong>, an <strong>autosomal recessive disorder</strong> caused by <strong>frataxin deficiency</strong>. Complications include <strong>hypertrophic cardiomyopathy</strong>, which is the <strong>leading cause of death</strong> in these patients.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Option:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Aortic dissection:</strong> Associated with <strong>Marfan syndrome</strong>, not Friedreich ataxia.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Brain tumor:</strong> Not characteristic of Friedreich ataxia.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Intracranial bleeding:</strong> Not a common cause of death in this condition.</span></p>",
    "correct_choice_id": 367718,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 74351,
    "choices": [
      {
        "id": 296325,
        "text": "<p><span style=\"font-size:14.0pt;\">1-B, 2-C, 3-D, 4-D</span></p>"
      },
      {
        "id": 296326,
        "text": "<p><span style=\"font-size:14.0pt;\">1-B, 2-B, 3-C, 4-A</span></p>"
      },
      {
        "id": 296327,
        "text": "<p><span style=\"font-size:14.0pt;\">1-C, 2-D, 3-C, 4-D</span></p>"
      },
      {
        "id": 296328,
        "text": "<p><span style=\"font-size:14.0pt;\">1-D, 2-C, 3-D, 4-B</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">Match the following with types of hypersensitivity:</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-03-15%20125509.jpg\" width=\"834\" height=\"499\"></span></p>",
    "unique_key": "Q1449842",
    "question_audio": null,
    "question_video": null,
    "map_id": 33502686,
    "difficulty_level": "intermediate",
    "subjects_id": [
      43
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) 1-B, 2-B, 3-C, 4-A</strong></span></p><p>&nbsp;</p><ol><li><span style=\"font-size:14.0pt;\"><strong>A 38-year-old female with double vision and mass in the mediastinum:&nbsp;</strong>Type 2 hypersensitivity (B) (Myasthenia gravis\u2014antibody-mediated against acetylcholine receptors)</span></li><li><span style=\"font-size:14.0pt;\"><strong>Graft kidney showing mononuclear cell infiltrates with C4d deposition in peritubular capillaries on IF:&nbsp;</strong>Type 2 hypersensitivity (B) (Hyperacute and acute humoral rejection\u2014antibody mediated with complement activation)</span></li><li><span style=\"font-size:14.0pt;\"><strong>Renal biopsy in a patient with SLE presenting with hematuria shows thickened vessel walls with pink-staining material</strong></span><br><span style=\"font-size:14.0pt;\">\u2003\u2192 Type 3 hypersensitivity (C)</span><br><span style=\"font-size:14.0pt;\">\u2003(Immune complex-mediated\u2014SLE nephritis)</span></li><li><span style=\"font-size:14.0pt;\"><strong>Casoni test in a patient with hydatid cyst:&nbsp;</strong>Type 1 hypersensitivity (A) <strong>(Skin test\u2014immediate hypersensitivity reaction)</strong></span></li></ol>",
    "correct_choice_id": 296326,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 74421,
    "choices": [
      {
        "id": 296605,
        "text": "<p><span style=\"font-size:14.0pt;\">Contraindicated if platelet count &lt;40,000</span></p>"
      },
      {
        "id": 296606,
        "text": "<p><span style=\"font-size:14.0pt;\">Breath holding is required</span></p>"
      },
      {
        "id": 296607,
        "text": "<p><span style=\"font-size:14.0pt;\">Procedure can be done in both lateral &amp; prone position</span></p>"
      },
      {
        "id": 296608,
        "text": "<p><span style=\"font-size:14.0pt;\">Diagnosing an infiltrative or granulomatous disease</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">Which of the following is not true regarding the procedure done using the instrument given in the image below?&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_WQlRQDg.png\" width=\"381\" height=\"254\"></span></p>",
    "unique_key": "Q4773422",
    "question_audio": null,
    "question_video": null,
    "map_id": 33502687,
    "difficulty_level": "beginner",
    "subjects_id": [
      43
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Contraindicated if platelet count &lt;40,000</strong>&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The image shows a&nbsp;bone marrow biopsy needle&nbsp;set. Bone marrow biopsy is&nbsp;not absolutely contraindicated if platelet count is below 40,000, though relative caution is warranted and transfusion may be considered. Breath holding is required to minimize movement during the procedure, which can be performed with the patient in lateral or prone position. The biopsy aids diagnosis of infiltrative or granulomatous marrow diseases.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Option:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B.</strong> <strong>Breath holding is required:</strong> Breath holding stabilizes the patient during aspiration.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C.</strong> <strong>Procedure can be done in both lateral &amp; prone position:</strong> Both lateral and prone positions are accepted for posterior iliac crest biopsy.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D.</strong> <strong>Diagnosing an infiltrative or granulomatous disease:</strong> The procedure is essential for diagnosing infiltrative and granulomatous diseases.</span></p>",
    "correct_choice_id": 296605,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "ImageBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 25754,
    "choices": [
      {
        "id": 102966,
        "text": "<p><span style=\"font-size:18px;\">1-A, 2-D, 3-C, 4-B</span></p>"
      },
      {
        "id": 102967,
        "text": "<p><span style=\"font-size:18px;\">1-B, 2-C, 3-D, 4-A</span></p>"
      },
      {
        "id": 102968,
        "text": "<p><span style=\"font-size:18px;\">1-A, 2-C, 3-D, 4-B</span></p>"
      },
      {
        "id": 102969,
        "text": "<p><span style=\"font-size:18px;\">1-B, 2-D, 3-C, 4-A</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:18px;\">Match the following:</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-03-15%20150745.jpg\" width=\"791\" height=\"340\"></span></p>",
    "unique_key": "Q2155581",
    "question_audio": null,
    "question_video": null,
    "map_id": 33503698,
    "difficulty_level": "intermediate",
    "subjects_id": [
      43
    ],
    "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. A) 1-A, 2-D, 3-C, 4-B</strong></span></p><p>&nbsp;</p><ol><li><span style=\"font-size:14.0pt;\"><strong>Swan neck deformity with activation of caspase-1, 4, and release of IL-1\u03b2 in synovial fluid: Pyroptosis (A)&nbsp;</strong>(A form of inflammatory programmed cell death involving caspase-1 and IL-1\u03b2 release)</span></li><li><span style=\"font-size:14.0pt;\"><strong>Dysregulation of glutathione peroxidase 4 and increased lipid peroxidation in a chemo-resistant breast tumor: Ferroptosis (D) (</strong>Iron-dependent lipid peroxidation-mediated cell death regulated by glutathione peroxidase 4)</span></li><li><span style=\"font-size:14.0pt;\"><strong>Radiation induced activation of caspase 9 and 3:&nbsp;Apoptosis (C)&nbsp;</strong>(Mitochondrial intrinsic pathway caspase cascade in regulated cell death)</span></li><li><span style=\"font-size:14.0pt;\"><strong>In sepsis, TNF-alpha mediated activation of receptor-interacting protein kinase 1 disrupts plasma membrane integrity causing cell swelling: Necroptosis (B)</strong>(A programmed necrosis pathway involving receptor interacting protein kinases) note that Necroptosis is CasPase INDEPENDENT</span></li></ol>",
    "correct_choice_id": 102966,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 74429,
    "choices": [
      {
        "id": 296637,
        "text": "<p><span style=\"font-size:14.0pt;\">Cytoskeleton&nbsp;</span></p>"
      },
      {
        "id": 296638,
        "text": "<p><span style=\"font-size:14.0pt;\">Golgi apparatus&nbsp;</span></p>"
      },
      {
        "id": 296639,
        "text": "<p><span style=\"font-size:14.0pt;\">Nucleus</span></p>"
      },
      {
        "id": 296640,
        "text": "<p><span style=\"font-size:14.0pt;\">Peroxisomes&nbsp;</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">A 54-year-old man comes to the OPD due to severe foot pain. The patient attended a wedding reception where he drank several alcoholic beverages, then woke the following morning with pain. He has a long history of gouty arthritis, and his current symptoms are similar to previous flares of the disease. The patient is started on a new medication for gout that provides significant relief of his symptoms, but he returns to the clinic a week later with diarrhea and persistent nausea. The drug used in this patient most likely affects which of the following cell structure s?</span></p>",
    "unique_key": "Q7020610",
    "question_audio": null,
    "question_video": null,
    "map_id": 33503699,
    "difficulty_level": "beginner",
    "subjects_id": [
      43
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Cytoskeleton</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The patient was likely treated with <strong>colchicine</strong>, which relieves acute gout by <strong>binding tubulin and inhibiting microtubule polymerization</strong>, thus disrupting the <strong>cytoskeleton</strong> in neutrophils and reducing inflammation.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Option:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Golgi apparatus:</strong> Not targeted by colchicine; involved in protein processing and trafficking.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Nucleus:</strong> Colchicine does not directly affect nuclear function.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Peroxisomes:</strong> Not affected by colchicine; involved in lipid metabolism and reactive oxygen species detoxification</span></p>",
    "correct_choice_id": 296637,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 74447,
    "choices": [
      {
        "id": 296709,
        "text": "<p><span style=\"font-size:14.0pt;\">Amyotrophic lateral sclerosis&nbsp;</span></p>"
      },
      {
        "id": 296710,
        "text": "<p><span style=\"font-size:14.0pt;\">Friedrich ataxia&nbsp;</span></p>"
      },
      {
        "id": 296711,
        "text": "<p><span style=\"font-size:14.0pt;\">Spinal bulbar muscular atrophy&nbsp;</span></p>"
      },
      {
        "id": 296712,
        "text": "<p><span style=\"font-size:14.0pt;\">Multiple system atrophy</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">Which of the following neurodegenerative disease has misfolded superoxide dismutase 1 inclusions?</span></p>",
    "unique_key": "Q1669172",
    "question_audio": null,
    "question_video": null,
    "map_id": 33503700,
    "difficulty_level": "beginner",
    "subjects_id": [
      43
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans</strong>.&nbsp;<strong>A) Amyotrophic lateral sclerosis&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Mutations in SOD1 cause protein misfolding and aggregation in motor neurons, contributing to neuronal death in ALS.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Option:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Friedreich ataxia:&nbsp;</strong>Caused by frataxin deficiency, not SOD1 inclusions.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Spinal bulbar muscular atrophy:&nbsp;</strong>Caused by androgen receptor gene CAG repeat expansion, not SOD1.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Multiple system atrophy:&nbsp;</strong>Characterized by alpha-synuclein inclusions, not SOD1.</span></p>",
    "correct_choice_id": 296709,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 74500,
    "choices": [
      {
        "id": 296921,
        "text": "<p><span style=\"font-size:14.0pt;\">1, 2, 3, 4</span></p>"
      },
      {
        "id": 296922,
        "text": "<p><span style=\"font-size:14.0pt;\">1, 2, 3</span></p>"
      },
      {
        "id": 296923,
        "text": "<p><span style=\"font-size:14.0pt;\">2, 4</span></p>"
      },
      {
        "id": 296924,
        "text": "<p><span style=\"font-size:14.0pt;\">1, 3</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">Identify the correct statements</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:14.0pt;\">Leptin serves a permissive role in puberty</span></li><li><span style=\"font-size:14.0pt;\">Weber-Fechner law describes the relationship between the magnitude of a physical stimulus and the perceived intensity&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Golgi complex is located in supranuclear cytoplasm in serous acinar cells.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Ganglion cells are the third-order neurons in the optic pathway.</span></li></ol>",
    "unique_key": "Q2074529",
    "question_audio": null,
    "question_video": null,
    "map_id": 33503701,
    "difficulty_level": "beginner",
    "subjects_id": [
      43
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A)&nbsp;1, 2, 3, 4</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>All statements are correct&nbsp;</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">1. Leptin serves a permissive role in puberty \u2192 Leptin signals adequate energy stores to the hypothalamus, allowing pubertal onset.</span></li><li><span style=\"font-size:14.0pt;\">2. Weber-Fechner law \u2192 Describes the logarithmic relationship between stimulus magnitude and perceived intensity.</span></li><li><span style=\"font-size:14.0pt;\">3. Golgi complex in serous acinar cells \u2192 Located in the supranuclear cytoplasm, involved in protein processing and secretion.</span></li><li><span style=\"font-size:14.0pt;\">4. Ganglion cells as third-order neurons \u2192 In the optic pathway, ganglion cells transmit visual signals from the retina to the lateral geniculate nucleus.</span></li></ul>",
    "correct_choice_id": 296921,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 73791,
    "choices": [
      {
        "id": 294105,
        "text": "<p><span style=\"font-size:14.0pt;\">Cyclin B- Cyclin E- Cyclin A- Cyclin D&nbsp;</span></p>"
      },
      {
        "id": 294106,
        "text": "<p><span style=\"font-size:14.0pt;\">Cyclin E- Cyclin B- Cyclin A- Cyclin D&nbsp;</span></p>"
      },
      {
        "id": 294107,
        "text": "<p><span style=\"font-size:14.0pt;\">Cyclin D- Cyclin E- Cyclin A- Cyclin B&nbsp;</span></p>"
      },
      {
        "id": 294108,
        "text": "<p><span style=\"font-size:14.0pt;\">Cyclin B- Cyclin A- Cyclin E- Cyclin D&nbsp;</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">Arrange in sequence the cyclins at different stages of the cell cycle starting from the G1 phase.</span></p>",
    "unique_key": "Q9006231",
    "question_audio": null,
    "question_video": null,
    "map_id": 33503702,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Cyclin D- Cyclin E- Cyclin A- Cyclin B&nbsp;</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Cyclin D:&nbsp;</strong>G1 phase, drives progression through G1.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Cyclin E:&nbsp;</strong>G1/S transition, initiates DNA replication.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Cyclin A:&nbsp;</strong>S phase and G2, promotes DNA synthesis and prepares for mitosis.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Cyclin B:&nbsp;</strong>M phase, required for entry into mitosis.</span></li></ul>",
    "correct_choice_id": 294107,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 73794,
    "choices": [
      {
        "id": 294117,
        "text": "<p><span style=\"font-size:14.0pt;\">2 only</span></p>"
      },
      {
        "id": 294118,
        "text": "<p><span style=\"font-size:14.0pt;\">1 only</span></p>"
      },
      {
        "id": 294119,
        "text": "<p><span style=\"font-size:14.0pt;\">1 and 3</span></p>"
      },
      {
        "id": 294120,
        "text": "<p><span style=\"font-size:14.0pt;\">2 and 3</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">Which of the following statements is true about proto-oncogenes?&nbsp;</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:14.0pt;\">KIT has increased expression in GIST.</span></li><li><span style=\"font-size:14.0pt;\">KRAS mutation is more commonly associated with small-cell lung carcinoma.</span></li><li><span style=\"font-size:14.0pt;\">ERBB2 over-expression is associated with breast carcinomas.</span></li><li><span style=\"font-size:14.0pt;\">PDGFR-\u03b2 has suppressed expression in colorectal cancers.&nbsp;</span></li></ol>",
    "unique_key": "Q5279650",
    "question_audio": null,
    "question_video": null,
    "map_id": 33504413,
    "difficulty_level": "intermediate",
    "subjects_id": [
      43
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>&nbsp;Ans. C) 1 and 3</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>1. KIT has increased expression in GIST:&nbsp;</strong>True; KIT (CD117) mutations drive gastrointestinal stromal tumors.</span></li><li><span style=\"font-size:14.0pt;\"><strong>3. ERBB2 over-expression is associated with breast carcinomas:&nbsp;</strong>True; HER2/neu (ERBB2) amplification promotes breast cancer progression.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Incorrect statements:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>2. KRAS mutation is more commonly associated with small-cell lung carcinoma:&nbsp;</strong>False; KRAS mutations are more common in non-small cell lung carcinoma (NSCLC).</span></li><li><span style=\"font-size:14.0pt;\"><strong>4. PDGFR-\u03b2 has suppressed expression in colorectal cancers:&nbsp;</strong>False; PDGFR-\u03b2 is often overexpressed in certain cancers, not specifically <strong>suppressed in colorectal cancer.</strong></span></li></ul>",
    "correct_choice_id": 294119,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 73796,
    "choices": [
      {
        "id": 294125,
        "text": "<p><span style=\"font-size:14.0pt;\">4, 5</span></p>"
      },
      {
        "id": 294126,
        "text": "<p><span style=\"font-size:14.0pt;\">1, 3, 4</span></p>"
      },
      {
        "id": 294127,
        "text": "<p><span style=\"font-size:14.0pt;\">2, 3</span></p>"
      },
      {
        "id": 294128,
        "text": "<p><span style=\"font-size:14.0pt;\">1, 2, 3</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">Among the following, which cells have both MHC class I and MHC class II?&nbsp;</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:14.0pt;\">NK cells</span></li><li><span style=\"font-size:14.0pt;\">B-lymphocytes</span></li><li><span style=\"font-size:14.0pt;\">Dendritic cells</span></li><li><span style=\"font-size:14.0pt;\">Platelets</span></li><li><span style=\"font-size:14.0pt;\">RBC</span></li></ol>",
    "unique_key": "Q5684946",
    "question_audio": null,
    "question_video": null,
    "map_id": 33504414,
    "difficulty_level": "intermediate",
    "subjects_id": [
      43
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) 2, 3</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>B-lymphocytes:&nbsp;</strong>Express MHC I and II, present antigens to helper T-cells.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Dendritic cells:&nbsp;</strong>Professional antigen-presenting cells expressing both MHC I and II.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Incorrect options:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>1. NK cells:&nbsp;</strong>Express MHC I but not MHC II.</span></li><li><span style=\"font-size:14.0pt;\"><strong>4. Platelets:&nbsp;</strong>Express MHC I only, no MHC II.</span></li><li><span style=\"font-size:14.0pt;\"><strong>5. RBC:&nbsp;</strong>Lack both MHC I and II.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_h78VaYE.png\" width=\"918\" height=\"496\"></span></p>",
    "correct_choice_id": 294127,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 73804,
    "choices": [
      {
        "id": 294153,
        "text": "<p><span style=\"font-size:14.0pt;\">Spinocerebellar ataxia</span></p>"
      },
      {
        "id": 294154,
        "text": "<p><span style=\"font-size:14.0pt;\">Myotonic dystrophy</span></p>"
      },
      {
        "id": 294155,
        "text": "<p><span style=\"font-size:14.0pt;\">Huntington disease</span></p>"
      },
      {
        "id": 294156,
        "text": "<p><span style=\"font-size:14.0pt;\">Kennedy disease</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">Which of the following conditions is not caused by Trinucleotide repeat mutations involving coding regions?</span></p>",
    "unique_key": "Q1258467",
    "question_audio": null,
    "question_video": null,
    "map_id": 33504415,
    "difficulty_level": "intermediate",
    "subjects_id": [
      43
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Myotonic dystrophy</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Myotonic dystrophy is caused by CTG repeat expansion in the 3\u2032 untranslated region (non-coding region) of the DMPK gene.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Option:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Spinocerebellar ataxia:&nbsp;</strong>Caused by CAG repeat expansions in coding regions.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Huntington disease:&nbsp;</strong>Caused by CAG repeats in the coding region of the HTT gene.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Kennedy disease:&nbsp;</strong>Caused by CAG repeats in the coding region of the androgen receptor gene.</span></p>",
    "correct_choice_id": 294154,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 73812,
    "choices": [
      {
        "id": 294185,
        "text": "<p><span style=\"font-size:14.0pt;\">Myoepithelial cells</span></p>"
      },
      {
        "id": 294186,
        "text": "<p><span style=\"font-size:14.0pt;\">Keratin pearls</span></p>"
      },
      {
        "id": 294187,
        "text": "<p><span style=\"font-size:14.0pt;\">Chondroid differentiation</span></p>"
      },
      {
        "id": 294188,
        "text": "<p><span style=\"font-size:14.0pt;\">Perineural invasion</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">All of the following features are observed in pleomorphic adenoma except:&nbsp;</span></p>",
    "unique_key": "Q5229689",
    "question_audio": null,
    "question_video": null,
    "map_id": 33504416,
    "difficulty_level": "intermediate",
    "subjects_id": [
      43
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) Perineural invasion</strong>&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Pleomorphic adenoma is a <strong>benign salivary gland tumor</strong> and typically <strong>does not show perineural invasion</strong>. It is infact shown by adenoid cystic carcinoma</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Option:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Myoepithelial cells:</strong> Present; contribute to the tumor\u2019s <strong>pleomorphic histology</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Keratin pearls:</strong> Can be seen in areas of <strong>squamous differentiation</strong> within the tumor.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Chondroid differentiation:</strong> Common; gives the characteristic <strong>cartilage-like stroma</strong>.</span></p>",
    "correct_choice_id": 294188,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 73815,
    "choices": [
      {
        "id": 294197,
        "text": "<p><span style=\"font-size:14.0pt;\">1, 2, 3, 4&nbsp;</span></p>"
      },
      {
        "id": 294198,
        "text": "<p><span style=\"font-size:14.0pt;\">2, 4</span></p>"
      },
      {
        "id": 294199,
        "text": "<p><span style=\"font-size:14.0pt;\">1, 3, 4</span></p>"
      },
      {
        "id": 294200,
        "text": "<p><span style=\"font-size:14.0pt;\">1, 3</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">Identify the correct statements:</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:14.0pt;\">In nutmeg liver, dark areas represent necrosis due to passive congestion, and white areas represent viable liver tissue.</span></li><li><span style=\"font-size:14.0pt;\">Sirtuins are a family of seven histone deacetylases involved in increasing insulin sensitivity.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Long-term hemodialysis patients with renal failure lead to development of amyloidosis due to the accumulation of A\u03b22-microglobulin.</span></li><li><span style=\"font-size:14.0pt;\">Factor V Leiden mutation is the most common inherited cause of hypercoagulability.</span></li></ol>",
    "unique_key": "Q1876254",
    "question_audio": null,
    "question_video": null,
    "map_id": 33504417,
    "difficulty_level": "intermediate",
    "subjects_id": [
      43
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) 1, 2, 3, 4</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>All statements are correct</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>1. In nutmeg liver, dark areas represent necrosis due to passive congestion, and white areas represent viable liver tissue:&nbsp;</strong>Dark areas = congested/necrotic, pale areas = viable tissue.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>2. Sirtuins are a family of seven histone deacetylases involved in increasing insulin sensitivity:&nbsp;</strong>Histone deacetylases that improve insulin sensitivity and metabolic regulation.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>3. Long-term hemodialysis patients with renal failure lead to development of amyloidosis due to the accumulation of A\u03b22-microglobulin:&nbsp;</strong>Complication of long-term hemodialysis.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>4. Factor V Leiden mutation is the most common inherited cause of hypercoagulability:&nbsp;</strong>Most common genetic hypercoagulable disorder.</span></p>",
    "correct_choice_id": 294197,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 73838,
    "choices": [
      {
        "id": 294289,
        "text": "<p><span style=\"font-size:14.0pt;\">1, 2, 4, 5&nbsp;</span></p>"
      },
      {
        "id": 294290,
        "text": "<p><span style=\"font-size:14.0pt;\">1, 2, 3</span></p>"
      },
      {
        "id": 294291,
        "text": "<p><span style=\"font-size:14.0pt;\">2, 3, 4, 5</span></p>"
      },
      {
        "id": 294292,
        "text": "<p><span style=\"font-size:14.0pt;\">1, 3, 4</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">What characteristics define necrosis among the options provided?&nbsp;</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:14.0pt;\">Disrupted cell membrane</span></li><li><span style=\"font-size:14.0pt;\">Induces inflammation</span></li><li><span style=\"font-size:14.0pt;\">Swelling of the cell</span></li><li><span style=\"font-size:14.0pt;\">Can be seen physiologically</span></li><li><span style=\"font-size:14.0pt;\">Causes nuclear fragmentation&nbsp;</span></li></ol>",
    "unique_key": "Q3135417",
    "question_audio": null,
    "question_video": null,
    "map_id": 33504871,
    "difficulty_level": "difficult",
    "subjects_id": [
      43
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) 1, 2, 3&nbsp;</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>1. Disrupted cell membrane:&nbsp;</strong>Necrotic cells lose membrane integrity.</span></li><li><span style=\"font-size:14.0pt;\"><strong>2. Induces inflammation:&nbsp;</strong>Necrosis releases intracellular contents, triggering inflammatory response.</span></li><li><span style=\"font-size:14.0pt;\"><strong>3. Swelling of the cell:&nbsp;</strong>Necrotic cells often swell (oncosis) before lysis.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Incorrect statements:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>4. Can be seen physiologically:&nbsp;</strong>False; necrosis is pathological, not physiological.</span></li><li><span style=\"font-size:14.0pt;\"><strong>5. Causes nuclear fragmentation:&nbsp;</strong>More characteristic of apoptosis, not typical necrosis.</span></li></ul>",
    "correct_choice_id": 294290,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 73879,
    "choices": [
      {
        "id": 294453,
        "text": "<p><span style=\"font-size:14.0pt;\">Leukotriene&nbsp;</span></p>"
      },
      {
        "id": 294454,
        "text": "<p><span style=\"font-size:14.0pt;\">Bradykinin&nbsp;</span></p>"
      },
      {
        "id": 294455,
        "text": "<p><span style=\"font-size:14.0pt;\">Prostaglandin E2&nbsp;</span></p>"
      },
      {
        "id": 294456,
        "text": "<p><span style=\"font-size:14.0pt;\">Histamine&nbsp;</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">A 12-year-old boy has frequent episodes of facial edema around his lips. It usually occurs after an emotional stressor. He also has a family history of similar conditions. Which of the following is the main mediator of these symptoms?</span></p>",
    "unique_key": "Q6653066",
    "question_audio": null,
    "question_video": null,
    "map_id": 33504872,
    "difficulty_level": "intermediate",
    "subjects_id": [
      43
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Bradykinin</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The patient likely has hereditary angioedema, where bradykinin is the main mediator causing vascular permeability and swelling.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Option:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Leukotriene:&nbsp;</strong>Involved in allergic reactions and asthma, not hereditary angioedema.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Prostaglandin E2:&nbsp;</strong>Mediates fever and inflammation, not primary in angioedema.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Histamine:&nbsp;</strong>Responsible for allergic urticaria, not bradykinin-mediated hereditary angioedema.</span></p>",
    "correct_choice_id": 294454,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 73905,
    "choices": [
      {
        "id": 294553,
        "text": "<p><span style=\"font-size:14.0pt;\">Rosai-Dorfman disease</span></p>"
      },
      {
        "id": 294554,
        "text": "<p><span style=\"font-size:14.0pt;\">Kimura disease</span></p>"
      },
      {
        "id": 294555,
        "text": "<p><span style=\"font-size:14.0pt;\">Langerhans cell histiocytosis</span></p>"
      },
      {
        "id": 294556,
        "text": "<p><span style=\"font-size:14.0pt;\">Juvenile Xanthogranuloma</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">A 7-year-old child brought to OPD with complaints of fever, erythematous rash, and bone pain. X-ray of the skull revealed multiple lytic lesions. Skin biopsy shows prominent nuclear grooves with eosinophils as in the image below. Immunohistochemistry is positive for S100, CD1a. What is the likely diagnosis?&nbsp;&nbsp;</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_bD8KkFJ.png\" width=\"441\" height=\"388\"></p>",
    "unique_key": "Q8719025",
    "question_audio": null,
    "question_video": null,
    "map_id": 33504873,
    "difficulty_level": "intermediate",
    "subjects_id": [
      43
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Langerhans cell histiocytosis</strong>&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The clinical scenario of a child with fever, rash, bone pain, and multiple lytic skull lesions, together with the skin biopsy showing&nbsp;cells with nuclear grooves and numerous eosinophils, and immunohistochemistry positive for&nbsp;S100 and CD1a, is classic for&nbsp;Langerhans cell histiocytosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Option:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Rosai-Dorfman disease:</strong> Characterized by massive lymphadenopathy with S100+, but not CD1a+, and lacks the nuclear grooves.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Kimura disease:</strong> Presents as chronic subcutaneous inflammation and eosinophilia, not nuclear grooves or CD1a+ staining.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Juvenile Xanthogranuloma:</strong> Shows foam cells and Touton giant cells, not nuclear grooves or CD1a positivity.</span></p>",
    "correct_choice_id": 294555,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "ImageBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 73914,
    "choices": [
      {
        "id": 294589,
        "text": "<p><span style=\"font-size:14.0pt;\">Medullary thyroid carcinoma</span></p>"
      },
      {
        "id": 294590,
        "text": "<p><span style=\"font-size:14.0pt;\">Pituitary adenoma</span></p>"
      },
      {
        "id": 294591,
        "text": "<p><span style=\"font-size:14.0pt;\">Paraganglioma</span></p>"
      },
      {
        "id": 294592,
        "text": "<p><span style=\"font-size:14.0pt;\">Adrenal cortical tumor</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">All of the following conditions are associated with Neurosecretory bodies except:&nbsp;</span></p>",
    "unique_key": "Q4258202",
    "question_audio": null,
    "question_video": null,
    "map_id": 33504874,
    "difficulty_level": "intermediate",
    "subjects_id": [
      43
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) Adrenal cortical tumor</strong>&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Adrenal cortical tumors are of <strong>cortical origin</strong> and <strong>do not contain neurosecretory granules</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Option:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Medullary thyroid carcinoma:</strong> Contains <strong>neurosecretory granules</strong> producing calcitonin.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Pituitary adenoma:</strong> Some <strong>hormone-secreting adenomas</strong> have neurosecretory granules.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Paraganglioma:</strong> Derived from <strong>chromaffin tissue</strong>, contains <strong>neurosecretory granules</strong>.</span></p>",
    "correct_choice_id": 294592,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 73925,
    "choices": [
      {
        "id": 294633,
        "text": "<p><span style=\"font-size:14.0pt;\">1, 2, 3, 4</span></p>"
      },
      {
        "id": 294634,
        "text": "<p><span style=\"font-size:14.0pt;\">1, 2, 4</span></p>"
      },
      {
        "id": 294635,
        "text": "<p><span style=\"font-size:14.0pt;\">3, 4</span></p>"
      },
      {
        "id": 294636,
        "text": "<p><span style=\"font-size:14.0pt;\">1, 3</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">Identify the correct statements</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:14.0pt;\">MCL 1 is an anti-apoptotic gene belonging to the BCL-2 family.</span></li><li><span style=\"font-size:14.0pt;\">Beta-pleated sheets are seen on X-ray crystallography in amyloidosis</span></li><li><span style=\"font-size:14.0pt;\">Complete gonadal dysgenesis in a 46XY individual is caused by the point mutation of the SRY gene.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Diaminobenzidine is a preferred chromogen for peroxidase-mediated reactions in immunohistochemistry</span></li></ol>",
    "unique_key": "Q1266674",
    "question_audio": null,
    "question_video": null,
    "map_id": 33504875,
    "difficulty_level": "intermediate",
    "subjects_id": [
      43
    ],
    "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. B) 1, 2, 4</strong></span></p><p>&nbsp;</p><ol style=\"list-style-type:decimal;\"><li><span style=\"font-size:18px;\">MCL-1 \u2192 Anti-apoptotic member of the BCL-2 family.</span></li><li><span style=\"font-size:18px;\">Beta-pleated sheets \u2192 Characteristic amyloid structure seen on X-ray crystallography.</span></li><li><span style=\"font-size:18px;\">Complete gonadal dysgenesis \u2192 Usually caused by deletions or point mutations in SRY</span></li><li><span style=\"font-size:18px;\">Diaminobenzidine (DAB) \u2192 Commonly used chromogen for peroxidase reactions in IHC, producing a brown precipitate.</span></li></ol>",
    "correct_choice_id": 294634,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 73954,
    "choices": [
      {
        "id": 294749,
        "text": "<p><span style=\"font-size:14.0pt;\">Ewing's sarcoma</span></p>"
      },
      {
        "id": 294750,
        "text": "<p><span style=\"font-size:14.0pt;\">Embryonal rhabdomyosarcoma</span></p>"
      },
      {
        "id": 294751,
        "text": "<p><span style=\"font-size:14.0pt;\">Leukemia</span></p>"
      },
      {
        "id": 294752,
        "text": "<p><span style=\"font-size:14.0pt;\">Retinoblastoma</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">A 4-year-old child was brought to OPD with proptosis of left eye. On investigation, it was found to be a Desmin positive tumour. What can be the likely diagnosis?&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_Mn3XsVG.png\" width=\"1152\" height=\"250\"></span></p>",
    "unique_key": "Q5581420",
    "question_audio": null,
    "question_video": null,
    "map_id": 33504926,
    "difficulty_level": "intermediate",
    "subjects_id": [
      43
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong>&nbsp;<strong>B) Embryonal rhabdomyosarcoma</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The clinical presentation of proptosis in a young child, along with histopathology showing desmin-positive tumor cells on immunohistochemistry, is characteristic of embryonal rhabdomyosarcoma. Desmin is a muscle-specific intermediate filament and a marker for rhabdomyosarcoma.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Option:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Ewing's sarcoma:&nbsp;</strong>Typically CD99 positive, not desmin positive.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Leukemia:&nbsp;</strong>Not associated with desmin positivity or proptosis as a primary feature.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Retinoblastoma:&nbsp;</strong>Mostly presents intraocularly, not with desmin positivity.</span></p>",
    "correct_choice_id": 294750,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "ImageBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 73959,
    "choices": [
      {
        "id": 294769,
        "text": "<p><span style=\"font-size:14.0pt;\">The survival rate of graft is 95% in the first year</span></p>"
      },
      {
        "id": 294770,
        "text": "<p><span style=\"font-size:14.0pt;\">The life expectancy is doubled in a diabetic patient with renal transplant</span></p>"
      },
      {
        "id": 294771,
        "text": "<p><span style=\"font-size:14.0pt;\">The transplantation is cost effective after the second transplant year</span></p>"
      },
      {
        "id": 294772,
        "text": "<p><span style=\"font-size:14.0pt;\">The treatment of chronic rejection has improved over the last 10 years</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">A diabetic nephropathy patient is an ideal candidate for renal graft transplant. Which of the following statements is true?&nbsp;</span></p>",
    "unique_key": "Q8614481",
    "question_audio": null,
    "question_video": null,
    "map_id": 33504927,
    "difficulty_level": "intermediate",
    "subjects_id": [
      43
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C)&nbsp;The transplantation is cost effective after the second transplant year</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Renal transplantation has high initial costs, but becomes cost-effective compared to dialysis typically after 1\u20132 years.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Option:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. The survival rate of graft is 95% in the first year:&nbsp;</strong>Slightly overestimated; one-year graft survival is high but usually around 85\u201390%.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Life expectancy is doubled in a diabetic patient with renal transplant:&nbsp;</strong>Improves survival, but not exactly doubled.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. The treatment of chronic rejection has improved over the last 10 years:&nbsp;</strong>Chronic rejection remains difficult to treat, with limited therapeutic advancements.</span></p>",
    "correct_choice_id": 294771,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 74013,
    "choices": [
      {
        "id": 294981,
        "text": "<p><span style=\"font-size:14.0pt;\">1, 2, 3, 4</span></p>"
      },
      {
        "id": 294982,
        "text": "<p><span style=\"font-size:14.0pt;\">2, 1, 4, 3</span></p>"
      },
      {
        "id": 294983,
        "text": "<p><span style=\"font-size:14.0pt;\">4, 1, 2, 3</span></p>"
      },
      {
        "id": 294984,
        "text": "<p><span style=\"font-size:14.0pt;\">3, 4, 1, 2</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">What is the correct sequence of cellular events of inflammation?</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:14.0pt;\">Selectin&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">ICAM-1</span></li><li><span style=\"font-size:14.0pt;\">CD31</span></li><li><span style=\"font-size:14.0pt;\">IL-8&nbsp;</span></li></ol>",
    "unique_key": "Q2404877",
    "question_audio": null,
    "question_video": null,
    "map_id": 33504928,
    "difficulty_level": "intermediate",
    "subjects_id": [
      43
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong>&nbsp;<strong>A) 1, 2, 3, 4</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>1. Selectin:</strong> Mediates <strong>rolling</strong> of leukocytes along the endothelium.</span></li><li><span style=\"font-size:14.0pt;\"><strong>2. ICAM-1:</strong> Facilitates <strong>firm adhesion</strong> of leukocytes to the endothelial surface.</span></li><li><span style=\"font-size:14.0pt;\"><strong>3. CD31:</strong> Involved in <strong>diapedesis</strong>, allowing leukocytes to <strong>migrate through the endothelium</strong>.</span></li><li><span style=\"font-size:14.0pt;\"><strong>4. IL-8:</strong> Acts as a <strong>chemotactic factor</strong>, guiding leukocytes to the site of inflammation.</span></li></ul>",
    "correct_choice_id": 294981,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 74018,
    "choices": [
      {
        "id": 295001,
        "text": "<p><span style=\"font-size:14.0pt;\">Angiolymphoma</span></p>"
      },
      {
        "id": 295002,
        "text": "<p><span style=\"font-size:14.0pt;\">Hodgkin's lymphoma</span></p>"
      },
      {
        "id": 295003,
        "text": "<p><span style=\"font-size:14.0pt;\">Thymoma</span></p>"
      },
      {
        "id": 295004,
        "text": "<p><span style=\"font-size:14.0pt;\">Castleman disease</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">A CECT of a 35-year-old male is reported as \u201cHypervascular anterior mediastinal mass\u201d. The tumor is resected and the histopathology image of the resected lymph node is shown below. What is the most probable diagnosis?&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-03-10%20163114.jpg\" width=\"534\" height=\"358\"></span></p>",
    "unique_key": "Q6975257",
    "question_audio": null,
    "question_video": null,
    "map_id": 33504929,
    "difficulty_level": "intermediate",
    "subjects_id": [
      43
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) Castleman disease</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The histopathology slide demonstrates lymph node architecture with prominent lymphoid follicles and expanded mantle zones, characteristic of&nbsp;Castleman disease. The associated clinical description of a hypervascular anterior mediastinal mass further supports this diagnosis, as Castleman disease often presents as a solitary mass in the mediastinum and can show \u201conion-skin\u201d appearance of lymphoid tissue.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Option:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Angiolymphoma:&nbsp;</strong>Rare, does not show these features.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Hodgkin's lymphoma:&nbsp;</strong>Typically has Reed-Sternberg cells and different lymph node pattern.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Thymoma:&nbsp;</strong>Originates from thymic epithelial cells, not lymphoid tissue, and histology is distinct.</span></p>",
    "correct_choice_id": 295004,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "ImageBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 74022,
    "choices": [
      {
        "id": 295017,
        "text": "<p><span style=\"font-size:14.0pt;\">1, 5</span></p>"
      },
      {
        "id": 295018,
        "text": "<p><span style=\"font-size:14.0pt;\">1, 2, 3, 4</span></p>"
      },
      {
        "id": 295019,
        "text": "<p><span style=\"font-size:14.0pt;\">1, 2, 4, 5</span></p>"
      },
      {
        "id": 295020,
        "text": "<p><span style=\"font-size:14.0pt;\">2, 3, 4</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">Which mediators involved in the early phase of type 1 hypersensitivity?</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:14.0pt;\">Mast cell</span></li><li><span style=\"font-size:14.0pt;\">Histamine</span></li><li><span style=\"font-size:14.0pt;\">Neutrophils</span></li><li><span style=\"font-size:14.0pt;\">Prostaglandins</span></li><li><span style=\"font-size:14.0pt;\">Leukotrienes</span></li></ol>",
    "unique_key": "Q2272514",
    "question_audio": null,
    "question_video": null,
    "map_id": 33504930,
    "difficulty_level": "intermediate",
    "subjects_id": [
      43
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) 1, 2, 4, 5</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>1. Mast cells:&nbsp;</strong>Activated by IgE, initiate the early phase.</span></li><li><span style=\"font-size:14.0pt;\"><strong>2. Histamine:&nbsp;</strong>Released from mast cells, causing vasodilation, increased permeability, and smooth muscle contraction.</span></li><li><span style=\"font-size:14.0pt;\"><strong>4. Prostaglandins:&nbsp;</strong>Lipid mediators contributing to vasodilation and bronchoconstriction.</span></li><li><span style=\"font-size:14.0pt;\"><strong>5. Leukotrienes: &nbsp;</strong>Lipid mediators causing smooth muscle contraction, increased vascular permeability, and chemotaxis.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Incorrect statement:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>3.&nbsp;</strong>Neutrophils are involved in the late phase, not early phase.</span></li></ul>",
    "correct_choice_id": 295019,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 74025,
    "choices": [
      {
        "id": 295029,
        "text": "<p><span style=\"font-size:14.0pt;\">1, 2, 3, 4, 5</span></p>"
      },
      {
        "id": 295030,
        "text": "<p><span style=\"font-size:14.0pt;\">2, 5</span></p>"
      },
      {
        "id": 295031,
        "text": "<p><span style=\"font-size:14.0pt;\">1, 3, 4</span></p>"
      },
      {
        "id": 295032,
        "text": "<p><span style=\"font-size:14.0pt;\">1, 2, 5</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">Antibody-dependent cellular cytotoxicity (ADCC) is seen with:&nbsp;</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:14.0pt;\">Natural killer (NK) cells&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Macrophages</span></li><li><span style=\"font-size:14.0pt;\">Neutrophils</span></li><li><span style=\"font-size:14.0pt;\">Eosinophils</span></li><li><span style=\"font-size:14.0pt;\">CD4 lymphocytes</span></li></ol>",
    "unique_key": "Q7834466",
    "question_audio": null,
    "question_video": null,
    "map_id": 33505411,
    "difficulty_level": "difficult",
    "subjects_id": [
      43
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) 1, 3, 4</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>1. NK cells:&nbsp;</strong>Express Fc\u03b3RIII (CD16); kill IgG-coated target cells.</span></li><li><span style=\"font-size:14.0pt;\"><strong>3. Neutrophils:&nbsp;</strong>Mediate ADCC via Fc receptors.</span></li><li><span style=\"font-size:14.0pt;\"><strong>4. Eosinophils:&nbsp;</strong>Kill IgE-coated parasites by releasing major basic protein.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Incorrect statements:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>2. Macrophages:&nbsp;</strong>Mainly phagocytose via opsonization, not classical ADCC.</span></li><li><span style=\"font-size:14.0pt;\"><strong>5. CD4 lymphocytes:&nbsp;</strong>Provide help via cytokines, not direct ADCC.</span></li></ul>",
    "correct_choice_id": 295031,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 73979,
    "choices": [
      {
        "id": 294849,
        "text": "<p><span style=\"font-size:14.0pt;\">Involves degranulation of mast cells</span></p>"
      },
      {
        "id": 294850,
        "text": "<p><span style=\"font-size:14.0pt;\">IgE mediated</span></p>"
      },
      {
        "id": 294851,
        "text": "<p><span style=\"font-size:14.0pt;\">Can occur on first exposure</span></p>"
      },
      {
        "id": 294852,
        "text": "<p><span style=\"font-size:14.0pt;\">Most commonly caused by NSAIDs</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">True about anaphylactoid reaction are all except:</span></p>",
    "unique_key": "Q6570286",
    "question_audio": null,
    "question_video": null,
    "map_id": 33505412,
    "difficulty_level": "intermediate",
    "subjects_id": [
      43
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) IgE mediated</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Anaphylactoid reactions are not IgE-mediated; they result from direct mast cell/basophil degranulation.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Option:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Involves degranulation of mast cells:&nbsp;</strong>True, but through non-IgE pathways.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Can occur on first exposure:&nbsp;</strong>True, since prior sensitization is not required.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Most commonly caused by NSAIDs:&nbsp;</strong>True, NSAIDs are frequent triggers along with radiocontrast agents and opioids.</span></p>",
    "correct_choice_id": 294850,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 25663,
    "choices": [
      {
        "id": 102602,
        "text": "<p><span style=\"font-size:18px;\">1, 2, 3, 4</span></p>"
      },
      {
        "id": 102603,
        "text": "<p><span style=\"font-size:18px;\">1, 2, 4, 5</span></p>"
      },
      {
        "id": 102604,
        "text": "<p><span style=\"font-size:18px;\">2, 3, 4, 5</span></p>"
      },
      {
        "id": 102605,
        "text": "<p><span style=\"font-size:18px;\">2, 4</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:18px;\">Identify the true statements:</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:18px;\">TxA2 has platelet aggregating and vasoconstricting effect</span></li><li><span style=\"font-size:18px;\">Lipoxin B4 inhibits inhibit neutrophil chemotaxis and adhesion to endothelium.</span></li><li><span style=\"font-size:18px;\">Il-1, Il-18, TNF are pyrogenic cytokines</span></li><li><span style=\"font-size:18px;\">C3 can be activated in&nbsp;both common as well as alternative pathways</span></li><li><span style=\"font-size:18px;\">T cells with a TCR composed of a \u03b3 and \u03b4 subunit are found associated with GI mucosa</span></li></ol>",
    "unique_key": "Q1839761",
    "question_audio": null,
    "question_video": null,
    "map_id": 33505413,
    "difficulty_level": "intermediate",
    "subjects_id": [
      43
    ],
    "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. B) 1, 2, 4, 5</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>1. TxA\u2082 has platelet aggregating and vasoconstricting effect:&nbsp;</strong>True, it promotes thrombosis and vasoconstriction.</span></li><li><span style=\"font-size:14.0pt;\"><strong>2. Lipoxin B\u2084 inhibits neutrophil chemotaxis and adhesion:&nbsp;</strong>True, it is an anti-inflammatory mediator.</span></li><li><span style=\"font-size:14.0pt;\"><strong>4. C3 can be activated in both classical and alternative pathways:&nbsp;</strong>True, it is central to complement activation.</span></li><li><span style=\"font-size:14.0pt;\"><strong>5. \u03b3\u03b4 T cells are associated with GI mucosa:&nbsp;</strong>True, they act as intraepithelial lymphocytes.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Incorrect statement:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>3. IL-1, IL-18, TNF are pyrogenic cytokines:&nbsp;</strong>IL-1 &amp; TNF are pyrogenic, but IL-18 mainly induces IFN-\u03b3 and is not a classical pyrogen.</span></li></ul>",
    "correct_choice_id": 102603,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 74043,
    "choices": [
      {
        "id": 295101,
        "text": "<p><span style=\"font-size:14.0pt;\">Marfan syndrome</span></p>"
      },
      {
        "id": 295102,
        "text": "<p><span style=\"font-size:14.0pt;\">Hemophilia A</span></p>"
      },
      {
        "id": 295103,
        "text": "<p><span style=\"font-size:14.0pt;\">Hemophilia C</span></p>"
      },
      {
        "id": 295104,
        "text": "<p><span style=\"font-size:14.0pt;\">NARP</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">Identify the disorder inherited by the following pedigree:</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-03-10%20173800.jpg\" width=\"633\" height=\"244\"></span></p>",
    "unique_key": "Q5550455",
    "question_audio": null,
    "question_video": null,
    "map_id": 33505414,
    "difficulty_level": "intermediate",
    "subjects_id": [
      43
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong></span> <span style=\"font-size:14.0pt;\"><strong>D) NARP</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The pedigree shows&nbsp;inheritance only through females with affected males and females in each generation, consistent with&nbsp;mitochondrial inheritance. NARP (Neuropathy, Ataxia, and Retinitis Pigmentosa) is a mitochondrial disorder inherited exclusively from the mother; all offspring of affected mothers may show the disease, while offspring of affected fathers are unaffected.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Option:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A.&nbsp;Marfan syndrome:&nbsp;</strong>Autosomal dominant, would be seen in both males and females, but not restricted to maternal inheritance.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B and C.&nbsp;Hemophilia A and C:&nbsp;</strong>X-linked recessive; mostly affects males, and would show different pattern in pedigree.</span></p>",
    "correct_choice_id": 295104,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "ImageBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 73900,
    "choices": [
      {
        "id": 294533,
        "text": "<p><span style=\"font-size:14.0pt;\">CGH&nbsp;</span></p>"
      },
      {
        "id": 294534,
        "text": "<p><span style=\"font-size:14.0pt;\">Micro nucleus test&nbsp;</span></p>"
      },
      {
        "id": 294535,
        "text": "<p><span style=\"font-size:14.0pt;\">Microtox bio-assay</span></p>"
      },
      {
        "id": 294536,
        "text": "<p><span style=\"font-size:14.0pt;\">Ames test</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">You work under a research scientist who is working on determining the association of adenocarcinoma of pancreas with a compound X. He uses a test whose steps are shown in the image below to determine the mutagenic effect and potential carcinogenicity of compound X. What is this test that he has used?</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-03-10%20133236.jpg\" width=\"854\" height=\"510\"></span></p>",
    "unique_key": "Q8003735",
    "question_audio": null,
    "question_video": null,
    "map_id": 33505415,
    "difficulty_level": "beginner",
    "subjects_id": [
      43
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) Ames test</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The image shows the classic Ames test, which is used to assess the mutagenic and carcinogenic potential of a compound by observing its ability to induce genetic mutations in a strain of Salmonella that requires histidine for growth. An increased number of revertant colonies (his- to his+) after exposure to the compound, especially compared to the control, indicates that the compound X may cause mutations.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Option:</strong></span></p><p><br><span style=\"font-size:14.0pt;\"><strong>Option A.&nbsp;CGH (Comparative Genomic Hybridization):&nbsp;</strong>detects genomic abnormalities, not mutagenicity.</span></p><p><br><span style=\"font-size:14.0pt;\"><strong>Option B.&nbsp;Micro nucleus test:&nbsp;</strong>evaluates chromosomal damage, not point mutations in bacteria.</span></p><p><br><span style=\"font-size:14.0pt;\"><strong>Option C.&nbsp;Microtox bio-assay:&nbsp;</strong>measures toxicity using bioluminescent bacteria, not mutagenicity.</span></p>",
    "correct_choice_id": 294536,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "ImageBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 35614,
    "choices": [
      {
        "id": 142263,
        "text": "<p><span style=\"font-size:14.0pt;\">Light blue&nbsp;\u2192 Red \u2192 Lavender&nbsp;\u2192 Grey</span></p>"
      },
      {
        "id": 142264,
        "text": "<p><span style=\"font-size:14.0pt;\">Light blue \u2192 Lavender&nbsp;\u2192 Red&nbsp;\u2192 Grey</span></p>"
      },
      {
        "id": 142265,
        "text": "<p><span style=\"font-size:14.0pt;\">Grey&nbsp;\u2192 Red \u2192 Light blue&nbsp;\u2192 Lavender</span></p>"
      },
      {
        "id": 142266,
        "text": "<p><span style=\"font-size:14.0pt;\">Red&nbsp;\u2192 Lavender&nbsp;\u2192 Grey&nbsp;\u2192 Light blue</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:18px;\">The phlebotomist needs to collect samples from a patient for various tests. Among the options provided, which sequence of blood collection for testing ensures that the sample remains uncontaminated, considering the additives present in the collection tubes?</span></p>",
    "unique_key": "Q6579686",
    "question_audio": null,
    "question_video": null,
    "map_id": 33505476,
    "difficulty_level": "beginner",
    "subjects_id": [
      43
    ],
    "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. A) Light blue \u2192 Red \u2192 Lavender \u2192 Grey</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Light blue (Citrate tube):&nbsp;</strong>Collected first to avoid contamination with clot activators or EDTA that can affect coagulation studies.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Red (Plain tube, no anticoagulant):&nbsp;</strong>Collected next for serology/chemistry, avoids interference from EDTA or fluoride.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Lavender (EDTA tube):&nbsp;</strong>Collected later for hematology; prevents EDTA carryover from affecting earlier tests.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Grey (Fluoride oxalate tube):&nbsp;</strong>Collected last for glucose/lactate estimation, since fluoride inhibits glycolysis and would interfere with other tests if drawn earlier.</span></li></ul>",
    "correct_choice_id": 142263,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 73913,
    "choices": [
      {
        "id": 294585,
        "text": "<p><span style=\"font-size:14.0pt;\">Glutaraldehyde</span></p>"
      },
      {
        "id": 294586,
        "text": "<p><span style=\"font-size:14.0pt;\">Formaldehyde</span></p>"
      },
      {
        "id": 294587,
        "text": "<p><span style=\"font-size:14.0pt;\">Methanol</span></p>"
      },
      {
        "id": 294588,
        "text": "<p><span style=\"font-size:14.0pt;\">Osmium tetraoxide</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">All of the following are crosslinking fixatives except:</span></p>",
    "unique_key": "Q8400399",
    "question_audio": null,
    "question_video": null,
    "map_id": 33505477,
    "difficulty_level": "intermediate",
    "subjects_id": [
      43
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Methanol</strong>&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Methanol</strong> <strong>Not a crosslinking fixative</strong>; it is a <strong>precipitating/coagulant fixative</strong> that denatures proteins rather than crosslinking them.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Option:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Glutaraldehyde:</strong> Crosslinking fixative; links proteins by forming covalent bonds.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Formaldehyde:</strong> Crosslinking fixative; creates methylene bridges between proteins.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Osmium tetroxide:</strong> Crosslinking fixative; reacts with lipids and proteins, mainly used in EM.</span></p>",
    "correct_choice_id": 294587,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 59858,
    "choices": [
      {
        "id": 238733,
        "text": "<p><span style=\"font-size:18px;\">Donor T cells in the graft</span></p>"
      },
      {
        "id": 238734,
        "text": "<p><span style=\"font-size:18px;\">Newly formed anti-HLA antibodies</span></p>"
      },
      {
        "id": 238735,
        "text": "<p><span style=\"font-size:18px;\">Proliferating transplanted B cells</span></p>"
      },
      {
        "id": 238736,
        "text": "<p><span style=\"font-size:18px;\">Activated recipient T cells</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:18px;\">Two weeks after undergoing allogeneic stem cell transplant for multiple myeloma, a 55-year-old man develops a severely pruritic rash, abdominal cramps, and profuse diarrhea. He appears lethargic. Physical examination shows yellow sclerae. There is a generalized maculopapular rash on his face, trunk, and lower extremities, and desquamation of both soles. His serum alanine aminotransferase is 115 U/L, serum aspartate aminotransferase is 97 U/L, and serum total bilirubin is 2.7 mg/dL. Which of the following is the most likely underlying cause of this patient's condition?</span></p>",
    "unique_key": "Q2846534",
    "question_audio": null,
    "question_video": null,
    "map_id": 33505478,
    "difficulty_level": "intermediate",
    "subjects_id": [
      43
    ],
    "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. A) Donor T cells in the graft</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Clinical scenario: Patient develops rash, diarrhoea, jaundice, and liver enzyme elevation 2 weeks post\u2013allogeneic stem cell transplant \u2192 classic for acute graft-versus-host disease (GVHD).</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Mechanism: Donor T cells in the graft recognize recipient (host) antigens as foreign and mount an immune attack against host tissues (skin, liver, GI tract).</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Option:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Newly formed anti-HLA antibodies:&nbsp;</strong>Seen in graft rejection, not GVHD.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Proliferating transplanted B cells:&nbsp;</strong>May cause post-transplant lymphoproliferative disorder (EBV-related), not GVHD.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Activated recipient T cells:&nbsp;</strong>Would mediate host-versus-graft rejection, but here the host marrow has been ablated.</span></p>",
    "correct_choice_id": 238733,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 82874,
    "choices": [
      {
        "id": 330104,
        "text": "<p><span style=\"font-size:14.0pt;\">Bielchowsky stain</span></p>"
      },
      {
        "id": 330105,
        "text": "<p><span style=\"font-size:14.0pt;\">Verhoeff's stain</span></p>"
      },
      {
        "id": 330106,
        "text": "<p><span style=\"font-size:14.0pt;\">GMS Silver stain</span></p>"
      },
      {
        "id": 330107,
        "text": "<p><span style=\"font-size:14.0pt;\">Alcian Blue stain</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">Which of the following stains are used to visualize the specific fibers present in the following cartilage?</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-06-07%20095425.jpg\" width=\"486\" height=\"305\"></span></p>",
    "unique_key": "Q9487566",
    "question_audio": null,
    "question_video": null,
    "map_id": 33505479,
    "difficulty_level": "intermediate",
    "subjects_id": [
      43
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Verhoeff's stain</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The image shows&nbsp;elastic cartilage, identified by the presence of densely packed chondrocytes and a matrix containing elastic fibers.&nbsp;Verhoeff\u2019s stain&nbsp;is specifically used to visualize&nbsp;elastic fibers, turning them black and allowing for detailed study of their distribution in tissues like elastic cartilage.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Option:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Bielchowsky stain</strong>: Used for nerve fibers.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_ICqPIBT.png\" width=\"536\" height=\"426\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C.</strong> <strong>GMS silver stain:&nbsp;</strong>Used for fungi.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_qMk2SlA.png\" width=\"551\" height=\"440\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D.</strong> <strong>Alcian Blue stain:&nbsp;</strong>Used for acidic mucopolysaccharides, not specifically elastic fibers.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_V3N7XhZ.png\" width=\"597\" height=\"426\"></span></p>",
    "correct_choice_id": 330105,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 73977,
    "choices": [
      {
        "id": 294841,
        "text": "<p><span style=\"font-size:14.0pt;\">Is both intra and extra cellular</span></p>"
      },
      {
        "id": 294842,
        "text": "<p><span style=\"font-size:14.0pt;\">Can happen due to nutrient deprivation&nbsp;</span></p>"
      },
      {
        "id": 294843,
        "text": "<p><span style=\"font-size:14.0pt;\">Phagolysosome fuses with lysosome to form autophagolysosome</span></p>"
      },
      {
        "id": 294844,
        "text": "<p><span style=\"font-size:14.0pt;\">Bound by a double membrane&nbsp;</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">All of following are the correct statement about autophagy except:</span></p>",
    "unique_key": "Q3855279",
    "question_audio": null,
    "question_video": null,
    "map_id": 33505480,
    "difficulty_level": "intermediate",
    "subjects_id": [
      43
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Is both intra and extra cellular</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Autophagy</strong> is a strictly <strong>intracellular process</strong>, not extracellular.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Option:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Can happen due to nutrient deprivation:</strong> True; autophagy is upregulated during <strong>starvation</strong> to recycle cellular components.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Phagophore/autophagosome fuses with lysosome to form autophagolysosome:</strong> True; degradation occurs here.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Bound by a double membrane:</strong> True; autophagosomes are typically <strong>double-membrane bound vesicles</strong>.</span></p>",
    "correct_choice_id": 294841,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 25748,
    "choices": [
      {
        "id": 102942,
        "text": "<p><span style=\"font-size:14.0pt;\">1, 2&nbsp;</span></p>"
      },
      {
        "id": 102943,
        "text": "<p><span style=\"font-size:14.0pt;\">2, 4</span></p>"
      },
      {
        "id": 102944,
        "text": "<p><span style=\"font-size:14.0pt;\">1, 3, 4&nbsp;</span></p>"
      },
      {
        "id": 102945,
        "text": "<p><span style=\"font-size:14.0pt;\">1, 2, 3, 4</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:18px;\">Which of the following is true about nitric oxide?</span></p><ol><li><span style=\"font-size:18px;\">eNOS is constitutively expressed and helps regulate vascular tone.</span></li><li><span style=\"font-size:18px;\">NO helps in generation of free radicals in neutrophil at the time of inflammation&nbsp;</span></li><li><span style=\"font-size:18px;\">Interferon-\u03b3 (IFN-\u03b3) or microbial products can activate inducible NOS.</span></li><li><span style=\"font-size:18px;\">Synthesis of NO requires NOS action on arginine.</span></li></ol>",
    "unique_key": "Q2570789",
    "question_audio": null,
    "question_video": null,
    "map_id": 33505981,
    "difficulty_level": "difficult",
    "subjects_id": [
      43
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) 1, 3, 4&nbsp;</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">1. eNOS is constitutively expressed and helps regulate vascular tone \u2192 True, not false; eNOS is always active in endothelium.</span></li><li><span style=\"font-size:14.0pt;\">3. IFN-\u03b3 or microbial products can activate inducible NOS \u2192 True, iNOS is induced by cytokines (e.g., IFN-\u03b3) and endotoxin.</span></li><li><span style=\"font-size:14.0pt;\">4. Synthesis of NO requires NOS action on arginine \u2192 True, arginine \u2192 citrulline + NO via nitric oxide synthase.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Incorrect statement:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">2. NO helps in generation of free radicals in neutrophil at the time of inflammation \u2192 Not true; neutrophils use NADPH oxidase to make superoxide, not NO.</span></li></ul>",
    "correct_choice_id": 102944,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 55376,
    "choices": [
      {
        "id": 220965,
        "text": "<p><span style=\"font-size:18px;\">Heparin + EDTA</span></p>"
      },
      {
        "id": 220966,
        "text": "<p><span style=\"font-size:18px;\">Sodium fluoride + Potassium dichromate</span></p>"
      },
      {
        "id": 220967,
        "text": "<p><span style=\"font-size:18px;\">Heparin</span></p>"
      },
      {
        "id": 220968,
        "text": "<p><span style=\"font-size:18px;\">Sodium citrate</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:18px;\">Which of the following substances is used for sample collection in a tube for blood alcohol concentration measurement? (FMGE JULY 2024)</span></p>",
    "unique_key": "Q4721064",
    "question_audio": null,
    "question_video": null,
    "map_id": 33505982,
    "difficulty_level": "beginner",
    "subjects_id": [],
    "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. B) Sodium fluoride + Potassium dichromate</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">Blood alcohol concentration (BAC) can be measured through various methods, including gas chromatography. For accurate measurement of BAC, the blood sample is typically collected in a <strong>gray-top vial.</strong> This vial contains a mixture of sodium fluoride and potassium oxalate.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">Sodium fluoride acts as a preservative and prevents glycolysis, which could otherwise lower the concentration of alcohol in the blood sample.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">However, when using the potassium dichromate test for BAC, potassium dichromate is included in the sample collection tube. In this test, potassium dichromate, which is orange in color, reacts with ethanol present in the blood sample. This reaction converts ethanol to acetic acid and simultaneously reduces potassium dichromate to chromium, which turns the solution green. The intensity of the green color directly correlates with the alcohol concentration in the sample, providing a visual indication of BAC.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option A. Heparin + EDTA</strong>: This combination is generally used as an anticoagulant in blood samples for various laboratory tests but is not specifically used for BAC measurement.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option C. Heparin</strong>: While heparin is an anticoagulant, it is not used in the collection tubes for blood alcohol concentration testing.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option D. Sodium citrate</strong>: Sodium citrate is also an anticoagulant, commonly used in coagulation studies, but it is not relevant for BAC measurement.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Sodium fluoride and potassium dichromate are the substances used in the tube for blood alcohol concentration measurement.</strong> Potassium dichromate reacts with ethanol in the blood sample, facilitating the detection and quantification of alcohol concentration</span></p>",
    "correct_choice_id": 220966,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "FMGE",
      "InvestigationBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 67035,
    "choices": [
      {
        "id": 267273,
        "text": "<p><span style=\"font-size:14.0pt;\">Desmoid tumor</span></p>"
      },
      {
        "id": 267274,
        "text": "<p><span style=\"font-size:14.0pt;\">Leiomyosarcoma</span></p>"
      },
      {
        "id": 267275,
        "text": "<p><span style=\"font-size:14.0pt;\">Mesothelioma</span></p>"
      },
      {
        "id": 267276,
        "text": "<p><span style=\"font-size:14.0pt;\">Synovial sarcoma</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">A 66-year-old woman has experienced pain in the area around the left knee for the past 6 weeks. MRI shows a well-circumscribed 4-cm mass superior and inferior to the patella. The mass is within soft tissue, without bony erosion. A biopsy of the mass is obtained and on microscopic examination shows a biphasic pattern of spindle cells and epithelial cells forming glands. Karyotypic analysis of tumor cells shows a t(X;18) translocation. What is the most likely diagnosis?</span></p>",
    "unique_key": "Q8013120",
    "question_audio": null,
    "question_video": null,
    "map_id": 33505983,
    "difficulty_level": "difficult",
    "subjects_id": [
      43
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) Synovial sarcoma</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Characterized by biphasic pattern (spindle cells + epithelial gland-like structures) and t(X;18) translocation, most common near large joints in young to middle-aged adults.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Desmoid tumor:&nbsp;</strong>Fibroblastic proliferation, locally aggressive, no glandular structures or t(X;18).</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Leiomyosarcoma:&nbsp;</strong>Malignant smooth muscle tumor, shows fascicles of spindle cells with blunt-ended nuclei, no biphasic pattern or translocation.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Mesothelioma:&nbsp;</strong>Malignancy of pleura/peritoneum, not localized to knee, no specific t(X;18).</span></p>",
    "correct_choice_id": 267276,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 85654,
    "choices": [
      {
        "id": 341156,
        "text": "<p><span style=\"font-size:14.0pt;\">Caused by turbulent blood flow</span></p>"
      },
      {
        "id": 341157,
        "text": "<p><span style=\"font-size:14.0pt;\">Common in deep leg veins</span></p>"
      },
      {
        "id": 341158,
        "text": "<p><span style=\"font-size:14.0pt;\">Propagate in antegrade manner</span></p>"
      },
      {
        "id": 341159,
        "text": "<p><span style=\"font-size:14.0pt;\">Composed mainly of red cells (Red Thrombi)</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">All are features of venous thrombus, except:</span></p>",
    "unique_key": "Q6866449",
    "question_audio": null,
    "question_video": null,
    "map_id": 33505984,
    "difficulty_level": "difficult",
    "subjects_id": [
      43
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Caused by turbulent blood flow</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Venous thrombi are caused by stasis of blood, not turbulence (which is seen in arterial thrombi).</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Common in deep leg veins:&nbsp;</strong>True, most venous thrombi occur in deep veins of the leg.</span><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Propagate in antegrade manner:&nbsp;</strong>True, venous thrombi extend in the direction of blood flow.</span><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Composed mainly of red cells (red thrombi):&nbsp;</strong>True, venous thrombi are rich in RBCs and fibrin.</span></p>",
    "correct_choice_id": 341156,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 85753,
    "choices": [
      {
        "id": 341548,
        "text": "<p><span style=\"font-size:14.0pt;\">CK7 positive, CK20 positive</span></p>"
      },
      {
        "id": 341549,
        "text": "<p><span style=\"font-size:14.0pt;\">CK7 negative, CK20 positive</span></p>"
      },
      {
        "id": 341550,
        "text": "<p><span style=\"font-size:14.0pt;\">CK7 positive, CK20 negative</span></p>"
      },
      {
        "id": 341551,
        "text": "<p><span style=\"font-size:14.0pt;\">CK7 negative, CK20 negative</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">Which of the following pairs correctly describes the immunohistochemical property of renal cell carcinoma?</span></p>",
    "unique_key": "Q6990727",
    "question_audio": null,
    "question_video": null,
    "map_id": 33505985,
    "difficulty_level": "intermediate",
    "subjects_id": [
      43
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) CK7 negative, CK20 negative</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Clear cell renal cell carcinoma is characteristically negative for both CK7 and CK20.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p><br><span style=\"font-size:14.0pt;\"><strong>Option A. CK7 positive, CK20 positive:&nbsp;</strong>Incorrect, this pattern is typical for some urothelial carcinomas, not RCC.</span><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. CK7 negative, CK20 positive:&nbsp;</strong>Incorrect, CK20 positivity is not seen in RCC.</span><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. CK7 positive, CK20 negative:&nbsp;</strong>Incorrect, CK7 can be positive in papillary RCC, but not in clear cell RCC (the most common subtype).</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_L9qh5kS.png\" width=\"978\" height=\"428\"></span></p>",
    "correct_choice_id": 341551,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 92362,
    "choices": [
      {
        "id": 367756,
        "text": "<p><span style=\"font-size:14.0pt;\">Dynein</span></p>"
      },
      {
        "id": 367757,
        "text": "<p><span style=\"font-size:14.0pt;\">Kinesin&nbsp;</span></p>"
      },
      {
        "id": 367758,
        "text": "<p><span style=\"font-size:14.0pt;\">Lamin&nbsp;</span></p>"
      },
      {
        "id": 367759,
        "text": "<p><span style=\"font-size:14.0pt;\">Selectin</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">Upon reactivation of VZV, the virus is transported through the nerve axon to the skin. Which of the following proteins is most likely involved in the transport process leading to disease recurrence?</span></p>",
    "unique_key": "Q9884086",
    "question_audio": null,
    "question_video": null,
    "map_id": 33506406,
    "difficulty_level": "intermediate",
    "subjects_id": [
      43
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Kinesin</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Kinesin is the motor protein responsible for anterograde transport of VZV along microtubules from the neuronal cell body to the skin during reactivation.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p><br><span style=\"font-size:14.0pt;\"><strong>Option</strong> <strong>A.</strong> <strong>Dynein:&nbsp;</strong>Incorrect, dynein mediates retrograde transport (from periphery to neuronal cell body).</span><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option</strong> <strong>C. Lamin:&nbsp;</strong>Incorrect, lamins are nuclear envelope structural proteins, not involved in axonal transport.</span><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Selectin:&nbsp;</strong>Incorrect, selectins mediate leukocyte adhesion and rolling, not viral transport.</span></p>",
    "correct_choice_id": 367757,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 92363,
    "choices": [
      {
        "id": 367760,
        "text": "<p><span style=\"font-size:14.0pt;\">Acute gastrointestinal hemorrhage</span></p>"
      },
      {
        "id": 367761,
        "text": "<p><span style=\"font-size:14.0pt;\">Diabetes insipidus</span></p>"
      },
      {
        "id": 367762,
        "text": "<p><span style=\"font-size:14.0pt;\">Hypertonic saline infusion</span></p>"
      },
      {
        "id": 367763,
        "text": "<p><span style=\"font-size:14.0pt;\">Primary polydipsia</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">The solid line represents a normal individual, and the dotted line represents this patient. Which of the following conditions is most likely causing this patient\u2019s findings?</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_fDEHnH7.png\" width=\"863\" height=\"295\"></span></p>",
    "unique_key": "Q5681809",
    "question_audio": null,
    "question_video": null,
    "map_id": 33506407,
    "difficulty_level": "intermediate",
    "subjects_id": [
      43
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) Primary polydipsia</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The graph shows <strong>reduced concentration of solute with increased volume</strong> in the dotted line compared to the solid line, which represents a normal individual. This pattern is characteristic of <strong>primary polydipsia</strong>, a condition in which excessive water intake leads to dilute urine (low solute concentration) and high urine volume.image.jpg</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Acute gastrointestinal hemorrhage:</strong> Typically causes low urinary volume, not dilute urine.</span><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Diabetes insipidus:&nbsp;</strong>Has increased urine volume but with poor concentration ability, not matching the dilution seen here.</span><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option</strong> <strong>C. Hypertonic saline infusion:</strong> Would result in concentrated urine, not dilute.</span></p>",
    "correct_choice_id": 367763,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 92364,
    "choices": [
      {
        "id": 367764,
        "text": "<p><span style=\"font-size:14.0pt;\">PaCo2 normal, PaO2 normal, pH decreases, PvCo2 high, PvO2 low</span></p>"
      },
      {
        "id": 367765,
        "text": "<p><span style=\"font-size:14.0pt;\">PaCo2 low, PaO2 normal, pH decreases, PvCo2 high, PvO2 low</span></p>"
      },
      {
        "id": 367766,
        "text": "<p><span style=\"font-size:14.0pt;\">PaCo2 high, PaO2 low, pH increases, PvCo2 high, PvO2 low</span></p>"
      },
      {
        "id": 367767,
        "text": "<p><span style=\"font-size:14.0pt;\">PaCo2 low, PaO2 low, pH normal, PvCo2 high, PvO2 low</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">23-year-old man undergoes exercise physiology testing. He jogs on a treadmill to achieve a moderate-intensity physical activity level based on a target heart rate of 50%-70% of his estimated maximum heart rate. Which of the following is expected at peak exercise?</span></p>",
    "unique_key": "Q6895972",
    "question_audio": null,
    "question_video": null,
    "map_id": 33506408,
    "difficulty_level": "intermediate",
    "subjects_id": [
      43
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) PaCO\u2082 low, PaO\u2082 normal, pH decreases, PvCO\u2082 high, PvO\u2082 low:&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">At peak exercise:</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>PaCO\u2082 low</strong>: Hyperventilation during exercise causes more CO\u2082 to be blown off.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>PaO\u2082 normal:</strong> Arterial oxygenation is usually preserved due to efficient gas exchange.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>pH decreases</strong>: Due to lactic acidosis from anaerobic metabolism.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>PvCO\u2082 high</strong>: More CO\u2082 is generated by working muscles.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>PvO\u2082 low</strong>: Increased O\u2082 extraction by tissues.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p><br><span style=\"font-size:14.0pt;\"><strong>Option</strong> <strong>A.&nbsp;PaCo2 normal, PaO2 normal, pH decreases, PvCo2 high, PvO2 low:</strong> Incorrect, because hyperventilation lowers PaCO\u2082.</span><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option</strong> <strong>C.&nbsp;PaCo2 low, PaO2 normal, pH decreases, PvCo2 high, PvO2 low:&nbsp;</strong>Incorrect, acidosis (\u2193pH) occurs, not alkalosis; PaO\u2082 is maintained.</span><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option</strong> <strong>D.&nbsp;PaCo2 high, PaO2 low, pH increases, PvCo2 high, PvO2 low:&nbsp;</strong>Incorrect, PaO\u2082 remains normal and pH decreases.</span></p>",
    "correct_choice_id": 367765,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 74435,
    "choices": [
      {
        "id": 296661,
        "text": "<p><span style=\"font-size:14.0pt;\">Lateral inhibition&nbsp;</span></p>"
      },
      {
        "id": 296662,
        "text": "<p><span style=\"font-size:14.0pt;\">Feedback inhibition&nbsp;</span></p>"
      },
      {
        "id": 296663,
        "text": "<p><span style=\"font-size:14.0pt;\">Feedforward inhibition&nbsp;</span></p>"
      },
      {
        "id": 296664,
        "text": "<p><span style=\"font-size:14.0pt;\">Recurrent inhibition&nbsp;</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">All of the following are the properties of Renshaw cells except:</span></p>",
    "unique_key": "Q9059851",
    "question_audio": null,
    "question_video": null,
    "map_id": 33506479,
    "difficulty_level": "beginner",
    "subjects_id": [
      43
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Feedforward inhibition&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Renshaw cells are inhibitory interneurons in the spinal cord that receive excitatory input from \u03b1-motor neurons and, in turn, inhibit the same motor neuron or its neighbors.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p><br><span style=\"font-size:14.0pt;\"><strong>Option A. Lateral inhibition:&nbsp;</strong>Renshaw cells can inhibit neighboring motor neurons, helping sharpen motor signals.</span><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Feedback inhibition:&nbsp;</strong>They are activated by motor neurons and send inhibitory signals back, a classic example of feedback inhibition.</span><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Recurrent inhibition:&nbsp;</strong>Renshaw cells provide recurrent inhibition of motor neurons via glycine release.</span></p>",
    "correct_choice_id": 296663,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 74458,
    "choices": [
      {
        "id": 296753,
        "text": "<p><span style=\"font-size:14.0pt;\">Actin</span></p>"
      },
      {
        "id": 296754,
        "text": "<p><span style=\"font-size:14.0pt;\">Myosin&nbsp;</span></p>"
      },
      {
        "id": 296755,
        "text": "<p><span style=\"font-size:14.0pt;\">Tropomyosin&nbsp;</span></p>"
      },
      {
        "id": 296756,
        "text": "<p><span style=\"font-size:14.0pt;\">Troponin&nbsp;</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">An 18-year-old man, who was recently started on risperidone therapy for schizophrenia, comes to the office due to involuntary deviation of his head. There is palpable tightening of the right sternocleidomastoid muscle. It is determined that the patient is experiencing a medication-induced dystonic reaction due to motor neuron hyperactivity. The persistent myocyte stimulation causes a substance to be released from the sarcoplasmic reticulum. This substance most likely binds to which of the following proteins to cause this patient's symptoms?</span></p>",
    "unique_key": "Q8036112",
    "question_audio": null,
    "question_video": null,
    "map_id": 33506480,
    "difficulty_level": "beginner",
    "subjects_id": [
      43
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) Troponin</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">In acute dystonia caused by antipsychotics (eg, risperidone), excessive stimulation of motor neurons leads to sustained depolarization at the neuromuscular junction.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">This causes continuous release of calcium from the sarcoplasmic reticulum via ryanodine receptors.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Calcium then binds to troponin C, which moves tropomyosin away from actin\u2019s myosin-binding sites, allowing persistent actin-myosin cross-bridge cycling \u2192 sustained muscle contraction.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Actin:&nbsp;</strong>Structural protein of thin filaments, but calcium does not bind directly to it.</span><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Myosin:&nbsp;</strong>Thick filament motor protein that binds actin once tropomyosin shifts, but it is not the calcium-binding site.</span><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Tropomyosin:&nbsp;</strong>Covers myosin-binding sites on actin; calcium binding does not occur here, but calcium binding to troponin moves tropomyosin.</span></p>",
    "correct_choice_id": 296756,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 61892,
    "choices": [
      {
        "id": 246837,
        "text": "<p><span style=\"font-size:14.0pt;\">Calcium</span></p>"
      },
      {
        "id": 246838,
        "text": "<p><span style=\"font-size:14.0pt;\">Sodium</span></p>"
      },
      {
        "id": 246839,
        "text": "<p><span style=\"font-size:14.0pt;\">Potassium</span></p>"
      },
      {
        "id": 246840,
        "text": "<p><span style=\"font-size:14.0pt;\">Chloride</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">The resting membrane potential(RMP) of the nerve is - 70mV. Increased permeability of which ion is responsible for the RMP?</span></p>",
    "unique_key": "Q9888416",
    "question_audio": null,
    "question_video": null,
    "map_id": 33509120,
    "difficulty_level": "beginner",
    "subjects_id": [
      43
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Potassium</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The resting membrane potential (RMP \u2248 \u201370 mV) is mainly determined by the high permeability of the neuronal membrane to potassium (K\u207a) at rest.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Potassium leak channels allow K\u207a to diffuse out of the cell (down its concentration gradient), leaving behind negatively charged proteins, which stabilizes the negative RMP.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p><br><span style=\"font-size:14.0pt;\"><strong>Option A. Calcium:&nbsp;</strong>Intracellular calcium concentration is very low, but calcium channels are closed at rest; negligible role in RMP.</span><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Sodium:&nbsp;</strong>Some Na\u207a leaks in, but at rest the membrane is much less permeable to Na\u207a compared to K\u207a.</span><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Chloride:&nbsp;</strong>Helps in inhibitory signaling, but does not primarily set the RMP.</span></p>",
    "correct_choice_id": 246839,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 74494,
    "choices": [
      {
        "id": 296897,
        "text": "<p><span style=\"font-size:14.0pt;\">\ufeff\ufeff\ufeff20-25 Hz</span></p>"
      },
      {
        "id": 296898,
        "text": "<p><span style=\"font-size:14.0pt;\">\ufeff\ufeff\ufeff30-35 Hz</span></p>"
      },
      {
        "id": 296899,
        "text": "<p><span style=\"font-size:14.0pt;\">\ufeff\ufeff\ufeff15-20 Hz</span></p>"
      },
      {
        "id": 296900,
        "text": "<p><span style=\"font-size:14.0pt;\">\ufeff\ufeff\ufeff10-15 Hz</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">Given below is the demonstration of tetanisation in the gastrocnemius muscle of a frog. Identify the tetanising frequency?</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_74LzxNh.png\" width=\"261\" height=\"227\"></span></p>",
    "unique_key": "Q4005616",
    "question_audio": null,
    "question_video": null,
    "map_id": 33509121,
    "difficulty_level": "beginner",
    "subjects_id": [
      43
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) 20-25 Hz</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The graph illustrates the response of the gastrocnemius muscle to a single stimulus, typically showing a single twitch contraction. Formula for tetanizing frequency = 100/time taken to reach highest amplitude{tension}.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">100/[4-5] = 20-25Hz</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">This frequency is required for individual twitches to merge and produce a smooth, continuous increase in tension.</span></p>",
    "correct_choice_id": 296897,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "ImageBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 71221,
    "choices": [
      {
        "id": 283901,
        "text": "<p><span style=\"font-size:14.0pt;\">2-1-3-4&nbsp;</span></p>"
      },
      {
        "id": 283902,
        "text": "<p><span style=\"font-size:14.0pt;\">2-1-4-3</span></p>"
      },
      {
        "id": 283903,
        "text": "<p><span style=\"font-size:14.0pt;\">3-2-1-4</span></p>"
      },
      {
        "id": 283904,
        "text": "<p><span style=\"font-size:14.0pt;\">2-3-1-4</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">Sequentially arrange the steps involved in excitation-contraction coupling of smooth muscle cells.</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:14.0pt;\">\ufeff\ufeff\ufeffMyosin phosphorylation</span></li><li><span style=\"font-size:14.0pt;\">\ufeff\ufeff\ufeffIncreased influx of Ca2+ into the cell</span></li><li><span style=\"font-size:14.0pt;\">\ufeff\ufeff\ufeffActivation of calmodulin-dependent myosin light chain kinase</span></li><li><span style=\"font-size:14.0pt;\">\ufeff\ufeff\ufeffBinding of myosin to actin</span></li></ol>",
    "unique_key": "Q2254176",
    "question_audio": null,
    "question_video": null,
    "map_id": 33509122,
    "difficulty_level": "beginner",
    "subjects_id": [
      43
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) 2-3-1-4</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Sequence of events in smooth muscle excitation\u2013contraction coupling:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>2.</strong> Activation of calmodulin-dependent myosin light chain kinase (MLCK) \u2013 Ca\u00b2\u207a binds to calmodulin, forming a complex that activates MLCK.</span></p><p><span style=\"font-size:14.0pt;\"><strong>3.</strong> Myosin phosphorylation \u2013 MLCK phosphorylates the myosin light chain, enabling cross-bridge formation.</span></p><p><span style=\"font-size:14.0pt;\"><strong>1.</strong> Increased influx of Ca\u00b2\u207a into the cell \u2013 via voltage-gated, ligand-gated, or stretch-activated Ca\u00b2\u207a channels.</span></p><p><span style=\"font-size:14.0pt;\"><strong>4.</strong> Binding of myosin to actin \u2013 phosphorylated myosin interacts with actin, leading to contraction.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p><br><span style=\"font-size:14.0pt;\"><strong>Option A. 2-1-3-4:&nbsp;</strong>Wrong,phosphorylation cannot occur before MLCK activation.</span></p><p><br><span style=\"font-size:14.0pt;\"><strong>Option B. 2-1-4-3:&nbsp;</strong>Wrong,<strong>&nbsp;</strong>actin binding occurs only after phosphorylation.</span><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. 3-2-1-4:&nbsp;</strong>Wrong,<strong>&nbsp;</strong>Ca\u00b2\u207a influx must occur before MLCK activation.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_xB0UHHM.png\" width=\"1057\" height=\"717\"></span></p>",
    "correct_choice_id": 283904,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 66994,
    "choices": [
      {
        "id": 267109,
        "text": "<p><span style=\"font-size:14.0pt;\">100ml/hr&nbsp;</span></p>"
      },
      {
        "id": 267110,
        "text": "<p><span style=\"font-size:14.0pt;\">150ml/hr&nbsp;</span></p>"
      },
      {
        "id": 267111,
        "text": "<p><span style=\"font-size:14.0pt;\">50ml/hr</span></p>"
      },
      {
        "id": 267112,
        "text": "<p><span style=\"font-size:14.0pt;\">200ml/hr</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">What is the normal insensible water loss?&nbsp;</span></p>",
    "unique_key": "Q1639119",
    "question_audio": null,
    "question_video": null,
    "map_id": 33509123,
    "difficulty_level": "intermediate",
    "subjects_id": [
      43
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) 50ml/hr</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Insensible water loss refers to water lost through skin (evaporation, not sweating) and respiratory tract.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Normal insensible water loss is ~500\u2013700 ml/day, which averages to ~50 ml/hr in adults.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. 100 ml/hr:&nbsp;</strong>Too high (would be ~2.4 L/day, above normal range).</span><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. 150 ml/hr:&nbsp;</strong>Very high, exceeds physiologic baseline loss.</span><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. 200 ml/hr:&nbsp;</strong>Extremely high, pathological rather than normal.</span></p>",
    "correct_choice_id": 267111,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 74496,
    "choices": [
      {
        "id": 296905,
        "text": "<p><span style=\"font-size:14.0pt;\">1, 3 &amp; 5&nbsp;</span></p>"
      },
      {
        "id": 296906,
        "text": "<p><span style=\"font-size:14.0pt;\">2, 3, &amp; 5&nbsp;</span></p>"
      },
      {
        "id": 296907,
        "text": "<p><span style=\"font-size:14.0pt;\">1, 3, 4&nbsp;</span></p>"
      },
      {
        "id": 296908,
        "text": "<p><span style=\"font-size:14.0pt;\">1, 2, 3, 4</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">A 29-year-old goes on a month-long trek across the Himalayas. Which of the following physiological adaptations would you expect to see in him at high altitudes following acclimatization?</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">1. Erythropoietin secretion increases</span></p><p><span style=\"font-size:14.0pt;\">2. Tissue myoglobin decreases</span></p><p><span style=\"font-size:14.0pt;\">3. Tissue content of cytochrome oxidase increases</span></p><p><span style=\"font-size:14.0pt;\">4. pH of blood increases</span></p>",
    "unique_key": "Q8198834",
    "question_audio": null,
    "question_video": null,
    "map_id": 33509124,
    "difficulty_level": "beginner",
    "subjects_id": [
      43
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) 1, 3, 4</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">At high altitude, acclimatization involves increased erythropoietin secretion (to raise RBC mass), increased tissue cytochrome oxidase (to improve oxidative metabolism), and respiratory alkalosis with raised blood pH due to hyperventilation.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Incorrect statement:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>2. Tissue myoglobin decreases:&nbsp;</strong>Incorrect, tissue myoglobin actually increases to enhance oxygen storage and delivery.</span></p>",
    "correct_choice_id": 296907,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 73994,
    "choices": [
      {
        "id": 294909,
        "text": "<p><span style=\"font-size:14.0pt;\">64</span></p>"
      },
      {
        "id": 294910,
        "text": "<p><span style=\"font-size:14.0pt;\">16</span></p>"
      },
      {
        "id": 294911,
        "text": "<p><span style=\"font-size:14.0pt;\">8</span></p>"
      },
      {
        "id": 294912,
        "text": "<p><span style=\"font-size:14.0pt;\">32</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">A 72-year-old woman is admitted to the hospital for treatment of unstable angina. Cardiac catheterization shows occlusion that has caused a 50% reduction in the diameter of the left circumflex artery. Resistance to blood flow in this vessel has increased by what factor relative to a vessel with no occlusion?&nbsp;</span></p>",
    "unique_key": "Q3650765",
    "question_audio": null,
    "question_video": null,
    "map_id": 33509125,
    "difficulty_level": "intermediate",
    "subjects_id": [
      43
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) 16</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">According to Poiseuille\u2019s law, vascular resistance is inversely proportional to the fourth power of the vessel radius (R&nbsp;\u221d 1/r\u2074).</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">A 50% reduction in diameter \u2192 radius is also reduced to \u00bd of original.</span></li><li><span style=\"font-size:14.0pt;\">Resistance factor = (1/(\u00bd)4)=1/(1/16)=16</span></li></ul>",
    "correct_choice_id": 294910,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 85630,
    "choices": [
      {
        "id": 341068,
        "text": "<p><span style=\"font-size:14.0pt;\">Cardiac output</span></p>"
      },
      {
        "id": 341069,
        "text": "<p><span style=\"font-size:14.0pt;\">Left ventricular end-diastolic pressure</span></p>"
      },
      {
        "id": 341070,
        "text": "<p><span style=\"font-size:14.0pt;\">Systemic systolic blood pressure</span></p>"
      },
      {
        "id": 341071,
        "text": "<p><span style=\"font-size:14.0pt;\">Total systemic vascular resistance</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">A 48-year-old man with diabetes undergoes stress testing. He walks for 7 minutes without chest pain. Peak heart rate is 132/min, BP increases from 95 to 112 mmHg. Which of the following parameters was most likely decreased during peak stress?</span></p>",
    "unique_key": "Q2331147",
    "question_audio": null,
    "question_video": null,
    "map_id": 33509126,
    "difficulty_level": "intermediate",
    "subjects_id": [
      43
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) Total systemic vascular resistance</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">During exercise, cardiac output increases due to \u2191HR and \u2191stroke volume. Left ventricular end-diastolic pressure may rise slightly but does not decrease. Systolic BP rises, not falls. To accommodate increased flow, systemic vascular resistance decreases due to vasodilation in exercising muscles.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p><br><span style=\"font-size:14.0pt;\"><strong>Option A. Cardiac output:&nbsp;</strong>Increases during exercise.</span><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Left ventricular end-diastolic pressure:&nbsp;</strong>Usually stable or mildly \u2191, not decreased.</span></p><p><br><span style=\"font-size:14.0pt;\"><strong>Option C. Systemic systolic blood pressure:&nbsp;</strong>Rises, not reduced.</span></p>",
    "correct_choice_id": 341071,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 92366,
    "choices": [
      {
        "id": 367772,
        "text": "<p><span style=\"font-size:14.0pt;\">Neuropeptide Y</span></p>"
      },
      {
        "id": 367773,
        "text": "<p><span style=\"font-size:14.0pt;\">Leptin</span></p>"
      },
      {
        "id": 367774,
        "text": "<p><span style=\"font-size:14.0pt;\">Glucagon related peptide 1</span></p>"
      },
      {
        "id": 367775,
        "text": "<p><span style=\"font-size:14.0pt;\">Serotonin</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">In the study of appetite regulation, which of the following polypeptides is known to increase appetite?</span></p>",
    "unique_key": "Q2795014",
    "question_audio": null,
    "question_video": null,
    "map_id": 33509127,
    "difficulty_level": "intermediate",
    "subjects_id": [
      43
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Neuropeptide Y</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Neuropeptide Y, secreted in the hypothalamus (arcuate nucleus), is a <strong>potent orexigenic peptide</strong> that stimulates appetite.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Leptin:</strong> Decreases appetite (anorexigenic).</span><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Glucagon related peptide 1:</strong> Inhibits appetite, enhances satiety.</span></p><p><br><br><span style=\"font-size:14.0pt;\"><strong>Option D. Serotonin:</strong> Suppresses appetite, especially for carbohydrates.</span></p>",
    "correct_choice_id": 367772,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 25704,
    "choices": [
      {
        "id": 102766,
        "text": "<p><span style=\"font-size:14.0pt;\">1-A, 2-B, 3-B, 4-C, 5- D, 6-D</span></p>"
      },
      {
        "id": 102767,
        "text": "<p><span style=\"font-size:14.0pt;\">1-B, 2-A, 3-B, 4-C, 5- D, 6-D</span></p>"
      },
      {
        "id": 102768,
        "text": "<p><span style=\"font-size:14.0pt;\">1-A, 2-B, 3-D, 4-D, 5- C, 6-C</span></p>"
      },
      {
        "id": 102769,
        "text": "<p><span style=\"font-size:14.0pt;\">1-A, 2-B, 3-B, 4-D, 5- C, 6-C</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:18px;\">Match the following with the mode of cellular transport:</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_6t5DArW.png\" width=\"732\" height=\"181\"></p>",
    "unique_key": "Q1274042",
    "question_audio": null,
    "question_video": null,
    "map_id": 33509128,
    "difficulty_level": "beginner",
    "subjects_id": [
      43
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) 1-A, 2-B, 3-D, 4-D, 5-C, 6-C</strong></span></p><p><span style=\"font-size:14.0pt;\">Matching the substances with the mode of cellular transport:</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:14.0pt;\"><strong>Oxygen</strong></span><br><span style=\"font-size:14.0pt;\">\u2192 Simple diffusion (A)</span><br><span style=\"font-size:14.0pt;\">(Oxygen diffuses freely across cell membranes down its concentration gradient)</span></li><li><span style=\"font-size:14.0pt;\"><strong>GLUT (Glucose transporter)</strong></span><br><span style=\"font-size:14.0pt;\">\u2192 Facilitated diffusion (B)</span><br><span style=\"font-size:14.0pt;\">(GLUT transports glucose without ATP, down its concentration gradient)</span></li><li><span style=\"font-size:14.0pt;\"><strong>SGLT (Sodium-glucose linked transporter)</strong></span><br><span style=\"font-size:14.0pt;\">\u2192 Secondary active transport (D)</span><br><span style=\"font-size:14.0pt;\">(Uses Na+ gradient to drive glucose uptake against its gradient)</span></li><li><span style=\"font-size:14.0pt;\"><strong>Na+/Iodide symporter</strong></span><br><span style=\"font-size:14.0pt;\">\u2192 Secondary active transport (D)</span><br><span style=\"font-size:14.0pt;\">(Symporter couples iodide uptake with Na+ moving down its gradient)</span></li><li><span style=\"font-size:14.0pt;\"><strong>Na+/K+ ATPase</strong></span><br><span style=\"font-size:14.0pt;\">\u2192 Primary active transport (C)</span><br><span style=\"font-size:14.0pt;\">(Uses ATP directly to pump Na+ out and K+ into the cell)</span></li><li><span style=\"font-size:14.0pt;\"><strong>Proton pump</strong></span><br><span style=\"font-size:14.0pt;\">\u2192 Primary active transport (C)</span><br><span style=\"font-size:14.0pt;\">(ATP-driven transport of protons across membranes)</span></li></ol>",
    "correct_choice_id": 102768,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "ImageBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 29141,
    "choices": [
      {
        "id": 116470,
        "text": "<p><span style=\"font-size:14.0pt;\">A</span></p>"
      },
      {
        "id": 116471,
        "text": "<p><span style=\"font-size:14.0pt;\">C</span></p>"
      },
      {
        "id": 116472,
        "text": "<p><span style=\"font-size:14.0pt;\">D</span></p>"
      },
      {
        "id": 116473,
        "text": "<p><span style=\"font-size:14.0pt;\">E</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:18px;\">Which of the following regions contain only thick filaments and no thin filaments?</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:18px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/12/01/picture2_ef8kttj.jpg\" alt=\"\" width=\"300\" height=\"172\"></span></p>",
    "unique_key": "Q7715549",
    "question_audio": null,
    "question_video": null,
    "map_id": 33509129,
    "difficulty_level": "intermediate",
    "subjects_id": [
      43
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) E</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">In the image of the skeletal muscle sarcomere, region&nbsp;E&nbsp;corresponds to the&nbsp;H-zone, which contains&nbsp;only thick filaments (myosin)&nbsp;and no thin filaments (actin). The H-zone is found in the center of the A-band, and thin filaments do not overlap this region, distinguishing it from other sarcomere zones</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>A:&nbsp;</strong>Z line (Z disc) boundary between adjacent sarcomeres</span></li><li><span style=\"font-size:14.0pt;\"><strong>B:&nbsp;</strong>I band \u2013 contains only thin filaments (actin)</span></li><li><span style=\"font-size:14.0pt;\"><strong>C:&nbsp;</strong>M line \u2013 center of the sarcomere, where thick filaments are anchored</span></li><li><span style=\"font-size:14.0pt;\"><strong>D:&nbsp;</strong>A band \u2013 entire length of thick filaments; includes regions of overlap with thin filaments</span></li><li><span style=\"font-size:14.0pt;\"><strong>E:&nbsp;</strong>H zone \u2013 area with only thick filaments (myosin), no thin filaments</span></li></ul>",
    "correct_choice_id": 116473,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "ImageBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 57458,
    "choices": [
      {
        "id": 229205,
        "text": "<p><span style=\"color:black;font-size:14.0pt;\">IL-12 receptor</span></p>"
      },
      {
        "id": 229206,
        "text": "<p><span style=\"color:black;font-size:14.0pt;\">IL-2R gamma chain</span></p>"
      },
      {
        "id": 229207,
        "text": "<p><span style=\"color:black;font-size:14.0pt;\">NADPH oxidase</span></p>"
      },
      {
        "id": 229208,
        "text": "<p><span style=\"color:black;font-size:14.0pt;\">Dynein arm</span></p>"
      }
    ],
    "text": "<p><span style=\"color:black;font-size:18px;\">A 31-year-old man comes to the physician for evaluation of chronic cough, sinus pain, and nasal discharge. He has a history of frequent upper respiratory infections and recurrent sinusitis since childhood. He is also concerned about fertility, as he and his wife have been trying to conceive for 5 years unsuccessfully. Pulmonary examination shows crackles and wheezing throughout both lung fields. A CT scan of the chest is shown. The most likely cause of this patient's condition is a defect in which of the following molecular structures?</span></p><p>&nbsp;</p><p><span style=\"color:black;font-size:18px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/18/screenshot-2024-09-18-122349.png\" alt=\"\" width=\"300\" height=\"297\"></span></p>",
    "unique_key": "Q7437484",
    "question_audio": null,
    "question_video": null,
    "map_id": 33509310,
    "difficulty_level": "beginner",
    "subjects_id": [
      43
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D)&nbsp;</strong></span><span style=\"color:black;font-size:14.0pt;\"><strong>Dynein arm</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">This clinical scenario describes&nbsp;chronic respiratory infections, sinusitis, infertility, and a CT scan demonstrating dextrocardia (heart on the right side), most consistent with&nbsp;Kartagener syndrome&nbsp;(a subset of primary ciliary dyskinesia). The disorder results from a defect in the&nbsp;dynein arm, a molecular motor protein essential for ciliary movement. Dysfunctional cilia lead to poor mucociliary clearance, recurrent infections, impaired fertility, and situs inversus (dextrocardia).</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A and B. IL-12 receptor and IL-2R gamma chain:</strong> Related to immune deficiencies, not ciliary dyskinesia or situs inversus.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. NADPH oxidase:&nbsp;</strong>Deficient in chronic granulomatous disease, presenting with recurrent catalase-positive infections but not situs inversus or infertility.</span></p>",
    "correct_choice_id": 229208,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "ImageBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 57480,
    "choices": [
      {
        "id": 229293,
        "text": "<p><span style=\"font-size:14.0pt;\">Alpha neuron</span></p>"
      },
      {
        "id": 229294,
        "text": "<p><span style=\"font-size:14.0pt;\">Gamma neuron</span></p>"
      },
      {
        "id": 229295,
        "text": "<p><span style=\"font-size:14.0pt;\">Beta neuron</span></p>"
      },
      {
        "id": 229296,
        "text": "<p><span style=\"font-size:14.0pt;\">Delta neuron</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">The motor supply of the muscle spindle is which of the following?</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/18/screenshot-2024-09-18-125552_W36A4iO.png\" alt=\"\" width=\"300\" height=\"188\"></p>",
    "unique_key": "Q6161040",
    "question_audio": null,
    "question_video": null,
    "map_id": 33509311,
    "difficulty_level": "beginner",
    "subjects_id": [
      43
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Gamma neuron</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The&nbsp;motor supply of the muscle spindle&nbsp;(shown in the image) is provided by&nbsp;gamma motor neurons, which innervate the intrafusal muscle fibers and regulate their sensitivity to stretch. This allows the muscle spindle to adjust and respond to changes in muscle length, contributing to proprioceptive feedback and reflex control.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option</strong> <strong>A. Alpha neuron:</strong> Innervates&nbsp;extrafusal muscle fibers&nbsp;responsible for muscle contraction and generating force, not the muscle spindle itself.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option</strong> <strong>C. Beta neuron:</strong> Innervates both&nbsp;intrafusal and extrafusal muscle fibers, but their role is less prominent compared to alpha and gamma neurons and not the primary motor supply for muscle spindles.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Delta neuron:</strong> This term is not commonly used to describe motor neurons in the somatic system; it is generally associated with sensory neurons or other classifications, thus not relevant here.</span></p>",
    "correct_choice_id": 229294,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "ImageBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 56020,
    "choices": [
      {
        "id": 223509,
        "text": "<p><span style=\"font-size:18px;\">TRPV1 Channel</span></p>"
      },
      {
        "id": 223510,
        "text": "<p><span style=\"font-size:18px;\">Metabotropic Receptor</span></p>"
      },
      {
        "id": 223511,
        "text": "<p><span style=\"font-size:18px;\">GPCR T1R1</span></p>"
      },
      {
        "id": 223512,
        "text": "<p><span style=\"font-size:18px;\">GPCR T1R3</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:18px;\">Sour taste is mediated by:&nbsp;</span></p>",
    "unique_key": "Q1464909",
    "question_audio": null,
    "question_video": null,
    "map_id": 33509312,
    "difficulty_level": "intermediate",
    "subjects_id": [
      2
    ],
    "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. A) TRPV1 Channel</strong></span></p><p>&nbsp;</p><p style=\"text-align:center;\"><span style=\"font-size:18px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/04/screenshot-2024-09-04-164708_ph9q8pj.jpeg\" alt=\"\" width=\"500\" height=\"200\"></span></p><p style=\"text-align:justify;\"><span style=\"font-size:18px;\"><strong>Fig: Signal transduction in taste receptors:</strong> Salt and sour tastes are mediated via the epithelial sodium channel (ENaC). This receptor has two subunits (a and g), each crossing the membrane twice, resulting in intracellular N and C termini (NT, CT). Salt is sensed following Na<sup>+</sup> movement; sour is mediated by movement of H<sup>+</sup>. Sweet, bitter, and umami tastes are sensed via G-protein-coupled receptors that span the membrane seven times and have varying lengths of CT and NT (represented as ribbon structures). Sweet tastes are detected by the T1R2 and T1R3 families, bitter and umami tastes are detected by the T2R family and mGluR4, respectively.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:center;\"><span style=\"font-size:18px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/04/screenshot-2024-09-04-165350.jpeg\" alt=\"\" width=\"500\" height=\"517\"></span></p><p style=\"text-align:justify;\"><span style=\"font-size:18px;\"><strong>Fig: Receptors on nociceptive unmyelinated nerve terminals in the skin.</strong> Nociceptive stimuli (eg, heat) can activate some receptors directly due to transduction of the stimulus energy by receptors (eg, transient receptor potential (TRP) channel TRPV1) or indirectly by activation of TRP channels on keratinocytes (eg, TRPV3). Nociceptors (eg, mechanoreceptors) can also be activated by the release of intermediate molecules (eg, ATP), ASIC, acid-sensitive ion channel; P2X, ionotropic purinoceptor, P2Y, G-protein-coupled purinergic receptor.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">Sour taste is primarily mediated by the detection of H+ ions, which are present in acidic substances like citric acid. These H+ ions activate ion channels rather than G-protein-coupled receptors (GPCRs). Specifically, the TRPV1 (Transient Receptor Potential Vanilloid Receptor Type 1) channel and acid-sensitive ion channels are involved in mediating the sour taste. These channels open in response to the presence of H+ ions, allowing the ions to enter the taste cells, which leads to the perception of a sour taste.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">Metabotropic receptors, which involve GPCRs, mediate other taste modalities like sweet, bitter, and umami but are not involved in sour taste. The GPCR T1R1 and T1R3 are specifically involved in the sweet and umami taste pathways.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option B. Metabotropic Receptor</strong>: This type of receptor is associated with GPCRs and mediates taste sensations like sweet, bitter, and umami. It is not involved in sour taste, which is mediated by ion channels.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option C. GPCR T1R1</strong>: This receptor is part of the GPCR family and is involved in detecting umami (savory) tastes, not sour tastes.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option D. GPCR T1R3</strong>: This receptor is also a part of the GPCR family and contributes to the detection of sweet and umami tastes, not sour tastes.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">Sour taste is mediated by the activation of ion channels, particularly the TRPV1 channel and acid-sensitive ion channels, in response to H+ ions from acidic substances</span></p>",
    "correct_choice_id": 223509,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "RecentNEETPG"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 85616,
    "choices": [
      {
        "id": 341016,
        "text": "<p><span style=\"font-size:14.0pt;\">ATP binding site is located intracellularly</span></p>"
      },
      {
        "id": 341017,
        "text": "<p><span style=\"font-size:14.0pt;\">K\u207a binding site is on the extracellular side</span></p>"
      },
      {
        "id": 341018,
        "text": "<p><span style=\"font-size:14.0pt;\">Ouabain binds to the cytoplasmic domain</span></p>"
      },
      {
        "id": 341019,
        "text": "<p><span style=\"font-size:14.0pt;\">Phosphorylation site is intracellular</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">All of the following are true regarding Na\u207a/K\u207a ATPase structure, except:</span></p>",
    "unique_key": "Q3329210",
    "question_audio": null,
    "question_video": null,
    "map_id": 33509313,
    "difficulty_level": "intermediate",
    "subjects_id": [
      43
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Ouabain binds to the cytoplasmic domain</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Na\u207a/K\u207a ATPase is a transmembrane pump that maintains ionic gradients across the plasma membrane. The ATP binding site and phosphorylation site are located intracellularly, while K\u207a binding occurs extracellularly. Ouabain, a cardiac glycoside, inhibits the pump by binding to the extracellular domain, not the cytoplasmic side.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. ATP binding site is located intracellularly:&nbsp;</strong>True, fuels the pump.</span><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. K\u207a binding site is on the extracellular side:&nbsp;</strong>True, K\u207a enters from outside.</span><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Phosphorylation site is intracellular:&nbsp;</strong>True, phosphorylation drives conformational change.</span></p>",
    "correct_choice_id": 341018,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 85670,
    "choices": [
      {
        "id": 341220,
        "text": "<p><span style=\"font-size:14.0pt;\">Passive tension increases with muscle stretch</span></p>"
      },
      {
        "id": 341221,
        "text": "<p><span style=\"font-size:14.0pt;\">Active tension is highest at optimal length</span></p>"
      },
      {
        "id": 341222,
        "text": "<p><span style=\"font-size:14.0pt;\">Total tension equals sum of passive and active tension</span></p>"
      },
      {
        "id": 341223,
        "text": "<p><span style=\"font-size:14.0pt;\">Passive tension is highest at resting muscle length</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:18px;\">All are correct statements about muscle tension curves, except:</span></p>",
    "unique_key": "Q7317860",
    "question_audio": null,
    "question_video": null,
    "map_id": 33509314,
    "difficulty_level": "intermediate",
    "subjects_id": [
      43
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) Passive tension is highest at resting muscle length</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Passive tension develops only when a muscle is stretched beyond its resting length, due to elastic elements (like titin). At resting length, passive tension is minimal or absent. Active tension is maximal at the muscle\u2019s optimal length, and total tension is the sum of both active and passive components.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Passive tension increases with muscle stretch:&nbsp;</strong>True, rises exponentially after resting length.</span><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Active tension is highest at optimal length:&nbsp;</strong>True, due to maximum actin-myosin overlap.</span><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Total tension equals sum of passive and active tension:&nbsp;</strong>True, reflects combined forces.</span></p>",
    "correct_choice_id": 341223,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 85780,
    "choices": [
      {
        "id": 341652,
        "text": "<p><span style=\"font-size:14.0pt;\">GABA-A \u2013 Ionotropic</span></p>"
      },
      {
        "id": 341653,
        "text": "<p><span style=\"font-size:14.0pt;\">Glycine \u2013 G-Protein Coupled Receptor</span></p>"
      },
      {
        "id": 341654,
        "text": "<p><span style=\"font-size:14.0pt;\">Nicotinic \u2013 G-Protein Coupled Receptor</span></p>"
      },
      {
        "id": 341655,
        "text": "<p><span style=\"font-size:14.0pt;\">GABA-B \u2013 Ionotropic</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:18px;\">Match the neurotransmitter with its correct receptor type:</span></p>",
    "unique_key": "Q4356321",
    "question_audio": null,
    "question_video": null,
    "map_id": 33509984,
    "difficulty_level": "intermediate",
    "subjects_id": [
      43
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) GABA-A - Ionotropic&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">GABA-A is a ligand-gated chloride ion channel, hence ionotropic.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p><br><span style=\"font-size:14.0pt;\"><strong>Option B. Glycine \u2013 G-Protein Coupled Receptor:&nbsp;</strong>Glycine receptor is ionotropic (Cl\u207b channel), not GPCR.</span><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Nicotinic \u2013 G-Protein Coupled Receptor:&nbsp;</strong>Nicotinic ACh receptor is ionotropic (Na\u207a/K\u207a channel).</span><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. GABA-B \u2013 Ionotropic:&nbsp;</strong>GABA-B is metabotropic (GPCR), not ionotropic.</span></p>",
    "correct_choice_id": 341652,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 74375,
    "choices": [
      {
        "id": 296421,
        "text": "<p><span style=\"font-size:14.0pt;\">Periaqueductal gray area&nbsp;</span></p>"
      },
      {
        "id": 296422,
        "text": "<p><span style=\"font-size:14.0pt;\">Rostral ventromedial medulla</span></p>"
      },
      {
        "id": 296423,
        "text": "<p><span style=\"font-size:14.0pt;\">Locus ceruleus</span></p>"
      },
      {
        "id": 296424,
        "text": "<p><span style=\"font-size:14.0pt;\">Nucleus raphe&nbsp;</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">The serotonergic cell bodies of the analgesia pathway projecting to the dorsal horn of the spinal cord are located in which part of the brain?</span></p>",
    "unique_key": "Q1410400",
    "question_audio": null,
    "question_video": null,
    "map_id": 33509985,
    "difficulty_level": "intermediate",
    "subjects_id": [
      43
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong></span><strong>&nbsp;</strong><span style=\"font-size:14.0pt;\"><strong>D) Nucleus raphe</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The descending pain modulation pathway originates in the periaqueductal gray (PAG), which activates the nucleus raphe magnus (a raphe nucleus in the medulla). The raphe nuclei contain serotonergic neurons that project to the dorsal horn of the spinal cord to inhibit pain transmission.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p><br><span style=\"font-size:14.0pt;\"><strong>Option A. Periaqueductal gray area:&nbsp;</strong>Initiates descending pain inhibition but not the main serotonergic cell body site.</span><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Rostral ventromedial medulla:&nbsp;</strong>Includes the raphe nuclei, but serotonergic cell bodies are specifically in nucleus raphe magnus.</span><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Locus ceruleus:&nbsp;</strong>Noradrenergic center, not serotonergic.</span></p>",
    "correct_choice_id": 296424,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 92373,
    "choices": [
      {
        "id": 367800,
        "text": "<p><span style=\"font-size:14.0pt;\">Tolterodine</span></p>"
      },
      {
        "id": 367801,
        "text": "<p><span style=\"font-size:14.0pt;\">Tiotropium</span></p>"
      },
      {
        "id": 367802,
        "text": "<p><span style=\"font-size:14.0pt;\">Telenzepine</span></p>"
      },
      {
        "id": 367803,
        "text": "<p><span style=\"font-size:14.0pt;\">Tropicamide</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">Which of the following is the most appropriate treatment for COPD in a patient with dementia?&nbsp;</span></p>",
    "unique_key": "Q2825539",
    "question_audio": null,
    "question_video": null,
    "map_id": 33509986,
    "difficulty_level": "intermediate",
    "subjects_id": [
      43
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Tiotropium</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Tiotropium is an <strong>inhaled long-acting muscarinic antagonist (LAMA)</strong> used in COPD. Since it is inhaled and acts locally in the lungs, it causes minimal systemic anticholinergic effects, making it safer in <strong>elderly patients with dementia</strong>, where central anticholinergic drugs worsen cognition.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p><br><span style=\"font-size:14.0pt;\"><strong>Option A. Tolterodine:</strong> Used for overactive bladder; systemic anticholinergic, worsens dementia.</span></p><p><br><span style=\"font-size:14.0pt;\"><strong>Option C. Telenzepine:</strong> Antimuscarinic for peptic ulcers, not used in COPD.</span></p><p><br><span style=\"font-size:14.0pt;\"><strong>Option</strong> <strong>D. Tropicamide:</strong> Short-acting mydriatic used in eye exams, not for COPD.</span></p>",
    "correct_choice_id": 367801,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 92374,
    "choices": [
      {
        "id": 367804,
        "text": "<p><span style=\"font-size:14.0pt;\">It has low molecular weight&nbsp;</span></p>"
      },
      {
        "id": 367805,
        "text": "<p><span style=\"font-size:14.0pt;\">It is lipophilic</span></p>"
      },
      {
        "id": 367806,
        "text": "<p><span style=\"font-size:14.0pt;\">It does not bind to albumin&nbsp;</span></p>"
      },
      {
        "id": 367807,
        "text": "<p><span style=\"font-size:14.0pt;\">It is highly charged</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">A new aminoglycoside antibiotic is developed that is believed to be particularly effective against Pseudomonas. The volume of distribution of the drug is measured in a group of volunteers and is determined to be 4.5 L. This new drug is most likely to have which of the following properties?</span></p>",
    "unique_key": "Q3572573",
    "question_audio": null,
    "question_video": null,
    "map_id": 33509987,
    "difficulty_level": "intermediate",
    "subjects_id": [
      43
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) It is highly charged</strong></span><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The drug\u2019s <strong>volume of distribution (Vd) is only 4.5 L</strong>, which is close to plasma volume (\u22483\u20135 L). This means the drug stays mainly in the plasma and does <strong>not distribute into tissues</strong>. Such a property is typical of <strong>hydrophilic, highly charged molecules</strong> like aminoglycosides, which cannot cross lipid membranes.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option</strong> <strong>A. It has low molecular weight:</strong> Alone does not explain low Vd; small molecules can still diffuse widely.</span><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option</strong> <strong>B. It is lipophilic:</strong> Would increase tissue penetration \u2192 high Vd, not low.</span><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option</strong> <strong>C. It does not bind to albumin:</strong> Would increase free drug fraction, usually leading to higher tissue distribution, not restricted plasma distribution.</span></p>",
    "correct_choice_id": 367807,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 74321,
    "choices": [
      {
        "id": 296205,
        "text": "<p><span style=\"font-size:14.0pt;\">Amiodarone&nbsp;</span></p>"
      },
      {
        "id": 296206,
        "text": "<p><span style=\"font-size:14.0pt;\">Cimetidine</span></p>"
      },
      {
        "id": 296207,
        "text": "<p><span style=\"font-size:14.0pt;\">Ciprofloxacin</span></p>"
      },
      {
        "id": 296208,
        "text": "<p><span style=\"font-size:14.0pt;\">St John's wort</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">A 65-year-old man is brought to the emergency department after developing sudden-onset right-side weakness and difficulty speaking. He has a history of paroxysmal atrial fibrillation and has been taking warfarin for the past several years with a stable prothrombin time. His wife adds that he started taking a new drug 2 weeks ago, but she does not remember its name. Transesophageal echocardiogram reveals a small thrombus in the left atrium. This patient most likely started taking which of the following drugs recently?</span></p>",
    "unique_key": "Q3606024",
    "question_audio": null,
    "question_video": null,
    "map_id": 33509988,
    "difficulty_level": "intermediate",
    "subjects_id": [
      43
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) St John's wort</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Warfarin is metabolized by cytochrome P450 enzymes.</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">St John\u2019s wort is a potent CYP450 inducer, which increases the metabolism of warfarin \u2192 decreases its plasma levels \u2192 reduces anticoagulant effect \u2192 increased risk of thromboembolism (like this<strong> patient\u2019s atrial thrombus and stroke).</strong></span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p><br><span style=\"font-size:14.0pt;\"><strong>Option A. Amiodarone:&nbsp;</strong>CYP450 inhibitor \u2192 increases warfarin effect \u2192 \u2191 risk of bleeding, not clotting.</span></p><p><br><span style=\"font-size:14.0pt;\"><strong>Option B. Cimetidine:&nbsp;</strong>CYP450 inhibitor \u2192 increases warfarin levels \u2192 \u2191 bleeding risk.</span></p><p><br><span style=\"font-size:14.0pt;\"><strong>Option C. Ciprofloxacin:&nbsp;</strong>also inhibits CYP450 \u2192 \u2191 warfarin effect and bleeding tendency.</span></p>",
    "correct_choice_id": 296208,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 74335,
    "choices": [
      {
        "id": 296261,
        "text": "<p><span style=\"font-size:14.0pt;\">Zero order kinetics&nbsp;</span></p>"
      },
      {
        "id": 296262,
        "text": "<p><span style=\"font-size:14.0pt;\">First order kinetics&nbsp;</span></p>"
      },
      {
        "id": 296263,
        "text": "<p><span style=\"font-size:14.0pt;\">Second order kinetics</span></p>"
      },
      {
        "id": 296264,
        "text": "<p><span style=\"font-size:14.0pt;\">Cannot be determined from the image</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">Identify the drug pharmacokinetics from the graph:</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/WhatsApp%20Image%202025-06-23%20at%206.15.16%20PM.jpeg\" width=\"816\" height=\"585\"></p>",
    "unique_key": "Q8326244",
    "question_audio": null,
    "question_video": null,
    "map_id": 33510119,
    "difficulty_level": "intermediate",
    "subjects_id": [
      43
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) First order kinetics&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The graph shows a&nbsp;linear relationship between rate of elimination and drug concentration. This is characteristic of&nbsp;first order kinetics, where a constant proportion of the drug is eliminated per unit time, and the rate depends directly on the drug concentration.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Zero order kinetics:&nbsp;</strong>The rate of elimination is constant regardless of the drug concentration (graph shows a horizontal line), seen in drugs like phenytoin and ethanol when their elimination pathways are saturated.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Second order kinetics:&nbsp;</strong>Relates to reactions where the rate depends on the square of the concentration of one reactant or on two different reactants, not typically used for drug elimination graphs in pharmacokinetics.</span></p>",
    "correct_choice_id": 296262,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "ImageBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 74439,
    "choices": [
      {
        "id": 296677,
        "text": "<p><span style=\"font-size:18px;\">40 ng/min</span></p>"
      },
      {
        "id": 296678,
        "text": "<p><span style=\"font-size:18px;\">60 ng/min</span></p>"
      },
      {
        "id": 296679,
        "text": "<p><span style=\"font-size:18px;\">70 ng/min</span></p>"
      },
      {
        "id": 296680,
        "text": "<p><span style=\"font-size:18px;\">80 ng/min</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:18px;\">Oral digoxin is being given to a 65-year-old male as a maintenance dose. A target plasma concentration of 0.70 ng/ mL is decided upon. The digoxin clearance for this particular individual is calculated as 60 mL/min. Knowing that the oral bioavailability of digoxin is 70%, what is the dosing rate in this patient?</span></p>",
    "unique_key": "Q8327642",
    "question_audio": null,
    "question_video": null,
    "map_id": 33510120,
    "difficulty_level": "intermediate",
    "subjects_id": [
      43
    ],
    "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. B) 60 ng/min&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>We use the formula for maintenance dosing rate:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_cgdO0pP.png\" width=\"918\" height=\"338\"></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">Step= Multiply concentration \u00d7 clearance and divide by F</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">0.70\u2009ng/mL\u00d760\u2009mL/min divided by 0.7=60\u2009ng/min</span></p>",
    "correct_choice_id": 296678,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 73790,
    "choices": [
      {
        "id": 294101,
        "text": "<p><span style=\"font-size:18px;\">Aztreonam&nbsp;</span></p>"
      },
      {
        "id": 294102,
        "text": "<p><span style=\"font-size:18px;\">Vancomycin&nbsp;</span></p>"
      },
      {
        "id": 294103,
        "text": "<p><span style=\"font-size:18px;\">Ceftriaxone&nbsp;</span></p>"
      },
      {
        "id": 294104,
        "text": "<p><span style=\"font-size:18px;\">Piperacillin</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:18px;\">A 45-year-old patient with a penicillin allergy presents with enterococcal endocarditis. Which of the following drugs can be used safely in this patient?</span></p>",
    "unique_key": "Q2945317",
    "question_audio": null,
    "question_video": null,
    "map_id": 33510121,
    "difficulty_level": "intermediate",
    "subjects_id": [
      43
    ],
    "solution": "<p><span style=\"font-size:18px;\"><strong>Ans.</strong> <strong>B) Vancomycin</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">In a patient with enterococcal endocarditis who is allergic to penicillin, vancomycin is the drug of choice as it covers <i>Enterococcus</i> and is safe in penicillin allergy.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p><br><span style=\"font-size:14.0pt;\"><strong>Option A. Aztreonam:&nbsp;</strong>Active mainly against gram-negative rods; no activity against enterococci.</span></p><p><br><span style=\"font-size:14.0pt;\"><strong>Option C. Ceftriaxone:&nbsp;</strong>A \u03b2-lactam, can cross-react in severe penicillin allergy and is not reliably effective against enterococcus.</span></p><p><br><span style=\"font-size:14.0pt;\"><strong>Option D. Piperacillin:&nbsp;</strong>Penicillin derivative; contraindicated in penicillin allergy.</span></p>",
    "correct_choice_id": 294102,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 74474,
    "choices": [
      {
        "id": 296817,
        "text": "<p><span style=\"font-size:14.0pt;\">Salbutamol at beta-2 receptor</span></p>"
      },
      {
        "id": 296818,
        "text": "<p><span style=\"font-size:14.0pt;\">Naloxone at opioid receptors</span></p>"
      },
      {
        "id": 296819,
        "text": "<p><span style=\"font-size:14.0pt;\">Buprenorphine at opioid receptor</span></p>"
      },
      {
        "id": 296820,
        "text": "<p><span style=\"font-size:14.0pt;\">Carboline at benzodiazepine site of GABA-A receptor</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">Match the following drugs-receptor combination appropriate for A</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_wV7sURJ.png\" width=\"368\" height=\"384\"></span></p>",
    "unique_key": "Q2120492",
    "question_audio": null,
    "question_video": null,
    "map_id": 33510122,
    "difficulty_level": "beginner",
    "subjects_id": [
      43
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) Carboline at benzodiazepine site of GABA-A</strong> <strong>receptor</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The graph shows&nbsp;both positive and negative responses relative to the baseline (0)&nbsp;as drug concentration increases. This is characteristic of an&nbsp;inverse agonist, which produces a response below the baseline by decreasing constitutive receptor activity.&nbsp;Carboline acts as an inverse agonist at the benzodiazepine site of the GABA-A receptor, leading to negative intrinsic activity reflected in the lower half of the graph.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option</strong> <strong>A. Salbutamol at beta-2 receptor:</strong> Acts as an agonist, producing a positive response above baseline, not as an inverse agonist.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option</strong> <strong>B. Naloxone at opioid receptors:</strong> Functions as a competitive antagonist, blocking receptor activation but does not induce a negative response below baseline.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option</strong> <strong>C. Buprenorphine at opioid receptor:&nbsp;</strong>Acts as a partial agonist, producing less than maximal positive response, not a negative or inverse response.</span></p>",
    "correct_choice_id": 296820,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "ImageBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 74502,
    "choices": [
      {
        "id": 296929,
        "text": "<p><span style=\"font-size:14.0pt;\">\u03b11 agonist and \u03b21 agonist</span></p>"
      },
      {
        "id": 296930,
        "text": "<p><span style=\"font-size:14.0pt;\">\ufeff\ufeff\ufeffM2 agonist and M3 agonist</span></p>"
      },
      {
        "id": 296931,
        "text": "<p><span style=\"font-size:14.0pt;\">\ufeff\ufeff\ufeff\u03b1 1 antagonist and \u03b22 agonist</span></p><p>&nbsp;</p>"
      },
      {
        "id": 296932,
        "text": "<p><span style=\"font-size:14.0pt;\">\ufeff\ufeff\ufeff\u03b21 agonist and \u03b22 agonist</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">The following table gives BP values before and after administration of drug 'X'. What would be the probable mechanism of action of drug 'X'?&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_sirEDW8.png\" width=\"715\" height=\"182\"></span></p>",
    "unique_key": "Q3928719",
    "question_audio": null,
    "question_video": null,
    "map_id": 33510123,
    "difficulty_level": "beginner",
    "subjects_id": [
      43
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) \u03b21 agonist and \u03b22 agonist</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The drug's likely mechanism of action is \u03b21 and \u03b22 agonism.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Due to its action on \u03b21 receptors, there is an increase in the HR of the patient and also of the SBP (Increase in HR leads to an increase in the CO upto a certain extent). The agonistic action on the \u03b22 receptors causes vasodilation and leads to a fall in the DBP.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A.</strong> <strong>\u03b11 agonist and \u03b21 agonist</strong>: \u03b11 agonists typically cause vasoconstriction, which would increase both SBP and DBP. This does not align with the observed decrease in DBP.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. M2 agonist and M3 agonist</strong>: M2 and M3 receptor agonism would likely lead to bradycardia and increased gastrointestinal motility, respectively. They do not explain the observed increase in HR and SBP, nor the decrease in DBP.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. \u03b11 antagonist and \u03b22 agonist</strong>: While \u03b11 antagonism could contribute to a decrease in DBP through vasodilation, it would not typically cause an increase in SBP and HR, which are more specifically associated with \u03b21 agonism.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The combination of increased systolic blood pressure, decreased diastolic blood pressure, and increased heart rate suggests that drug 'X' acts as a \u03b21 and \u03b22 agonist, leading to increased cardiac output and vasodilation.</span></p>",
    "correct_choice_id": 296932,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 6943,
    "choices": [
      {
        "id": 27740,
        "text": "<p><span style=\"font-size:18px;\">Gentamicin</span></p>"
      },
      {
        "id": 27741,
        "text": "<p><span style=\"font-size:18px;\">Vancomycin</span></p>"
      },
      {
        "id": 27742,
        "text": "<p><span style=\"font-size:18px;\">Amphotericin B</span></p>"
      },
      {
        "id": 27743,
        "text": "<p><span style=\"font-size:18px;\">Doxycycline</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:18px;\">Which of the following drugs does not require dose reduction in patients with renal failure?</span></p>",
    "unique_key": "Q2604922",
    "question_audio": null,
    "question_video": null,
    "map_id": 33510214,
    "difficulty_level": "intermediate",
    "subjects_id": [
      4
    ],
    "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. D) Doxycycline</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">Doxycycline is an antibiotic that does not require dose adjustment in patients with renal failure because it is primarily excreted in the bile and not significantly through the kidneys. This makes it safer for use in patients with impaired renal function.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option A. Gentamicin:&nbsp;</strong>Gentamicin is an aminoglycoside antibiotic that is primarily excreted by the kidneys. In patients with renal failure, the clearance of gentamicin is significantly reduced, and therefore, dose adjustments are necessary to avoid toxicity, particularly nephrotoxicity and ototoxicity.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option B. Vancomycin:&nbsp;</strong>Vancomycin is an antibiotic that is also primarily excreted by the kidneys. In patients with renal impairment, dose adjustments are required to prevent accumulation of the drug and subsequent nephrotoxicity and ototoxicity.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option C. Amphotericin B:&nbsp;</strong>Amphotericin B is an antifungal medication that can cause nephrotoxicity. Although its dose does not typically require adjustment based solely on renal function, careful monitoring and possible dose adjustment are often necessary to manage its renal side effects.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>The drugs which are secreted in bile and safe in renal disease include:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">Cef in: Cefoperazone, Ceftriaxone</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">The: Tigecycline</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">R: Rifampicin</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">E: Erythromycin</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">N: Nafcillin</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">A: Ampicillin</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">L: Lincosamide (Clindamycin)</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">D: Doxycycline</span></p>",
    "correct_choice_id": 27743,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "Factual"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 74541,
    "choices": [
      {
        "id": 297085,
        "text": "<p><span style=\"font-size:18px;\">Misbranded drug&nbsp;</span></p>"
      },
      {
        "id": 297086,
        "text": "<p><span style=\"font-size:14.0pt;\">Adulterated drug&nbsp;</span></p>"
      },
      {
        "id": 297087,
        "text": "<p><span style=\"font-size:14.0pt;\">Unethical drug&nbsp;</span></p>"
      },
      {
        "id": 297088,
        "text": "<p><span style=\"font-size:14.0pt;\">Spurious drug&nbsp;</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:18px;\">A&nbsp;manufacturer substitutes a drug partly by another drug and doesn\u2019t add it in the label. What is this type of drug called?</span></p>",
    "unique_key": "Q5578364",
    "question_audio": null,
    "question_video": null,
    "map_id": 33510215,
    "difficulty_level": "beginner",
    "subjects_id": [
      43
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) Spurious drug</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">A drug is termed spurious if it is wholly or partly substituted by another drug or substance and not labeled accordingly.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p><br><span style=\"font-size:14.0pt;\"><strong>Option A. Misbranded drug:&nbsp;</strong>A drug with false/misleading claims on label/packaging (not about substitution).</span></p><p><br><span style=\"font-size:14.0pt;\"><strong>Option B. Adulterated drug:&nbsp;</strong>A drug prepared under unhygienic/contaminated conditions or containing harmful/toxic substances.</span></p><p><br><span style=\"font-size:14.0pt;\"><strong>Option C. Unethical drug:&nbsp;</strong>Drugs promoted/marketed in a manner violating medical ethics, not related to substitution.</span></p>",
    "correct_choice_id": 297088,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 74315,
    "choices": [
      {
        "id": 296181,
        "text": "<p><span style=\"font-size:14.0pt;\">10 hours</span></p>"
      },
      {
        "id": 296182,
        "text": "<p><span style=\"font-size:14.0pt;\">20 hours</span></p>"
      },
      {
        "id": 296183,
        "text": "<p><span style=\"font-size:14.0pt;\">30 hours</span></p>"
      },
      {
        "id": 296184,
        "text": "<p><span style=\"font-size:14.0pt;\">40 hours</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">A new antibiotic developed for the treatment of infections caused by resistant gram-positive cocci has a volume of distribution of 11L. It is eliminated by first-order kinetics and has a half-life of 10 hours. If given by a continuous infusion, approximately how much time would it require for the drug to achieve a 95% plasma steady state concentration?</span></p>",
    "unique_key": "Q9472170",
    "question_audio": null,
    "question_video": null,
    "map_id": 33510216,
    "difficulty_level": "intermediate",
    "subjects_id": [
      43
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.&nbsp;D) 40 hours</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Time to reach steady state (Css) with first-order kinetics depends only on the drug\u2019s half-life (t\u00bd).</span></li><li><span style=\"font-size:14.0pt;\">Steady state \u2248 4\u20135 half-lives.</span></li><li><span style=\"font-size:14.0pt;\">Here, t\u00bd = 10 hours \u2192</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">1 half-life = 50%</span></li><li><span style=\"font-size:14.0pt;\">2 half-lives = 75%</span></li><li><span style=\"font-size:14.0pt;\">3 half-lives = 87.5%</span></li><li><span style=\"font-size:14.0pt;\">4 half-lives = 93.75% (~95%)</span></li></ul></li><li><span style=\"font-size:14.0pt;\">Therefore, \u2248 4 \u00d7 10 hours = 40 hours.</span></li></ul>",
    "correct_choice_id": 296184,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 75779,
    "choices": [
      {
        "id": 301997,
        "text": "<p><span style=\"font-size:18px;\">Additive effect</span></p>"
      },
      {
        "id": 301998,
        "text": "<p><span style=\"font-size:18px;\">Synergistic effect</span></p>"
      },
      {
        "id": 301999,
        "text": "<p><span style=\"font-size:18px;\">Permisiveness</span></p>"
      },
      {
        "id": 302000,
        "text": "<p><span style=\"font-size:18px;\">Tachyphylaxis</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:18px;\">Physiologists conduct a series of experiments on hypophysectomized animals to investigate the effects of cortisol on vascular reactivity. Their initial tests show that administration of cortisol alone does not elicit a vascular response. Next, the researchers measure vascular reactivity to an infusion of norepinephrine both with and without pretreatment with cortisol. The results of their experiments are shown in the graph below. Which of the following pharmacologic principles best describes the effect of cortisol in this experiment?</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_I4svHUn.png\" width=\"486\" height=\"272\"></span></p>",
    "unique_key": "Q8899053",
    "question_audio": null,
    "question_video": null,
    "map_id": 33510217,
    "difficulty_level": "beginner",
    "subjects_id": [
      43
    ],
    "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. C) Permisiveness</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">The graph illustrates that&nbsp;cortisol alone does not elicit a vascular response, but pretreatment with cortisol enhances the response to norepinephrine. This exemplifies the pharmacologic principle of&nbsp;permissiveness, in which one hormone (cortisol) increases the effectiveness of another (norepinephrine) without itself producing the response.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option A. Additive effect:&nbsp;</strong>This occurs when the combined effect of two drugs equals the sum of their individual effects; here, cortisol alone produces no direct response, so this doesn't apply.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option B. Synergistic effect:&nbsp;</strong>When two drugs together produce an effect greater than the sum of their individual effects; in this case, cortisol enhances norepinephrine\u2019s effect but does not have an effect by itself, so it's not synergism.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option D. Tachyphylaxis:&nbsp;</strong>Refers to a rapid decrease in response to a drug after repeated administration, which is not shown in the experiment or graph</span></p>",
    "correct_choice_id": 301999,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "ImageBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 85804,
    "choices": [
      {
        "id": 341748,
        "text": "<p><span style=\"font-size:18px;\">Phosphodiesterase 3</span></p>"
      },
      {
        "id": 341749,
        "text": "<p><span style=\"font-size:18px;\">Phosphodiesterase 5</span></p>"
      },
      {
        "id": 341750,
        "text": "<p><span style=\"font-size:18px;\">Phosphodiesterase 6</span></p>"
      },
      {
        "id": 341751,
        "text": "<p><span style=\"font-size:18px;\">Phosphodiesterase 2</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:18px;\">A 45 year old male with erectile dysfunction was prescribed sildenafil. He develops bluish-green vision. Inhibition of which enzyme is the cause?</span></p>",
    "unique_key": "Q5943750",
    "question_audio": null,
    "question_video": null,
    "map_id": 33510218,
    "difficulty_level": "difficult",
    "subjects_id": [
      43
    ],
    "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. C) Phosphodiesterase 6</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">Sildenafil primarily inhibits PDE5 to treat erectile dysfunction, but cross-inhibition of PDE6 in retinal photoreceptors leads to bluish-green vision disturbances.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Phosphodiesterase 3:</strong> Found in heart &amp; vascular smooth muscle; inhibition affects contractility, not color vision.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Phosphodiesterase 5:</strong> Main target for erectile dysfunction; doesn\u2019t cause visual side effects directly.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option</strong> <strong>D. Phosphodiesterase 2:</strong> Found in heart and CNS; unrelated to visual perception.</span></p>",
    "correct_choice_id": 341750,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 75885,
    "choices": [
      {
        "id": 302417,
        "text": "<p><span style=\"font-size:14.0pt;\">Somatostatin and octreotide&nbsp;</span></p>"
      },
      {
        "id": 302418,
        "text": "<p><span style=\"font-size:14.0pt;\">Thioridazine and haloperidol</span></p>"
      },
      {
        "id": 302419,
        "text": "<p><span style=\"font-size:14.0pt;\">Pioglitazone and gemfibrozil</span></p>"
      },
      {
        "id": 302420,
        "text": "<p><span style=\"font-size:14.0pt;\">Diazoxide and nateglinide</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">Which of the following pairs of drugs act on the same receptor but have opposite effects?</span></p>",
    "unique_key": "Q6913254",
    "question_audio": null,
    "question_video": null,
    "map_id": 33510399,
    "difficulty_level": "intermediate",
    "subjects_id": [
      43
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) Diazoxide and nateglinide</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Diazoxide opens pancreatic K\u207a ATP channels (\u2193 insulin release), whereas nateglinide closes them (\u2191 insulin release). Both act on the same receptor (K\u207a ATP channel) but produce opposite effects.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Somatostatin &amp; octreotide:</strong> Both inhibit hormone secretion, similar effect.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option</strong> <strong>B. Thioridazine &amp; haloperidol:</strong> Both dopamine antagonists, same effect.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Pioglitazone &amp; gemfibrozil:</strong> Act on different receptors (PPAR-\u03b3 vs PPAR-\u03b1).</span></p>",
    "correct_choice_id": 302420,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 85771,
    "choices": [
      {
        "id": 341620,
        "text": "<p><span style=\"font-size:14.0pt;\">Valproate \u2013 Microvesicular steatosis</span></p>"
      },
      {
        "id": 341621,
        "text": "<p><span style=\"font-size:14.0pt;\">Halothane \u2013 Massive necrosis</span></p>"
      },
      {
        "id": 341622,
        "text": "<p><span style=\"font-size:14.0pt;\">Methotrexate \u2013 Cholestatic pattern</span></p>"
      },
      {
        "id": 341623,
        "text": "<p><span style=\"font-size:14.0pt;\">Allopurinol \u2013 Fibrin ring granulomas</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">All of the following are correctly matched drug-induced liver pathologies, except:</span></p>",
    "unique_key": "Q1138430",
    "question_audio": null,
    "question_video": null,
    "map_id": 33510400,
    "difficulty_level": "difficult",
    "subjects_id": [
      43
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Methotrexate \u2013 Cholestatic pattern</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Methotrexate primarily causes hepatic fibrosis and cirrhosis, not cholestatic injury.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option</strong> <strong>A. Valproate \u2013 Microvesicular steatosis:</strong> Valproate \u2192 Microvesicular steatosis (Reye-like).</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option</strong> <strong>B. Halothane \u2013 Massive necrosis:</strong> Halothane \u2192 Massive hepatic necrosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option</strong> <strong>D. Allopurinol \u2013 Fibrin ring granulomas:</strong> Allopurinol \u2192 Fibrin ring granulomas (rare hypersensitivity).</span></p>",
    "correct_choice_id": 341622,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 81940,
    "choices": [
      {
        "id": 326420,
        "text": "<p><span style=\"font-size:14.0pt;\">Azathiprine: PRPP synthetase</span></p>"
      },
      {
        "id": 326421,
        "text": "<p><span style=\"font-size:14.0pt;\">Mycophenolate: IMP -&gt; AMP conversion&nbsp;</span></p>"
      },
      {
        "id": 326422,
        "text": "<p><span style=\"font-size:14.0pt;\">Lefluomide: Carbamoyl phosphate -&gt; Orotic acid&nbsp;</span></p>"
      },
      {
        "id": 326423,
        "text": "<p><span style=\"font-size:14.0pt;\">5FU: Dihydrofolate reductase&nbsp;</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">Match the incorrect pair of drugs and enzyme/reaction they inhibit:&nbsp;</span></p>",
    "unique_key": "Q5326597",
    "question_audio": null,
    "question_video": null,
    "map_id": 33510401,
    "difficulty_level": "beginner",
    "subjects_id": [
      43
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) 5FU: Dihydrofolate reductase</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">5-FU inhibits thymidylate synthase, not DHFR.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option</strong> <strong>A. Azathioprine: PRPP synthetase:</strong> Azathioprine \u2192 Inhibits purine synthesis via PRPP amidotransferase.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option</strong> <strong>B. Mycophenolate: IMP \u2192 GMP conversion:</strong> Mycophenolate \u2192 Inhibits IMP dehydrogenase (IMP \u2192 GMP).</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option</strong> <strong>C. Leflunomide: Carbamoyl phosphate \u2192 Orotic acid:</strong> Leflunomide \u2192 Inhibits dihydroorotate dehydrogenase in pyrimidine synthesis.</span></p>",
    "correct_choice_id": 326423,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 75337,
    "choices": [
      {
        "id": 300237,
        "text": "<p><span style=\"font-size:14.0pt;\">Ibalizumab</span></p>"
      },
      {
        "id": 300238,
        "text": "<p><span style=\"font-size:14.0pt;\">Efavirenz&nbsp;</span></p>"
      },
      {
        "id": 300239,
        "text": "<p><span style=\"font-size:14.0pt;\">Fostemsavir</span></p>"
      },
      {
        "id": 300240,
        "text": "<p><span style=\"font-size:14.0pt;\">Abacavir&nbsp;</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">All of the following anti-retroviral drugs are given orally except:</span></p>",
    "unique_key": "Q8100410",
    "question_audio": null,
    "question_video": null,
    "map_id": 33510402,
    "difficulty_level": "intermediate",
    "subjects_id": [
      43
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Ibalizumab</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Ibalizumab is a monoclonal antibody given IV, not orally.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option</strong> <strong>B. Efavirenz:</strong> NNRTI, oral.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Fostemsavir:</strong> Oral gp120 attachment inhibitor.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option</strong> <strong>D. Abacavir:</strong> NRTI, oral.</span></p>",
    "correct_choice_id": 300237,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 60540,
    "choices": [
      {
        "id": 241453,
        "text": "<p><span style=\"font-size:14.0pt;\">Inhibition of dihydropteroate synthase</span></p>"
      },
      {
        "id": 241454,
        "text": "<p><span style=\"font-size:14.0pt;\">Binding to 50S ribosomal subunit</span></p>"
      },
      {
        "id": 241455,
        "text": "<p><span style=\"font-size:14.0pt;\">Inhibition of mycolic acid synthesis</span></p>"
      },
      {
        "id": 241456,
        "text": "<p><span style=\"font-size:14.0pt;\">Inhibition of arabinosyltransferase</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">A 46-year-old man comes to the physician for a pre-employment wellness examination. A tuberculin skin test is administered and he develops a raised, erythematous 12 mm lesion on his forearm within 48 hours. An x-ray of the chest shows no abnormalities. He is started on the recommended antibiotic treatment for latent tuberculosis. Four weeks later, he returns for a follow-up examination. Laboratory studies show a hemoglobin concentration of 9.3 g/dL, serum alanine aminotransferase activity of 86 U/L, and serum aspartate aminotransferase activity of 66 U/L. A photomicrograph of a Prussian blue-stained bone marrow smear is shown. Which of the following is the mechanism of action of the drug responsible for this patient's findings?</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/09/screenshot-2024-10-09-145000.jpg\" alt=\"\" width=\"300\" height=\"181\"></span></p>",
    "unique_key": "Q4476390",
    "question_audio": null,
    "question_video": null,
    "map_id": 33510403,
    "difficulty_level": "intermediate",
    "subjects_id": [
      43
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong></span><span style=\"font-size:12pt;\"><strong> </strong></span><span style=\"font-size:14.0pt;\"><strong>C) Inhibition of mycolic acid synthesis</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The Prussian blue-stained bone marrow photomicrograph shows&nbsp;ringed sideroblasts, which are erythroid precursors containing iron-laden mitochondria. This is a classic finding in sideroblastic anemia, which can be caused by&nbsp;isoniazid&nbsp;toxicity\u2014a drug used for latent tuberculosis. Isoniazid inhibits&nbsp;mycolic acid synthesis&nbsp;and can lead to pyridoxine deficiency, impairing heme synthesis and causing iron accumulation in the mitochondria.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Inhibition of dihydropteroate synthase:&nbsp;</strong>Sulfonamides, not used for TB.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Binding to 50S ribosomal subunit:&nbsp;</strong>Macrolides/chloramphenicol.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Inhibition of arabinosyltransferase:&nbsp;</strong>Ethambutol, another TB drug but not linked to sideroblastic anemia.</span></p>",
    "correct_choice_id": 241455,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "ImageBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 67132,
    "choices": [
      {
        "id": 267653,
        "text": "<p><span style=\"font-size:14.0pt;\">Methylation</span></p>"
      },
      {
        "id": 267654,
        "text": "<p><span style=\"font-size:14.0pt;\">Hydrolysis</span></p>"
      },
      {
        "id": 267655,
        "text": "<p><span style=\"font-size:14.0pt;\">Acetylation</span></p>"
      },
      {
        "id": 267656,
        "text": "<p><span style=\"font-size:14.0pt;\">Glucuronidation</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">A group of researchers is studying the variability in drug metabolism across individuals using isoniazid. Variation in which of the following metabolic processes is the most likely explanation for this observation?</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_w8tWfE2.png\" width=\"694\" height=\"349\"></span></p>",
    "unique_key": "Q8749783",
    "question_audio": null,
    "question_video": null,
    "map_id": 33510529,
    "difficulty_level": "intermediate",
    "subjects_id": [
      43
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Acetylation</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The graph shows a&nbsp;bimodal distribution&nbsp;of plasma isoniazid (INH) concentrations among individuals, representing populations of&nbsp;slow and fast acetylators. Acetylation&nbsp;is mediated by the N-acetyltransferase enzyme, which exhibits genetic polymorphism leading to classification of individuals as slow or fast acetylators, directly explaining the bimodal plasma concentrations of isoniazid.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option</strong> <strong>A. Methylation:</strong> Methylation is a phase II metabolic reaction that involves transferring a methyl group to substrates, often leading to detoxification or alteration of activity. While methylation occurs with many drugs, it is not the primary pathway responsible for the variability in isoniazid metabolism or plasma concentration differences seen in populations.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option</strong> <strong>B. Hydrolysis:&nbsp;</strong>Hydrolysis involves cleavage of chemical bonds through the addition of water, commonly seen in ester or amide bonds. This reaction is important for activating or deactivating some drugs, but it is not a significant metabolic pathway for isoniazid, hence not contributing to its variable plasma levels.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Glucuronidation:</strong> Glucuronidation is a major phase II conjugation reaction that attaches glucuronic acid to lipophilic molecules to enhance excretion. It typically affects drugs like morphine or bilirubin but is not the key metabolic step for isoniazid nor responsible for its polymorphic metabolism.</span></p>",
    "correct_choice_id": 267655,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "ImageBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 25731,
    "choices": [
      {
        "id": 102874,
        "text": "<p><span style=\"font-size:18px;\">Atrioventricular node</span></p>"
      },
      {
        "id": 102875,
        "text": "<p><span style=\"font-size:18px;\">Iris of the eye</span></p>"
      },
      {
        "id": 102876,
        "text": "<p><span style=\"font-size:18px;\">Bronchus</span></p>"
      },
      {
        "id": 102877,
        "text": "<p><span style=\"font-size:18px;\">Renal juxtaglomerular apparatus</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:18px;\">Which of the following organs can differentiate between the action of epinephrine and nor-epinephrine:</span></p>",
    "unique_key": "Q1592029",
    "question_audio": null,
    "question_video": null,
    "map_id": 33510530,
    "difficulty_level": "intermediate",
    "subjects_id": [
      43
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Bronchus</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Bronchial smooth muscle expresses \u03b22-adrenoceptors, which respond preferentially to epinephrine over norepinephrine, allowing differentiation.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option</strong> <strong>A. Atrioventricular</strong> <strong>node:</strong> Responds to both via \u03b21 receptors; doesn\u2019t distinguish.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option</strong> <strong>B. Iris of the eye:</strong> Both cause pupil dilation/constriction via \u03b1/\u03b2 receptors; limited differentiation.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option</strong> <strong>D. Renal juxtaglomerular apparatus:</strong> \u03b21 receptor-mediated renin release; minimal differentiation.</span></p>",
    "correct_choice_id": 102876,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 62540,
    "choices": [
      {
        "id": 249409,
        "text": "<p><span style=\"font-size:14.0pt;\">Rumack Matthew&nbsp;</span></p>"
      },
      {
        "id": 249410,
        "text": "<p><span style=\"font-size:14.0pt;\">Matzke</span></p>"
      },
      {
        "id": 249411,
        "text": "<p><span style=\"font-size:14.0pt;\">Hartford&nbsp;</span></p>"
      },
      {
        "id": 249412,
        "text": "<p><span style=\"font-size:14.0pt;\">Naranjo&nbsp;</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:18px;\">Which of the following is used to monitor PCM (paracetamol) toxicity?</span></p>",
    "unique_key": "Q7003968",
    "question_audio": null,
    "question_video": null,
    "map_id": 33510531,
    "difficulty_level": "intermediate",
    "subjects_id": [
      43
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Rumack Matthew</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The Rumack-Matthew nomogram is used to assess risk of hepatotoxicity after acute paracetamol overdose based on plasma concentration vs time.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_9wmTxwV.png\" width=\"901\" height=\"1041\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option</strong> <strong>B. Matzke:</strong> Used for aminoglycoside dosing.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option</strong> <strong>C. Hartford:</strong> Not relevant for paracetamol.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option</strong> <strong>D. Naranjo:</strong> Adverse drug reaction probability scale.</span></p>",
    "correct_choice_id": 249409,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 35594,
    "choices": [
      {
        "id": 142183,
        "text": "<p><span style=\"font-size:18px;\">Schedule G drugs</span></p>"
      },
      {
        "id": 142184,
        "text": "<p><span style=\"font-size:18px;\">Schedule H drugs</span></p>"
      },
      {
        "id": 142185,
        "text": "<p><span style=\"font-size:18px;\">Schedule J drugs</span></p>"
      },
      {
        "id": 142186,
        "text": "<p><span style=\"font-size:18px;\">Schedule X drugs</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:14.0pt;\">Which of the following drugs need labelling as \u201cDangerous to use except under medical supervision\u201d?</span></p>",
    "unique_key": "Q6677382",
    "question_audio": null,
    "question_video": null,
    "map_id": 33510532,
    "difficulty_level": "intermediate",
    "subjects_id": [
      43
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Schedule G drugs</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Schedule G drugs &nbsp;require a warning: Caution: It is dangerous to take this preparation except under medical supervision.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option</strong> <strong>B. Schedule H</strong> <strong>drugs:</strong> Prescription drugs, no specific wording.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option</strong> <strong>C. Schedule J drugs:</strong> Drugs exempted from patent or licensing rules.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option</strong> <strong>D. Schedule X drugs:</strong> Narcotics/psychotropic requiring special prescription.</span></p>",
    "correct_choice_id": 142183,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 67053,
    "choices": [
      {
        "id": 267345,
        "text": "<p><span style=\"font-size:14.0pt;\">1-a, 2-b, 3-c, 4-d</span></p>"
      },
      {
        "id": 267346,
        "text": "<p><span style=\"font-size:14.0pt;\">1-b, 2-c, 3-a, 4-d</span></p>"
      },
      {
        "id": 267347,
        "text": "<p><span style=\"font-size:14.0pt;\">1-a, 2-b, 3-d, 4-c</span></p>"
      },
      {
        "id": 267348,
        "text": "<p><span style=\"font-size:14.0pt;\">1-b, 2-a, 3-d, 4-c</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:18px;\">Match the following drugs with the reactivation of infections they are associated with:&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202024-12-19%20162940.png\" width=\"887\" height=\"208\"></span></p>",
    "unique_key": "Q9634034",
    "question_audio": null,
    "question_video": null,
    "map_id": 33510533,
    "difficulty_level": "intermediate",
    "subjects_id": [
      43
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) 1-a, 2-b, 3-c, 4-d</strong></span></p><p>&nbsp;</p><ol style=\"list-style-type:decimal;\"><li><span style=\"font-size:14.0pt;\">Bortezomib \u2192 HSV reactivation (common in multiple myeloma patients).</span></li><li><span style=\"font-size:14.0pt;\">Rituximab \u2192 Hepatitis B reactivation.</span></li><li><span style=\"font-size:14.0pt;\">TNF-\u03b1 inhibitors \u2192 TB reactivation.</span></li><li><span style=\"font-size:14.0pt;\">Fingolimod \u2192 Herpes zoster virus (HZV) reactivation.</span></li></ol>",
    "correct_choice_id": 267345,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "ImageBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  }
];
        let quizName = 'Btr General Path-Pharma-Physio - 05-09-2025';
        const quizFilename = 'btr-general-path-pharma-physio-05-09-2025-c78bb37d.html';
        let hierarchy = ["Cerebellum", "Mock Test", "BTR"];
        
        // Handle Custom Quiz Loading
        if (window.location.pathname.endsWith('custom_quiz.html')) {
            const customData = JSON.parse(localStorage.getItem('customQuizData'));
            if (customData) {
                questionsData = customData.questions;
                quizName = customData.name;
                hierarchy = customData.hierarchy;
                document.title = quizName + ' - Brain And Scalpel';
                document.getElementById('totalQuestions').textContent = questionsData.length;
                document.getElementById('quizHierarchy').textContent = hierarchy.join(' > ');
            }
        }

        let currentQuestionIndex = 0;
        let selectedOption = null;
        let currentMode = 'study';
        let timer = null;
        let timeRemaining = 0;
        let questionStartTime = Date.now();
        let quizStartTime = Date.now();
        let isQuizCompleted = false;
        
        let questionStates = new Array(questionsData.length).fill(null).map(() => ({
            status: 'not_attempted',
            bookmarked: false,
            markedForReview: false,
            selectedAnswer: null,
            timeSpent: 0
        }));
        
        let stats = {
            correctAnswers: 0,
            incorrectAnswers: 0,
            totalAttempted: 0,
            totalTime: 0,
            notAttempted: questionsData.length
        };

        // --- NEW: History Management ---
        function saveProgress() {
            if (isQuizCompleted) return; // Don't save after completion
            const userHistory = JSON.parse(localStorage.getItem('userHistory')) || {};
            userHistory[quizFilename] = {
                questionStates,
                stats,
                currentQuestionIndex,
                currentMode,
                status: 'incomplete',
                lastSeen: new Date().toISOString()
            };
            localStorage.setItem('userHistory', JSON.stringify(userHistory));
        }

        function loadProgress() {
            const userHistory = JSON.parse(localStorage.getItem('userHistory')) || {};
            const savedState = userHistory[quizFilename];
            if (savedState) {
                questionStates = savedState.questionStates;
                stats = savedState.stats;
                currentQuestionIndex = savedState.currentQuestionIndex;
                currentMode = savedState.currentMode;
                console.log('Progress loaded.');
                return true;
            }
            return false;
        }

        function clearProgress() {
            const userHistory = JSON.parse(localStorage.getItem('userHistory')) || {};
            if(userHistory[quizFilename]) {
                delete userHistory[quizFilename];
                localStorage.setItem('userHistory', JSON.stringify(userHistory));
                console.log('Previous progress cleared.');
            }
        }

        function markQuizAsCompleted() {
            const userHistory = JSON.parse(localStorage.getItem('userHistory')) || {};
            const totalQuestions = questionsData.length;
            const correct = stats.correctAnswers || 0;
            
            userHistory[quizFilename] = {
                score: correct,
                total: totalQuestions,
                status: 'completed',
                completedOn: new Date().toISOString()
            };
            localStorage.setItem('userHistory', JSON.stringify(userHistory));
        }
        // --- End of History Management ---

        const urlParams = new URLSearchParams(window.location.search);
        const startAt = parseInt(urlParams.get('startAt'));
        const resume = urlParams.get('resume') === 'true';

        function goBack() {
            if (!isQuizCompleted) saveProgress(); // Save progress before leaving
            window.location.href = document.referrer || 'index.html';
        }

        function selectMode(mode) {
            currentMode = mode;
            document.getElementById('modeModal').style.display = 'none';
            initializeQuiz();
        }

        function initializeQuiz() {
            quizStartTime = Date.now();
            
            const bookmarkBtn = document.getElementById('bookmarkBtn');
            const markReviewBtn = document.getElementById('markReviewBtn');
            const testModeReviewLegend = document.getElementById('testModeReviewLegend');
            const isTestMode = currentMode === 'test' || currentMode === 'timed_exam';
            
            document.getElementById('statsBar').style.display = isTestMode ? 'none' : 'block';
            document.getElementById('studyModeLegend').style.display = isTestMode ? 'none' : 'block';
            document.getElementById('testModeLegend').style.display = isTestMode ? 'block' : 'none';
            document.getElementById('submitSection').style.display = isTestMode ? 'block' : 'none';
            bookmarkBtn.style.display = isTestMode ? 'none' : 'flex';
            markReviewBtn.style.display = isTestMode ? 'flex' : 'none';
            testModeReviewLegend.style.display = isTestMode ? 'flex' : 'none';
            
            if (currentMode === 'timed_study' || currentMode === 'timed_exam') {
                document.getElementById('timerContainer').classList.remove('hidden');
            }
            
            if (!isNaN(startAt) && startAt >= 0 && startAt < questionsData.length) {
                currentQuestionIndex = startAt;
            }

            loadBookmarkedQuestions();
            generateQuestionNav();
            updateStats();
            displayQuestion();
        }

        function generateQuestionNav() {
            const nav = document.getElementById('questionNav');
            nav.innerHTML = '';
            
            for (let i = 0; i < questionsData.length; i++) {
                const btn = document.createElement('button');
                btn.textContent = i + 1;
                btn.className = 'w-8 h-8 text-sm font-medium rounded transition-all duration-200';
                btn.onclick = () => jumpToQuestion(i);
                btn.id = `navBtn_${i}`;
                nav.appendChild(btn);
            }
            
            updateQuestionNav();
        }

        function updateQuestionNav() {
            for (let i = 0; i < questionsData.length; i++) {
                const btn = document.getElementById(`navBtn_${i}`);
                const state = questionStates[i];
                let className = '';
                
                if (i === currentQuestionIndex) {
                    className = 'nav-btn-current';
                } else if (state.bookmarked) {
                    className = 'nav-btn-bookmarked';
                } else if (state.markedForReview) {
                    className = 'nav-btn-marked-review';
                } else if (currentMode === 'study' || currentMode === 'timed_study') {
                    if (state.status === 'correct') className = 'nav-btn-correct';
                    else if (state.status === 'incorrect') className = 'nav-btn-incorrect';
                    else className = 'nav-btn-not-attempted hover:bg-white hover:bg-opacity-20';
                } else {
                    if (state.selectedAnswer !== null) className = 'nav-btn-answered';
                    else className = 'nav-btn-not-attempted hover:bg-white hover:bg-opacity-20';
                }
                btn.className = `w-8 h-8 text-sm font-medium rounded ${className}`;
            }
        }

        function jumpToQuestion(index) {
            if (index >= 0 && index < questionsData.length) {
                if (questionStartTime) {
                    questionStates[currentQuestionIndex].timeSpent += Date.now() - questionStartTime;
                }
                
                currentQuestionIndex = index;
                displayQuestion();
                saveProgress(); // NEW: Save on navigation
            }
        }

        function updateStats() {
            if (currentMode === 'study' || currentMode === 'timed_study') {
                document.getElementById('correctCount').textContent = stats.correctAnswers;
                document.getElementById('incorrectCount').textContent = stats.incorrectAnswers;
                document.getElementById('totalAttempted').textContent = stats.totalAttempted;
                
                const accuracy = stats.totalAttempted > 0 
                    ? Math.round((stats.correctAnswers / stats.totalAttempted) * 100)
                    : 0;
                document.getElementById('accuracy').textContent = accuracy + '%';
                
                stats.totalTime = questionStates.reduce((acc, state) => acc + state.timeSpent, 0);
                const timeSpent = Math.floor(stats.totalTime / 1000);
                const minutes = Math.floor(timeSpent / 60);
                const seconds = timeSpent % 60;
                document.getElementById('timeSpent').textContent = 
                    minutes + ':' + seconds.toString().padStart(2, '0');
            }
        }

        function setupVideo(videoElement, url) {
            if (Hls.isSupported()) {
                const hls = new Hls();
                hls.loadSource(url);
                hls.attachMedia(videoElement);
            } else if (videoElement.canPlayType('application/vnd.apple.mpegurl')) {
                videoElement.src = url;
            }
        }

        function displayQuestion() {
            if (!questionsData || questionsData.length === 0) {
                document.getElementById('questionText').innerHTML = 'No questions available for this quiz.';
                return;
            };
            
            const question = questionsData[currentQuestionIndex];
            questionStartTime = Date.now();
            
            selectedOption = questionStates[currentQuestionIndex].selectedAnswer;
            
            const progress = ((currentQuestionIndex + 1) / questionsData.length) * 100;
            document.getElementById('progressBar').style.width = progress + '%';
            document.getElementById('currentQuestion').textContent = currentQuestionIndex + 1;
            updateQuestionNav();
            
            document.getElementById('prevBtn').disabled = currentQuestionIndex === 0;
            
            document.getElementById('solutionContainer').classList.add('hidden');
            
            document.getElementById('questionText').innerHTML = question.text || 'No question text available';
            
            let mediaHtml = '';
            if (question.question_audio) mediaHtml += `<div class="glass-light p-4 mb-4"><audio src="${question.question_audio}" controls class="w-full"></audio></div>`;
            if (question.question_video) mediaHtml += `<div class="glass-light p-4 mb-4"><video src="${question.question_video}" controls class="w-full rounded-lg"></video></div>`;
            if (question.question_images) {
                question.question_images.forEach(imgSrc => {
                    if (imgSrc) mediaHtml += `<div class="glass-light p-4 mb-4"><img src="${imgSrc}" alt="Question Image" class="w-full rounded-lg"></div>`;
                });
            }
            document.getElementById('questionMedia').innerHTML = mediaHtml;
            
            const optionsContainer = document.getElementById('optionsContainer');
            optionsContainer.innerHTML = '';
            optionsContainer.classList.remove('answered');
            
            if (question.choices && Array.isArray(question.choices)) {
                question.choices.forEach((choice, index) => {
                    const optionLetter = String.fromCharCode(65 + index);
                    const isSelected = selectedOption === index;
                    
                    const optionDiv = document.createElement('div');
                    optionDiv.innerHTML = `
                        <button type="button" class="option-button ${isSelected ? 'selected' : ''}" data-option-index="${index}">
                            <div class="option-letter">${optionLetter}</div>
                            <div class="option-text">${choice.text || 'Option ' + (index + 1)}</div>
                        </button>
                    `;
                    optionsContainer.appendChild(optionDiv);
                });
                
                optionsContainer.addEventListener('click', function(e) {
                    const optionButton = e.target.closest('.option-button');
                    if (optionButton) {
                        const optionIndex = parseInt(optionButton.getAttribute('data-option-index'));
                        selectOption(optionIndex);
                    }
                });
            }
            
            updateBookmarkButton();
            updateMarkReviewButton();

            if ((currentMode === 'timed_study' || currentMode === 'timed_exam') && !isQuizCompleted) {
                startTimer();
            }
        }

        function selectOption(index) {
            const optionsContainer = document.getElementById('optionsContainer');
            if (optionsContainer.classList.contains('answered')) return;

            if (questionStartTime) {
                questionStates[currentQuestionIndex].timeSpent += Date.now() - questionStartTime;
                questionStartTime = Date.now();
            }
            
            selectedOption = index;
            questionStates[currentQuestionIndex].selectedAnswer = index;
            
            document.querySelectorAll('.option-button').forEach((btn, i) => {
                btn.classList.toggle('selected', i === index);
            });
            
            if (currentMode === 'study' || currentMode === 'timed_study') {
                processAnswer();
            } else {
                if (questionStates[currentQuestionIndex].status === 'not_attempted') {
                    questionStates[currentQuestionIndex].status = 'answered';
                    stats.totalAttempted++;
                    stats.notAttempted--;
                }
                updateQuestionNav();
            }
            saveProgress(); // NEW: Save on answer selection
        }

        function processAnswer() {
            const question = questionsData[currentQuestionIndex];
            const correctChoiceId = question.correct_choice_id;
            
            if(selectedOption === null) return;

            const selectedChoice = question.choices[selectedOption];
            const isCorrect = selectedChoice.id === correctChoiceId;
            
            if (questionStates[currentQuestionIndex].status === 'not_attempted') {
                stats.totalAttempted++;
                stats.notAttempted--;
                if(isCorrect) stats.correctAnswers++; else stats.incorrectAnswers++;
            }
            questionStates[currentQuestionIndex].status = isCorrect ? 'correct' : 'incorrect';
            
            updateStats();
            showInlineFeedback(isCorrect);
            updateQuestionNav();
        }

        function showInlineFeedback(isCorrect) {
            if (currentMode !== 'study' && currentMode !== 'timed_study') return;

            const optionsContainer = document.getElementById('optionsContainer');
            const optionButtons = optionsContainer.querySelectorAll('.option-button');
            const question = questionsData[currentQuestionIndex];
            const correctChoiceId = question.correct_choice_id;
            let correctOptionIndex = question.choices.findIndex(c => c.id === correctChoiceId);

            optionsContainer.classList.add('answered');

            optionButtons.forEach((btn, index) => {
                btn.classList.remove('selected');
                if (index === correctOptionIndex) btn.classList.add('correct');
                else if (index === selectedOption && !isCorrect) btn.classList.add('incorrect');
            });

            showSolution();
        }


        function showSolution() {
            if (currentMode !== 'study' && currentMode !== 'timed_study') return;
            
            const question = questionsData[currentQuestionIndex];
            document.getElementById('solutionText').innerHTML = question.solution || 'No solution provided';
            
            const videoContainer = document.getElementById('solutionVideo');
            const videoPlayer = document.getElementById('explanationVideoPlayer');
            const explanationVideo = question.explanation_video;
            
            if (explanationVideo) {
                videoContainer.classList.remove('hidden');
                if (explanationVideo.includes('.m3u8')) setupVideo(videoPlayer, explanationVideo);
                else videoPlayer.src = explanationVideo;
            } else {
                videoContainer.classList.add('hidden');
            }

            const audioContainer = document.getElementById('solutionAudio');
            audioContainer.innerHTML = '';
            if (question.explanation_audio_eng) {
                audioContainer.innerHTML += `<div class="mt-2"><p class="text-sm text-white text-opacity-70 mb-1">English Explanation:</p><audio src="${question.explanation_audio_eng}" controls class="w-full"></audio></div>`;
            }
            if (question.explanation_audio_hin) {
                audioContainer.innerHTML += `<div class="mt-2"><p class="text-sm text-white text-opacity-70 mb-1">Hinglish Explanation:</p><audio src="${question.explanation_audio_hin}" controls class="w-full"></audio></div>`;
            }
            
            const imagesContainer = document.getElementById('solutionImages');
            imagesContainer.innerHTML = '';
            if (question.explanation_images) {
                 question.explanation_images.forEach(imgSrc => {
                    if(imgSrc) imagesContainer.innerHTML += `<div class="mt-4"><img src="${imgSrc}" alt="Explanation Image" class="w-full rounded-lg"></div>`;
                });
            }

            document.getElementById('solutionContainer').classList.remove('hidden');
        }

        function submitQuiz() {
            if (timer) clearInterval(timer);
            if (!confirm('Are you sure you want to submit the quiz?')) return;
            
            isQuizCompleted = true;
            let correct = 0, incorrect = 0;
            const totalTime = Date.now() - quizStartTime;
            
            questionsData.forEach((question, index) => {
                const state = questionStates[index];
                if (state.selectedAnswer !== null) {
                    if (question.choices[state.selectedAnswer].id === question.correct_choice_id) {
                        correct++;
                        state.status = 'correct';
                    } else {
                        incorrect++;
                        state.status = 'incorrect';
                    }
                }
            });
            
            // Save performance data
            const performanceData = JSON.parse(localStorage.getItem('quizPerformanceData')) || [];
            performanceData.push({
                quizName: quizName,
                hierarchy: hierarchy,
                timestamp: Date.now(),
                totalTime: totalTime,
                stats: {
                    correct: correct,
                    incorrect: incorrect,
                    notAttempted: questionsData.length - (correct + incorrect)
                }
            });
            localStorage.setItem('quizPerformanceData', JSON.stringify(performanceData));

            stats.correctAnswers = correct; // Update global stats
            stats.incorrectAnswers = incorrect;
            markQuizAsCompleted(); // NEW: Mark quiz as complete in history
            showPerformanceAnalysis(correct, incorrect, questionsData.length - (correct + incorrect), totalTime);
        }

        function showPerformanceAnalysis(correct, incorrect, notAttempted, totalTime) {
            const modal = document.getElementById('performanceModal');
            const accuracy = (correct + incorrect) > 0 ? Math.round((correct / (correct + incorrect)) * 100) : 0;
            
            const circumference = 2 * Math.PI * 65;
            const scoreCircle = document.getElementById('scoreCircle');
            scoreCircle.style.strokeDasharray = `${circumference} ${circumference}`;
            scoreCircle.style.strokeDashoffset = circumference - (accuracy / 100) * circumference;
            
            document.getElementById('accuracyScore').textContent = `${accuracy}%`;
            document.getElementById('totalQuestionsResult').textContent = questionsData.length;
            document.getElementById('correctResult').textContent = correct;
            document.getElementById('incorrectResult').textContent = incorrect;
            document.getElementById('notAttemptedResult').textContent = notAttempted;
            
            const totalMinutes = Math.floor(totalTime / 60000);
            const totalSeconds = Math.floor((totalTime % 60000) / 1000);
            document.getElementById('totalTimeResult').textContent = `${totalMinutes}:${totalSeconds.toString().padStart(2, '0')}`;
            
            const avgTime = totalTime / questionsData.length;
            const avgMinutes = Math.floor(avgTime / 60000);
            const avgSeconds = Math.floor((avgTime % 60000) / 1000);
            document.getElementById('avgTimeResult').textContent = `${avgMinutes}:${avgSeconds.toString().padStart(2, '0')}`;
            
            modal.classList.remove('hidden');
        }

        function closePerformanceModal() { document.getElementById('performanceModal').classList.add('hidden'); }

        function reviewQuestions() {
            document.getElementById('questionReviewSection').classList.remove('hidden');
            const container = document.getElementById('reviewQuestionsContainer');
            container.innerHTML = '';
            
            questionsData.forEach((question, index) => {
                const state = questionStates[index];
                const correctChoiceId = question.correct_choice_id;
                
                let statusClass = 'not-attempted', statusText = 'Not Attempted';
                if (state.selectedAnswer !== null) {
                    const selectedChoice = question.choices[state.selectedAnswer];
                    if (selectedChoice.id === correctChoiceId) { statusClass = 'correct'; statusText = 'Correct'; }
                     else { statusClass = 'incorrect'; statusText = 'Incorrect'; }
                }
                
                const reviewDiv = document.createElement('div');
                reviewDiv.className = `review-question ${statusClass}`;
                
                let optionsHtml = (question.choices || []).map((choice, choiceIndex) => {
                    const isSelected = state.selectedAnswer === choiceIndex;
                    const isCorrect = choice.id === correctChoiceId;
                    let borderClass = 'border-gray-600';
                    if(isCorrect) borderClass = 'border-green-500';
                    else if(isSelected) borderClass = 'border-red-500';
                    
                    return `<div class="p-3 rounded-lg border ${borderClass}"><span class="font-bold mr-3">${String.fromCharCode(65 + choiceIndex)}</span><span>${choice.text}</span></div>`;
                }).join('');

                const videoHtml = question.explanation_video ? `<div class="mt-4"><video id="review-video-${index}" data-src="${question.explanation_video}" class="w-full rounded-lg" controls></video></div>` : '';
                
                let audioHtml = '';
                if(question.explanation_audio_eng) audioHtml += `<div class="mt-2"><p class="text-sm text-white text-opacity-70 mb-1">English:</p><audio src="${question.explanation_audio_eng}" controls class="w-full"></audio></div>`;
                if(question.explanation_audio_hin) audioHtml += `<div class="mt-2"><p class="text-sm text-white text-opacity-70 mb-1">Hinglish:</p><audio src="${question.explanation_audio_hin}" controls class="w-full"></audio></div>`;

                let imagesHtml = (question.explanation_images || []).map(src => src ? `<div class="mt-4"><img src="${src}" alt="Explanation Image" class="w-full rounded-lg"></div>` : '').join('');

                reviewDiv.innerHTML = `
                    <div class="mb-4">
                        <div class="flex justify-between items-center mb-3">
                            <h4 class="text-lg font-bold text-white">Question ${index + 1}</h4>
                            <span class="text-sm px-3 py-1 rounded-full bg-${statusClass === 'correct' ? 'green' : statusClass === 'incorrect' ? 'red' : 'gray'}-600 text-white">${statusText}</span>
                        </div>
                        <div class="text-white mb-4">${question.text}</div>
                    </div>
                    <div class="space-y-2 mb-4">${optionsHtml}</div>
                    <div class="bg-green-900 bg-opacity-20 p-4 rounded-lg border border-green-700">
                        <h5 class="text-green-400 font-bold mb-2">Explanation:</h5>
                        <div class="text-white text-opacity-90">${question.solution || 'No solution available.'}</div>
                        ${videoHtml}
                        ${audioHtml}
                        ${imagesHtml}
                    </div>`;
                container.appendChild(reviewDiv);
            });
            initializeReviewVideos();
        }

        function initializeReviewVideos() {
            document.querySelectorAll('video[data-src]').forEach(videoEl => {
                const src = videoEl.dataset.src;
                if (src && src.includes('.m3u8')) {
                    setupVideo(videoEl, src);
                } else if (src) {
                    videoEl.src = src;
                }
            });
        }

        function retakeQuiz() {
            if (confirm('Are you sure you want to retake the quiz? This will reset all your answers.')) {
                if (window.location.pathname.endsWith('custom_quiz.html')) {
                    localStorage.removeItem('customQuizData');
                }
                clearProgress(); // NEW: Clear history on retake
                location.reload();
            }
        }

        function loadBookmarkedQuestions() {
            const bookmarks = JSON.parse(localStorage.getItem('bookmarkedQuestions')) || [];
            bookmarks.forEach(bookmark => {
                if (bookmark.quizFile.includes(quizName.toLowerCase().replace(/ /g, '-'))) {
                    if (bookmark.questionIndex < questionsData.length) {
                        questionStates[bookmark.questionIndex].bookmarked = true;
                    }
                }
            });
        }

        function toggleBookmark() {
            const isBookmarked = !questionStates[currentQuestionIndex].bookmarked;
            questionStates[currentQuestionIndex].bookmarked = isBookmarked;
            
            let bookmarks = JSON.parse(localStorage.getItem('bookmarkedQuestions')) || [];
            
            if (isBookmarked) {
                const bookmarkData = {
                    quizName: quizName,
                    quizFile: window.location.pathname.split('/').pop(),
                    questionIndex: currentQuestionIndex,
                    question: questionsData[currentQuestionIndex],
                    hierarchy: hierarchy,
                    timestamp: Date.now()
                };
                bookmarks.push(bookmarkData);
            } else {
                bookmarks = bookmarks.filter(b => 
                    !(b.quizFile.includes(quizName.toLowerCase().replace(/ /g, '-')) && b.questionIndex === currentQuestionIndex)
                );
            }
            
            localStorage.setItem('bookmarkedQuestions', JSON.stringify(bookmarks));
            updateBookmarkButton();
            updateQuestionNav();
        }

        function updateBookmarkButton() {
            const btn = document.getElementById('bookmarkBtn');
            const text = document.getElementById('bookmarkText');
            const isBookmarked = questionStates[currentQuestionIndex].bookmarked;
            
            btn.className = isBookmarked ? 'gradient-yellow px-6 py-3 text-white transition-all duration-300 flex items-center' : 'glass-light px-6 py-3 text-white hover:bg-yellow-500 hover:bg-opacity-20 transition-all duration-300 flex items-center';
            text.textContent = isBookmarked ? 'Bookmarked' : 'Bookmark';
        }
        
        function toggleMarkForReview() {
            questionStates[currentQuestionIndex].markedForReview = !questionStates[currentQuestionIndex].markedForReview;
            updateMarkReviewButton();
            updateQuestionNav();
        }

        function updateMarkReviewButton() {
            const btn = document.getElementById('markReviewBtn');
            const text = document.getElementById('markReviewText');
            const isMarked = questionStates[currentQuestionIndex].markedForReview;
            
            btn.className = isMarked ? 'gradient-purple px-6 py-3 text-white transition-all duration-300 flex items-center' : 'glass-light px-6 py-3 text-white hover:bg-purple-500 hover:bg-opacity-20 transition-all duration-300 flex items-center';
            text.textContent = isMarked ? 'Marked' : 'Mark for Review';
        }

        function previousQuestion() {
            if (currentQuestionIndex > 0) {
                if (questionStartTime) {
                    questionStates[currentQuestionIndex].timeSpent += Date.now() - questionStartTime;
                }
                
                currentQuestionIndex--;
                displayQuestion();
                saveProgress(); // NEW: Save on navigation
            }
        }

        function nextQuestion() {
            if (questionStartTime) {
                questionStates[currentQuestionIndex].timeSpent += Date.now() - questionStartTime;
            }
            
            if (currentQuestionIndex < questionsData.length - 1) {
                currentQuestionIndex++;
                displayQuestion();
                saveProgress(); // NEW: Save on navigation
            } else {
                if (currentMode === 'test' || currentMode === 'timed_exam') {
                    if (confirm('You have reached the end of the quiz. Would you like to submit your answers now?')) {
                        submitQuiz();
                    }
                } else {
                    if (confirm('You have completed all questions. Would you like to review from the beginning?')) {
                        currentQuestionIndex = 0;
                        displayQuestion();
                        saveProgress();
                    }
                }
            }
        }

        function startTimer() {
            if (timer) clearInterval(timer);
            timeRemaining = 120; // 2 minutes per question
            updateTimerDisplay();
            
            timer = setInterval(() => {
                timeRemaining--;
                updateTimerDisplay();
                
                if (timeRemaining <= 0) {
                    clearInterval(timer);
                    if (currentMode === 'timed_exam') {
                        submitQuiz();
                    } else {
                        nextQuestion();
                    }
                }
            }, 1000);
        }

        function updateTimerDisplay() {
            const minutes = Math.floor(timeRemaining / 60);
            const seconds = timeRemaining % 60;
            document.getElementById('timeDisplay').textContent = 
                minutes + ':' + seconds.toString().padStart(2, '0');
        }

        function toggleSidebar() {
            document.getElementById('quizSidebar').classList.toggle('open');
        }

        document.addEventListener('DOMContentLoaded', () => {
             if (resume) {
                if (loadProgress()) {
                    document.getElementById('modeModal').style.display = 'none';
                    initializeQuiz(); // Resume directly into the saved mode and state
                } else {
                    // If resume fails (e.g., cleared history), start fresh
                    clearProgress();
                    document.getElementById('modeModal').style.display = 'flex';
                }
             } else if (!window.location.pathname.endsWith('custom_quiz.html')) {
                clearProgress(); // Clear old progress if not resuming
                document.getElementById('modeModal').style.display = 'flex';
             } else {
                initializeQuiz();
             }
        });
        
        document.addEventListener('keydown', function(e) {
            if (document.getElementById('modeModal').style.display !== 'none') return;
            if (document.getElementById('performanceModal').classList.contains('hidden') === false) return;
            
            if (e.key >= '1' && e.key <= '4') {
                const optionIndex = parseInt(e.key) - 1;
                const options = document.querySelectorAll('.option-button');
                if (optionIndex < options.length) selectOption(optionIndex);
            } else if (e.key === 'ArrowLeft') {
                previousQuestion();
            } else if (e.key === 'ArrowRight' || e.key === ' ') {
                e.preventDefault();
                nextQuestion();
            } else if (e.key.toLowerCase() === 'b' && (currentMode === 'study' || currentMode === 'timed_study')) {
                toggleBookmark();
            } else if (e.key.toLowerCase() === 'm' && (currentMode === 'test' || currentMode === 'timed_exam')) {
                toggleMarkForReview();
            } else if (e.key.toLowerCase() === 's' && (currentMode === 'test' || currentMode === 'timed_exam')) {
                submitQuiz();
            }
        });
    </script>
</body>
</html>